P-value | ln(P) | Term | GO Tree | GO ID | # of Genes in Term | # of Target Genes in Term | # of Total Genes | # of Target Genes | Common Genes |
1.790e-08 | -17.84 | lymph_node | COSMIC cancer mutations | lymph_node | 1703 | 20 | 16828 | 49 |
DTNA,NRG3,TRPS1,PRKG1,CTNND2,NAV2,DCLK1,LSAMP,SOX5,DPP10,LIFR,PCDH9,ERBB4,CAMK2G,TRPM3,SLC39A11,RYR3,WDR49,RPS6KA2,ARAP2 |
4.446e-08 | -16.93 | mantle_cell_lymphoma | COSMIC cancer mutations | mantle_cell_lymphoma | 2849 | 25 | 16828 | 49 |
PPP2R2B,ABR,WDR49,RYR3,SLC39A11,RFX4,DST,ADCY2,ERBB4,LIFR,SLC1A2,SOX5,IQCA1,NAV2,HIF3A,PRKG1,NRG3,TRPM3,PCDH9,LSAMP,HPSE2,DAAM2,FMN2,CTNND2,TRPS1 |
9.120e-08 | -16.21 | haematopoietic_and_lymphoid_tissue-lymph_node-lymphoid_neoplasm-mantle_cell_lymphoma | COSMIC cancer mutations | haematopoietic_and_lymphoid_tissue-lymph_node-lymphoid_neoplasm-mantle_cell_lymphoma | 476 | 11 | 16828 | 49 |
NRG3,RYR3,PRKG1,WDR49,SLC39A11,CTNND2,NAV2,LSAMP,PCDH9,ERBB4,TRPM3 |
1.057e-07 | -16.06 | haematopoietic_and_lymphoid_tissue-haematopoietic_neoplasm-myelodysplastic_syndrome | COSMIC cancer mutations | haematopoietic_and_lymphoid_tissue-haematopoietic_neoplasm-myelodysplastic_syndrome | 1174 | 16 | 16828 | 49 |
ERBB4,ADCY2,CAMK2G,LSAMP,DCLK1,SOX5,SLC1A2,BMPR1B,NPAS3,NAV2,HPSE2,NRG3,PRKG1,DCLK2,RPS6KA2,RYR3 |
1.057e-07 | -16.06 | myelodysplastic_syndrome | COSMIC cancer mutations | myelodysplastic_syndrome | 1174 | 16 | 16828 | 49 |
LSAMP,DCLK1,NPAS3,BMPR1B,SLC1A2,SOX5,CAMK2G,ADCY2,ERBB4,NRG3,PRKG1,HPSE2,NAV2,RYR3,DCLK2,RPS6KA2 |
1.451e-07 | -15.75 | chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma | COSMIC cancer mutations | chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma | 3511 | 27 | 16828 | 49 |
PITPNC1,MGAT4C,DAAM2,HPSE2,CTNND2,FMN2,BMPR1B,NPAS3,PCDH9,LSAMP,DCLK1,TRPM3,RYR3,PPP2R2B,ABR,MSI2,PRKG1,NRG3,DTNA,NAV2,MACF1,LIFR,IQCA1,DST,TNRC6A,ADCY2,ERBB4 |
1.451e-07 | -15.75 | haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm-chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma | COSMIC cancer mutations | haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm-chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma | 3511 | 27 | 16828 | 49 |
RYR3,PPP2R2B,ABR,MSI2,PRKG1,NRG3,DTNA,MACF1,NAV2,LIFR,IQCA1,DST,ADCY2,ERBB4,TNRC6A,PITPNC1,MGAT4C,HPSE2,DAAM2,FMN2,CTNND2,PCDH9,NPAS3,BMPR1B,DCLK1,LSAMP,TRPM3 |
2.171e-07 | -15.34 | central nervous system development | biological process | GO:0007417 | 995 | 14 | 18204 | 49 |
ERBB4,GFAP,NAV2,PCDH9,DCLK2,NRG3,PRKG1,DCLK1,DAAM2,QKI,RFX4,SLC1A2,MSI2,BMPR1B |
2.627e-07 | -15.15 | SYNM (synemin) | protein interactions | 23336 | 54 | 5 | 19454 | 50 |
ERBB4,TNRC6A,PPP2R2B,DTNA,GFAP |
2.894e-07 | -15.06 | chondroblastoma | COSMIC cancer mutations | chondroblastoma | 534 | 11 | 16828 | 49 |
SLC39A11,PRKG1,RYR3,NRG3,CTNND2,FMN2,SOX5,PCDH9,LSAMP,PPP2R2B,ADCY2 |
8.499e-07 | -13.98 | trunk | COSMIC cancer mutations | trunk | 3554 | 26 | 16828 | 49 |
RPS6KA2,ARAP2,MGAT4C,TRPS1,HPSE2,CTNND2,NPAS3,PCDH9,DPP10,LSAMP,DCLK1,RYR3,DCLK2,PPP2R2B,GLIS3,CDH20,ABR,NRG3,MACF1,SLC14A1,HIF3A,LIFR,SOX5,DST,ERBB4,TNRC6A |
1.189e-06 | -13.64 | upper_aerodigestive_tract-mouth-carcinoma-squamous_cell_carcinoma | COSMIC cancer mutations | upper_aerodigestive_tract-mouth-carcinoma-squamous_cell_carcinoma | 6953 | 37 | 16828 | 49 |
FMN2,CTNND2,NTM,DAAM2,TRPS1,TRPM3,SORBS1,DCLK1,LSAMP,PCDH9,RPS6KA2,ARAP2,MGAT4C,PITPNC1,HIF3A,MACF1,NAV2,NRG3,GFAP,DTNA,PRKG1,CAMK2G,ADCY2,ERBB4,DST,SOX5,SLC1A2,DCLK2,RFX4,WDR49,RYR3,SLC39A11,ABR,CDH20,QKI,PPP2R2B,SLC25A18 |
1.565e-06 | -13.37 | nervous system development | biological process | GO:0007399 | 2185 | 19 | 18204 | 49 |
QKI,MSI2,BMPR1B,SOX5,CAMK2G,LSAMP,RFX4,SLC1A2,NAV2,ERBB4,GFAP,PRKG1,CTNND2,DCLK1,DAAM2,PCDH9,DCLK2,NRG3,NTM |
1.845e-06 | -13.20 | prostate-carcinoma | COSMIC cancer mutations | prostate-carcinoma | 9000 | 42 | 16828 | 49 |
FMN2,CTNND2,NTM,HPSE2,DAAM2,TRPS1,SORBS1,TRPM3,DCLK1,LSAMP,NPAS3,PCDH9,DPP10,BMPR1B,RPS6KA2,ARAP2,PITPNC1,HIF3A,MACF1,NAV2,SLC14A1,DTNA,NRG3,MSI2,PRKG1,ADCY2,ERBB4,DST,LIFR,SLC1A2,SOX5,DCLK2,RFX4,RYR3,WDR49,SLC39A11,CDH20,ABR,QKI,GLIS3,PPP2R2B,SLC25A18 |
2.070e-06 | -13.09 | LCK (LCK proto-oncogene, Src family tyrosine kinase) | protein interactions | 3932 | 455 | 9 | 19454 | 50 |
ERBB4,ARAP2,FMN2,CTNND2,MACF1,DTNA,SLC25A18,DST,CAMK2G |
2.232e-06 | -13.01 | central_nervous_system-brain-primitive_neuroectodermal_tumour-medulloblastoma-large_cell | COSMIC cancer mutations | central_nervous_system-brain-primitive_neuroectodermal_tumour-medulloblastoma-large_cell | 1117 | 14 | 16828 | 49 |
FMN2,NAV2,NRG3,PRKG1,ERBB4,TNRC6A,ADCY2,DST,SOX5,SLC1A2,RYR3,CDH20,ABR,QKI |
2.259e-06 | -13.00 | haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm-mantle_cell_lymphoma | COSMIC cancer mutations | haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm-mantle_cell_lymphoma | 2737 | 22 | 16828 | 49 |
IQCA1,SOX5,SLC1A2,LIFR,ERBB4,ADCY2,DST,NRG3,PRKG1,HIF3A,NAV2,ABR,PPP2R2B,RFX4,RYR3,LSAMP,PCDH9,TRPS1,CTNND2,FMN2,DAAM2,HPSE2 |
3.494e-06 | -12.56 | haematopoietic_and_lymphoid_tissue-haematopoietic_neoplasm-acute_myeloid_leukaemia_therapy_related | COSMIC cancer mutations | haematopoietic_and_lymphoid_tissue-haematopoietic_neoplasm-acute_myeloid_leukaemia_therapy_related | 1523 | 16 | 16828 | 49 |
RYR3,SLC39A11,QKI,PPP2R2B,PRKG1,NRG3,HPSE2,NAV2,FMN2,CTNND2,PCDH9,SOX5,LSAMP,ADCY2,TNRC6A,ERBB4 |
3.494e-06 | -12.56 | acute_myeloid_leukaemia_therapy_related | COSMIC cancer mutations | acute_myeloid_leukaemia_therapy_related | 1523 | 16 | 16828 | 49 |
SLC39A11,RYR3,QKI,PPP2R2B,PRKG1,NRG3,NAV2,HPSE2,CTNND2,FMN2,SOX5,PCDH9,LSAMP,TNRC6A,ADCY2,ERBB4 |
3.596e-06 | -12.54 | intestinal_adenocarcinoma | COSMIC cancer mutations | intestinal_adenocarcinoma | 7225 | 37 | 16828 | 49 |
ARAP2,PITPNC1,AQP4,RPS6KA2,TRPM3,DCLK1,LSAMP,PCDH9,NPAS3,DPP10,FMN2,NTM,CTNND2,HPSE2,DAAM2,TRPS1,CDH20,ABR,QKI,DCLK2,RFX4,RYR3,WDR49,TNRC6A,ERBB4,ADCY2,DST,IQCA1,LIFR,SLC1A2,SOX5,MACF1,SLC14A1,NAV2,NRG3,GFAP,PRKG1 |
3.596e-06 | -12.54 | stomach-carcinoma-intestinal_adenocarcinoma | COSMIC cancer mutations | stomach-carcinoma-intestinal_adenocarcinoma | 7225 | 37 | 16828 | 49 |
TRPM3,DCLK1,LSAMP,DPP10,NPAS3,PCDH9,NTM,CTNND2,FMN2,DAAM2,HPSE2,TRPS1,ARAP2,PITPNC1,AQP4,RPS6KA2,ADCY2,TNRC6A,ERBB4,DST,IQCA1,SLC1A2,SOX5,LIFR,SLC14A1,NAV2,MACF1,NRG3,GFAP,PRKG1,CDH20,ABR,QKI,DCLK2,RFX4,RYR3,WDR49 |
4.752e-06 | -12.26 | brainstem | COSMIC cancer mutations | brainstem | 3102 | 23 | 16828 | 49 |
ARAP2,LSAMP,DCLK1,NPAS3,PCDH9,CTNND2,FMN2,HPSE2,CDH20,QKI,PPP2R2B,WDR49,RYR3,TNRC6A,ADCY2,ERBB4,SLC1A2,SOX5,LIFR,SLC14A1,NAV2,NRG3,PRKG1 |
9.417e-06 | -11.57 | haematopoietic_and_lymphoid_tissue-haematopoietic_neoplasm | COSMIC cancer mutations | haematopoietic_and_lymphoid_tissue-haematopoietic_neoplasm | 764 | 11 | 16828 | 49 |
SOX5,SLC1A2,PCDH9,LSAMP,ERBB4,ADCY2,SLC39A11,RYR3,NRG3,NAV2,HPSE2 |
1.002e-05 | -11.51 | cerebellum | COSMIC cancer mutations | cerebellum | 769 | 11 | 16828 | 49 |
HPSE2,CTNND2,PRKG1,RYR3,NRG3,QKI,ERBB4,DPP10,PCDH9,NPAS3,IQCA1 |
1.114e-05 | -11.41 | central_nervous_system-brainstem-glioma-astrocytoma_Grade_IV | COSMIC cancer mutations | central_nervous_system-brainstem-glioma-astrocytoma_Grade_IV | 2531 | 20 | 16828 | 49 |
NRG3,PRKG1,CTNND2,FMN2,SLC14A1,NAV2,HPSE2,DCLK1,LSAMP,SOX5,PCDH9,LIFR,ERBB4,ADCY2,WDR49,RYR3,CDH20,ARAP2,PPP2R2B,QKI |
1.199e-05 | -11.33 | forebrain development | biological process | GO:0030900 | 408 | 8 | 18204 | 49 |
ERBB4,DCLK1,PRKG1,NRG3,SLC1A2,RFX4,DCLK2,PCDH9 |
1.413e-05 | -11.17 | haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm-Burkitt_lymphoma | COSMIC cancer mutations | haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm-Burkitt_lymphoma | 2119 | 18 | 16828 | 49 |
PPP2R2B,RFX4,WDR49,RYR3,LSAMP,NPAS3,PCDH9,SOX5,BMPR1B,SLC1A2,ADCY2,ERBB4,NRG3,PRKG1,FMN2,CTNND2,HPSE2,NAV2 |
1.413e-05 | -11.17 | Burkitt_lymphoma | COSMIC cancer mutations | Burkitt_lymphoma | 2119 | 18 | 16828 | 49 |
NRG3,PRKG1,CTNND2,FMN2,NAV2,HPSE2,LSAMP,SLC1A2,SOX5,BMPR1B,NPAS3,PCDH9,ADCY2,ERBB4,RFX4,RYR3,WDR49,PPP2R2B |
1.450e-05 | -11.14 | diffuse_adenocarcinoma | COSMIC cancer mutations | diffuse_adenocarcinoma | 4383 | 27 | 16828 | 49 |
MGAT4C,ARAP2,TRPS1,DAAM2,CTNND2,FMN2,DPP10,PCDH9,DCLK1,TRPM3,SLC39A11,WDR49,RYR3,RFX4,QKI,GLIS3,PRKG1,NRG3,DTNA,NAV2,MACF1,HIF3A,SOX5,LIFR,DST,ERBB4,ADCY2 |
1.450e-05 | -11.14 | stomach-carcinoma-diffuse_adenocarcinoma | COSMIC cancer mutations | stomach-carcinoma-diffuse_adenocarcinoma | 4383 | 27 | 16828 | 49 |
SOX5,LIFR,ADCY2,ERBB4,DST,DTNA,NRG3,PRKG1,HIF3A,NAV2,MACF1,GLIS3,QKI,RFX4,SLC39A11,RYR3,WDR49,DCLK1,DPP10,PCDH9,TRPM3,TRPS1,CTNND2,FMN2,DAAM2,MGAT4C,ARAP2 |
1.492e-05 | -11.11 | astrocyte projection | cellular component | GO:0097449 | 19 | 3 | 19108 | 49 |
GFAP,AQP4,SLC1A2 |
1.509e-05 | -11.10 | central_nervous_system-cerebellum-primitive_neuroectodermal_tumour-medulloblastoma-SHH_subtype | COSMIC cancer mutations | central_nervous_system-cerebellum-primitive_neuroectodermal_tumour-medulloblastoma-SHH_subtype | 653 | 10 | 16828 | 49 |
PCDH9,NPAS3,DPP10,IQCA1,ERBB4,RYR3,PRKG1,NRG3,HPSE2,CTNND2 |
1.529e-05 | -11.09 | SHH_subtype | COSMIC cancer mutations | SHH_subtype | 654 | 10 | 16828 | 49 |
RYR3,PRKG1,NRG3,HPSE2,CTNND2,DPP10,NPAS3,PCDH9,IQCA1,ERBB4 |
1.804e-05 | -10.92 | diffuse_large_B_cell_lymphoma | COSMIC cancer mutations | diffuse_large_B_cell_lymphoma | 4151 | 26 | 16828 | 49 |
AQP4,ARAP2,TRPS1,HPSE2,FMN2,CTNND2,PCDH9,DPP10,LSAMP,RYR3,WDR49,SLC39A11,QKI,PPP2R2B,CDH20,PRKG1,DTNA,NRG3,MACF1,NAV2,LIFR,SLC1A2,SOX5,DST,ADCY2,ERBB4 |
2.023e-05 | -10.81 | aspartate transmembrane transport | biological process | GO:0015810 | 20 | 3 | 18204 | 49 |
SLC25A18,SLC1A2,GFAP |
2.045e-05 | -10.80 | SR_plectin_7 | pfam domains | PF21097 | 3 | 2 | 17795 | 47 |
DST,MACF1 |
2.198e-05 | -10.73 | skin-trunk-malignant_melanoma | COSMIC cancer mutations | skin-trunk-malignant_melanoma | 2647 | 20 | 16828 | 49 |
RPS6KA2,RYR3,CDH20,ABR,ARAP2,PPP2R2B,MGAT4C,CTNND2,HPSE2,SLC14A1,NRG3,TRPS1,ERBB4,DST,LSAMP,DCLK1,LIFR,PCDH9,DPP10,SOX5 |
2.973e-05 | -10.42 | lymphoid_neoplasm | COSMIC cancer mutations | lymphoid_neoplasm | 12233 | 47 | 16828 | 49 |
MGAT4C,ARAP2,NTM,DAAM2,HPSE2,TRPS1,TRPM3,SORBS1,DPP10,BMPR1B,NPAS3,RYR3,WDR49,ABR,CDH20,PPP2R2B,MACF1,GFAP,DTNA,ERBB4,ADCY2,TNRC6A,DST,SLC1A2,LIFR,AQP4,RPS6KA2,PITPNC1,CTNND2,FMN2,LSAMP,DCLK1,PCDH9,DCLK2,RFX4,SLC39A11,GLIS3,QKI,SLC25A18,HIF3A,NAV2,NRG3,PRKG1,MSI2,CAMK2G,IQCA1,SOX5 |
3.062e-05 | -10.39 | oesophagus-carcinoma | COSMIC cancer mutations | oesophagus-carcinoma | 4269 | 26 | 16828 | 49 |
SORBS1,TRPM3,DCLK1,DPP10,PCDH9,CTNND2,NTM,FMN2,DAAM2,PTGDS,HPSE2,TRPS1,ARAP2,RPS6KA2,ADCY2,TNRC6A,SOX5,LIFR,HIF3A,MACF1,NRG3,PRKG1,CDH20,PPP2R2B,RFX4,RYR3 |
3.292e-05 | -10.32 | upper_aerodigestive_tract-mouth-carcinoma | COSMIC cancer mutations | upper_aerodigestive_tract-mouth-carcinoma | 6426 | 33 | 16828 | 49 |
SLC25A18,CDH20,ABR,QKI,PPP2R2B,RFX4,SLC39A11,RYR3,SLC1A2,SOX5,LIFR,ADCY2,ERBB4,DST,GFAP,NRG3,PRKG1,HIF3A,NAV2,MACF1,PITPNC1,MGAT4C,ARAP2,DCLK1,NPAS3,TRPM3,SORBS1,TRPS1,NTM,CTNND2,FMN2,DAAM2,HPSE2 |
3.403e-05 | -10.29 | Prot_kinase_dom | interpro domains | IPR000719 | 480 | 8 | 18521 | 49 |
PRKG1,DCLK1,RPS6KA2,DCLK2,BMPR1B,TTN,ERBB4,CAMK2G |
3.684e-05 | -10.21 | mouth | COSMIC cancer mutations | mouth | 9004 | 40 | 16828 | 49 |
DST,ADCY2,ERBB4,CAMK2G,SLC1A2,SOX5,LIFR,NAV2,MACF1,HIF3A,PRKG1,GFAP,DTNA,NRG3,QKI,PPP2R2B,CDH20,ABR,SLC25A18,DCLK2,SLC39A11,RYR3,WDR49,RFX4,SORBS1,TRPM3,NPAS3,PCDH9,DCLK1,LSAMP,DAAM2,HPSE2,NTM,CTNND2,FMN2,TRPS1,MGAT4C,ARAP2,PITPNC1,RPS6KA2 |
4.062e-05 | -10.11 | testis | COSMIC cancer mutations | testis | 733 | 10 | 16828 | 49 |
BMPR1B,DCLK1,ABR,CAMK2G,ERBB4,PRKG1,TRPS1,RPS6KA2,MACF1,DCLK2 |
4.083e-05 | -10.11 | Spectrin_4 | pfam domains | PF21020 | 4 | 2 | 17795 | 47 |
MACF1,DST |
4.083e-05 | -10.11 | Spectrin_2 | pfam domains | PF18373 | 4 | 2 | 17795 | 47 |
DST,MACF1 |
4.083e-05 | -10.11 | Spectrin_3 | pfam domains | PF21019 | 4 | 2 | 17795 | 47 |
MACF1,DST |
4.100e-05 | -10.10 | Desmoplakin_Spectrin-like | interpro domains | IPR041573 | 4 | 2 | 18521 | 49 |
DST,MACF1 |
4.100e-05 | -10.10 | PCN-like_spectrin-like_rpt | interpro domains | IPR049538 | 4 | 2 | 18521 | 49 |
MACF1,DST |
4.105e-05 | -10.10 | oesophagus-carcinoma-squamous_cell_carcinoma | COSMIC cancer mutations | oesophagus-carcinoma-squamous_cell_carcinoma | 6486 | 33 | 16828 | 49 |
DCLK2,RYR3,GLIS3,ABR,SLC25A18,MACF1,NAV2,HIF3A,PRKG1,NRG3,DST,ADCY2,ERBB4,LIFR,SOX5,IQCA1,RPS6KA2,AQP4,ARAP2,MGAT4C,PITPNC1,HPSE2,DAAM2,FMN2,CTNND2,TRPS1,TRPM3,SORBS1,NPAS3,PCDH9,DPP10,BMPR1B,DCLK1 |
4.265e-05 | -10.06 | system development | biological process | GO:0048731 | 3533 | 22 | 18204 | 49 |
MSI2,BMPR1B,SOX5,CAMK2G,LSAMP,HIF3A,SLC1A2,RFX4,TRPS1,TTN,QKI,CTNND2,DCLK1,PRKG1,DAAM2,PCDH9,NRG3,NTM,DCLK2,NAV2,GFAP,ERBB4 |
4.447e-05 | -10.02 | Nuclear signaling by ERBB4 | REACTOME pathways | R-HSA-1251985 | 25 | 3 | 10285 | 29 |
ERBB4,GFAP,NRG3 |
4.562e-05 | -10.00 | C4-dicarboxylate transport | biological process | GO:0015740 | 26 | 3 | 18204 | 49 |
GFAP,SLC1A2,SLC25A18 |
4.681e-05 | -9.97 | central_nervous_system-brain-primitive_neuroectodermal_tumour-medulloblastoma | COSMIC cancer mutations | central_nervous_system-brain-primitive_neuroectodermal_tumour-medulloblastoma | 7205 | 35 | 16828 | 49 |
PITPNC1,ARAP2,RPS6KA2,PCDH9,NPAS3,DPP10,LSAMP,TRPM3,SORBS1,TRPS1,HPSE2,DAAM2,FMN2,CTNND2,NTM,PPP2R2B,GLIS3,QKI,ABR,RYR3,WDR49,SLC39A11,RFX4,DCLK2,LIFR,SLC1A2,SOX5,DST,ADCY2,ERBB4,TNRC6A,PRKG1,NRG3,MACF1,NAV2 |
5.002e-05 | -9.90 | LRRC7 (leucine rich repeat containing 7) | protein interactions | 57554 | 28 | 3 | 19454 | 50 |
CTNND2,CAMK2G,ERBB4 |
5.007e-05 | -9.90 | acute_lymphoblastic_B_cell_leukaemia | COSMIC cancer mutations | acute_lymphoblastic_B_cell_leukaemia | 3828 | 24 | 16828 | 49 |
GLIS3,PPP2R2B,SLC39A11,RYR3,WDR49,SLC1A2,SOX5,LIFR,DST,ERBB4,ADCY2,PRKG1,NRG3,NAV2,HIF3A,MGAT4C,BMPR1B,PCDH9,LSAMP,DAAM2,HPSE2,CTNND2,NTM,FMN2 |
5.007e-05 | -9.90 | haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm-acute_lymphoblastic_B_cell_leukaemia | COSMIC cancer mutations | haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm-acute_lymphoblastic_B_cell_leukaemia | 3828 | 24 | 16828 | 49 |
MGAT4C,LSAMP,BMPR1B,PCDH9,NTM,CTNND2,FMN2,DAAM2,HPSE2,PPP2R2B,GLIS3,SLC39A11,WDR49,RYR3,ERBB4,ADCY2,DST,SOX5,SLC1A2,LIFR,HIF3A,NAV2,NRG3,PRKG1 |
5.552e-05 | -9.80 | KLHL15 (kelch like family member 15) | protein interactions | 80311 | 81 | 4 | 19454 | 50 |
DCLK2,DCLK1,PPP2R2B,TNRC6A |
5.633e-05 | -9.78 | Protein_kinase_ATP_BS | interpro domains | IPR017441 | 377 | 7 | 18521 | 49 |
CAMK2G,DCLK2,RPS6KA2,BMPR1B,DCLK1,PRKG1,ERBB4 |
6.170e-05 | -9.69 | - | gene3d domains | 1.20.58.1060 | 4 | 2 | 14470 | 47 |
DST,MACF1 |
6.236e-05 | -9.68 | haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm-diffuse_large_B_cell_lymphoma | COSMIC cancer mutations | haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm-diffuse_large_B_cell_lymphoma | 3608 | 23 | 16828 | 49 |
CDH20,PPP2R2B,QKI,SLC39A11,WDR49,RYR3,ERBB4,ADCY2,DST,SOX5,SLC1A2,LIFR,NAV2,MACF1,NRG3,PRKG1,ARAP2,AQP4,LSAMP,PCDH9,CTNND2,FMN2,HPSE2 |
6.236e-05 | -9.68 | Kinase-like_dom_sf | interpro domains | IPR011009 | 523 | 8 | 18521 | 49 |
TTN,BMPR1B,DCLK2,RPS6KA2,DCLK1,PRKG1,ERBB4,CAMK2G |
6.710e-05 | -9.61 | bronchioloalveolar_adenocarcinoma | COSMIC cancer mutations | bronchioloalveolar_adenocarcinoma | 778 | 10 | 16828 | 49 |
DCLK1,SOX5,BMPR1B,ERBB4,ADCY2,CAMK2G,PRKG1,DCLK2,CTNND2,RPS6KA2 |
6.710e-05 | -9.61 | lung-carcinoma-bronchioloalveolar_adenocarcinoma | COSMIC cancer mutations | lung-carcinoma-bronchioloalveolar_adenocarcinoma | 778 | 10 | 16828 | 49 |
DCLK1,BMPR1B,SOX5,ADCY2,ERBB4,CAMK2G,PRKG1,CTNND2,DCLK2,RPS6KA2 |
6.826e-05 | -9.59 | RYR1 (ryanodine receptor 1) | protein interactions | 6261 | 31 | 3 | 19454 | 50 |
CAMK2G,PRKG1,TTN |
7.061e-05 | -9.56 | D-aspartate import across plasma membrane | biological process | GO:0070779 | 5 | 2 | 18204 | 49 |
SLC1A2,GFAP |
7.061e-05 | -9.56 | D-aspartate transmembrane transport | biological process | GO:0070777 | 5 | 2 | 18204 | 49 |
GFAP,SLC1A2 |
7.377e-05 | -9.51 | testis-germ_cell_tumour-non_seminoma | COSMIC cancer mutations | testis-germ_cell_tumour-non_seminoma | 487 | 8 | 16828 | 49 |
DCLK1,BMPR1B,ERBB4,CAMK2G,PRKG1,DCLK2,RPS6KA2,MACF1 |
7.827e-05 | -9.46 | multicellular organism development | biological process | GO:0007275 | 3957 | 23 | 18204 | 49 |
ERBB4,NAV2,NRG3,PCDH9,DAAM2,DCLK1,PRKG1,TTN,SLC1A2,RFX4,LSAMP,CAMK2G,SOX5,BMPR1B,MSI2,GFAP,NTM,DCLK2,CTNND2,CDH20,QKI,TRPS1,HIF3A |
7.923e-05 | -9.44 | non_seminoma | COSMIC cancer mutations | non_seminoma | 492 | 8 | 16828 | 49 |
BMPR1B,DCLK1,CAMK2G,ERBB4,PRKG1,MACF1,RPS6KA2,DCLK2 |
7.933e-05 | -9.44 | haematopoietic_and_lymphoid_tissue-haematopoietic_neoplasm-mast_cell_neoplasm | COSMIC cancer mutations | haematopoietic_and_lymphoid_tissue-haematopoietic_neoplasm-mast_cell_neoplasm | 248 | 6 | 16828 | 49 |
ADCY2,ERBB4,HPSE2,NRG3,PCDH9,NPAS3 |
7.933e-05 | -9.44 | mast_cell_neoplasm | COSMIC cancer mutations | mast_cell_neoplasm | 248 | 6 | 16828 | 49 |
ERBB4,ADCY2,PCDH9,NPAS3,HPSE2,NRG3 |
9.079e-05 | -9.31 | upper_aerodigestive_tract | COSMIC cancer mutations | upper_aerodigestive_tract | 13181 | 48 | 16828 | 49 |
NPAS3,DPP10,BMPR1B,TRPM3,SORBS1,TRPS1,NTM,HPSE2,PTGDS,DAAM2,ARAP2,MGAT4C,LIFR,SLC1A2,ADCY2,TNRC6A,ERBB4,DST,GFAP,DTNA,MACF1,CDH20,ABR,PPP2R2B,RYR3,WDR49,DCLK1,LSAMP,PCDH9,FMN2,CTNND2,PITPNC1,RPS6KA2,IQCA1,SOX5,CAMK2G,NRG3,PRKG1,MSI2,HIF3A,SLC14A1,NAV2,SLC25A18,GLIS3,QKI,RFX4,SLC39A11,DCLK2 |
9.096e-05 | -9.31 | testis-germ_cell_tumour-seminoma | COSMIC cancer mutations | testis-germ_cell_tumour-seminoma | 648 | 9 | 16828 | 49 |
DCLK1,BMPR1B,ABR,CAMK2G,ERBB4,PRKG1,TRPS1,DCLK2,RPS6KA2 |
9.632e-05 | -9.25 | skin-ear-carcinoma-squamous_cell_carcinoma | COSMIC cancer mutations | skin-ear-carcinoma-squamous_cell_carcinoma | 506 | 8 | 16828 | 49 |
MGAT4C,TNRC6A,NPAS3,LIFR,DPP10,RPS6KA2,SLC14A1,PRKG1 |
1.017e-04 | -9.19 | GAS2 | pfam domains | PF02187 | 6 | 2 | 17795 | 47 |
DST,MACF1 |
1.017e-04 | -9.19 | SH3_10 | pfam domains | PF17902 | 6 | 2 | 17795 | 47 |
DST,MACF1 |
1.017e-04 | -9.19 | Plectin | pfam domains | PF00681 | 6 | 2 | 17795 | 47 |
DST,MACF1 |
1.022e-04 | -9.19 | Desmoplakin_SH3 | interpro domains | IPR041615 | 6 | 2 | 18521 | 49 |
MACF1,DST |
1.022e-04 | -9.19 | GAR_dom | interpro domains | IPR003108 | 6 | 2 | 18521 | 49 |
DST,MACF1 |
1.022e-04 | -9.19 | GAR_dom_sf | interpro domains | IPR036534 | 6 | 2 | 18521 | 49 |
MACF1,DST |
1.046e-04 | -9.17 | pharynx | COSMIC cancer mutations | pharynx | 2696 | 19 | 16828 | 49 |
QKI,PITPNC1,RPS6KA2,RYR3,WDR49,RFX4,DST,SORBS1,DPP10,SLC1A2,PCDH9,NPAS3,SLC14A1,DAAM2,MACF1,CTNND2,FMN2,NRG3,DTNA |
1.057e-04 | -9.15 | ERBB4-ERBB4 signaling pathway | biological process | GO:0038138 | 6 | 2 | 18204 | 49 |
ERBB4,NRG3 |
1.057e-04 | -9.15 | D-amino acid transport | biological process | GO:0042940 | 6 | 2 | 18204 | 49 |
SLC1A2,GFAP |
1.158e-04 | -9.06 | glial cell projection | cellular component | GO:0097386 | 37 | 3 | 19108 | 49 |
SLC1A2,AQP4,GFAP |
1.317e-04 | -8.94 | skin-face-carcinoma-squamous_cell_carcinoma | COSMIC cancer mutations | skin-face-carcinoma-squamous_cell_carcinoma | 2036 | 16 | 16828 | 49 |
LSAMP,PCDH9,DPP10,ERBB4,DST,TRPM3,NRG3,GFAP,MSI2,TRPS1,FMN2,MACF1,NAV2,PPP2R2B,AQP4,RPS6KA2 |
1.350e-04 | -8.91 | AFDN (afadin, adherens junction formation factor) | protein interactions | 4301 | 309 | 6 | 19454 | 50 |
DCLK1,SORBS1,DTNA,TNRC6A,MACF1,DST |
1.382e-04 | -8.89 | PROTEIN_KINASE_DOM | prosite domains | PS50011 | 480 | 8 | 12186 | 40 |
CAMK2G,RPS6KA2,TTN,PRKG1,DCLK2,ERBB4,DCLK1,BMPR1B |
1.428e-04 | -8.85 | Plectin_repeat | interpro domains | IPR001101 | 7 | 2 | 18521 | 49 |
MACF1,DST |
1.428e-04 | -8.85 | Plakin_repeat_sf | interpro domains | IPR035915 | 7 | 2 | 18521 | 49 |
MACF1,DST |
1.437e-04 | -8.85 | protein serine/threonine kinase activity | molecular function | GO:0004674 | 428 | 7 | 18094 | 49 |
BMPR1B,CAMK2G,DCLK2,PRKG1,TTN,RPS6KA2,DCLK1 |
1.449e-04 | -8.84 | protein kinase activity | molecular function | GO:0004672 | 577 | 8 | 18094 | 49 |
BMPR1B,DCLK2,CAMK2G,TTN,PRKG1,DCLK1,ERBB4,RPS6KA2 |
1.490e-04 | -8.81 | FLOT1 (flotillin 1) | protein interactions | 10211 | 453 | 7 | 19454 | 50 |
SORBS1,DTNA,SLC14A1,MACF1,FMN2,SOX5,DST |
1.495e-04 | -8.81 | ovary-carcinoma-serous_carcinoma | COSMIC cancer mutations | ovary-carcinoma-serous_carcinoma | 10710 | 43 | 16828 | 49 |
SOX5,IQCA1,CAMK2G,MSI2,PRKG1,NRG3,NAV2,GLIS3,QKI,SLC39A11,DCLK2,PCDH9,DCLK1,LSAMP,FMN2,CTNND2,RPS6KA2,LIFR,SLC1A2,DST,ADCY2,TNRC6A,ERBB4,DTNA,GFAP,MACF1,PPP2R2B,CDH20,ABR,WDR49,RYR3,NPAS3,BMPR1B,DPP10,SORBS1,TRPM3,TRPS1,HPSE2,PTGDS,DAAM2,NTM,ARAP2,MGAT4C |
1.536e-04 | -8.78 | Plakin repeat | gene3d domains | 3.90.1290.10 | 6 | 2 | 14470 | 47 |
MACF1,DST |
1.536e-04 | -8.78 | Gas2-like domain | gene3d domains | 3.30.920.20 | 6 | 2 | 14470 | 47 |
MACF1,DST |
1.544e-04 | -8.78 | Ser/Thr_kinase_AS | interpro domains | IPR008271 | 308 | 6 | 18521 | 49 |
CAMK2G,PRKG1,DCLK1,BMPR1B,DCLK2,RPS6KA2 |
1.563e-04 | -8.76 | GAR | prosite domains | PS51460 | 6 | 2 | 12186 | 40 |
DST,MACF1 |
1.604e-04 | -8.74 | Transferase(Phosphotransferase) domain 1 | gene3d domains | 1.10.510.10 | 490 | 8 | 14470 | 47 |
CAMK2G,DCLK2,TTN,PRKG1,RPS6KA2,BMPR1B,DCLK1,ERBB4 |
1.608e-04 | -8.74 | kidney-Wilms_tumour | COSMIC cancer mutations | kidney-Wilms_tumour | 545 | 8 | 16828 | 49 |
PRKG1,RPS6KA2,FMN2,DCLK2,BMPR1B,DCLK1,CAMK2G,ERBB4 |
1.627e-04 | -8.72 | TIAM1 (TIAM Rac1 associated GEF 1) | protein interactions | 7074 | 201 | 5 | 19454 | 50 |
DCLK1,RYR3,CAMK2G,DTNA,DAAM2 |
1.628e-04 | -8.72 | Wilms_tumour | COSMIC cancer mutations | Wilms_tumour | 546 | 8 | 16828 | 49 |
RPS6KA2,DCLK2,FMN2,PRKG1,ERBB4,CAMK2G,BMPR1B,DCLK1 |
1.633e-04 | -8.72 | seminoma | COSMIC cancer mutations | seminoma | 700 | 9 | 16828 | 49 |
TRPS1,PRKG1,RPS6KA2,DCLK2,BMPR1B,DCLK1,ERBB4,CAMK2G,ABR |
1.644e-04 | -8.71 | germ_cell_tumour | COSMIC cancer mutations | germ_cell_tumour | 867 | 10 | 16828 | 49 |
PRKG1,TRPS1,DCLK2,MACF1,RPS6KA2,DCLK1,BMPR1B,ABR,CAMK2G,ERBB4 |
1.767e-04 | -8.64 | GAS2 | smart domains | SM00243 | 6 | 2 | 9717 | 34 |
MACF1,DST |
1.795e-04 | -8.63 | LHB (luteinizing hormone subunit beta) | protein interactions | 3972 | 8 | 2 | 19454 | 50 |
NTM,GFAP |
1.810e-04 | -8.62 | lung-carcinoma-small_cell_carcinoma | COSMIC cancer mutations | lung-carcinoma-small_cell_carcinoma | 9908 | 41 | 16828 | 49 |
DAAM2,HPSE2,CTNND2,NTM,FMN2,TRPS1,SORBS1,TRPM3,DPP10,BMPR1B,NPAS3,PCDH9,DCLK1,RPS6KA2,MGAT4C,ARAP2,PITPNC1,SLC14A1,NAV2,MACF1,HIF3A,PRKG1,MSI2,DTNA,NRG3,DST,ERBB4,TNRC6A,CAMK2G,SOX5,LIFR,DCLK2,SLC39A11,RYR3,WDR49,RFX4,QKI,PPP2R2B,ABR,CDH20,SLC25A18 |
1.838e-04 | -8.60 | small_cell_carcinoma | COSMIC cancer mutations | small_cell_carcinoma | 9913 | 41 | 16828 | 49 |
PITPNC1,ARAP2,MGAT4C,RPS6KA2,PCDH9,NPAS3,DPP10,BMPR1B,DCLK1,TRPM3,SORBS1,TRPS1,HPSE2,DAAM2,FMN2,NTM,CTNND2,SLC25A18,QKI,PPP2R2B,CDH20,ABR,WDR49,RYR3,SLC39A11,RFX4,DCLK2,LIFR,SOX5,DST,CAMK2G,TNRC6A,ERBB4,MSI2,PRKG1,NRG3,DTNA,MACF1,NAV2,SLC14A1,HIF3A |
1.844e-04 | -8.60 | Circadian entrainment | KEGG pathways | ko04713 | 96 | 4 | 7161 | 22 |
PRKG1,RYR3,CAMK2G,ADCY2 |
1.844e-04 | -8.60 | Circadian entrainment | KEGG pathways | hsa04713 | 96 | 4 | 7161 | 22 |
ADCY2,CAMK2G,RYR3,PRKG1 |
1.893e-04 | -8.57 | DCX | pfam domains | PF03607 | 8 | 2 | 17795 | 47 |
DCLK2,DCLK1 |
1.901e-04 | -8.57 | Plakin | interpro domains | IPR043197 | 8 | 2 | 18521 | 49 |
DST,MACF1 |
1.967e-04 | -8.53 | ERBB4 signaling pathway | biological process | GO:0038130 | 8 | 2 | 18204 | 49 |
ERBB4,NRG3 |
1.980e-04 | -8.53 | PROTEIN_KINASE_ATP | prosite domains | PS00107 | 377 | 7 | 12186 | 40 |
CAMK2G,RPS6KA2,DCLK1,BMPR1B,PRKG1,ERBB4,DCLK2 |
2.158e-04 | -8.44 | large_intestine-rectum | COSMIC cancer mutations | large_intestine-rectum | 569 | 8 | 16828 | 49 |
DCLK1,DST,ADCY2,ERBB4,PRKG1,TRPS1,DAAM2,FMN2 |
2.293e-04 | -8.38 | astrocyte end-foot | cellular component | GO:0097450 | 9 | 2 | 19108 | 49 |
AQP4,GFAP |
2.302e-04 | -8.38 | kidney-carcinoma-chromophobe_renal_cell_carcinoma | COSMIC cancer mutations | kidney-carcinoma-chromophobe_renal_cell_carcinoma | 430 | 7 | 16828 | 49 |
DCLK1,PRKG1,BMPR1B,CAMK2G,ERBB4,DCLK2,RPS6KA2 |
2.302e-04 | -8.38 | chromophobe_renal_cell_carcinoma | COSMIC cancer mutations | chromophobe_renal_cell_carcinoma | 430 | 7 | 16828 | 49 |
RPS6KA2,CAMK2G,ERBB4,DCLK2,PRKG1,BMPR1B,DCLK1 |
2.304e-04 | -8.38 | NEGR1 (neuronal growth regulator 1) | protein interactions | 257194 | 9 | 2 | 19454 | 50 |
NTM,LSAMP |
2.304e-04 | -8.38 | LSAMP (limbic system associated membrane protein) | protein interactions | 4045 | 9 | 2 | 19454 | 50 |
LSAMP,NTM |
2.306e-04 | -8.37 | Signaling by ERBB4 | REACTOME pathways | R-HSA-1236394 | 43 | 3 | 10285 | 29 |
NRG3,GFAP,ERBB4 |
2.355e-04 | -8.35 | face | COSMIC cancer mutations | face | 2139 | 16 | 16828 | 49 |
MSI2,TRPS1,GFAP,NRG3,MACF1,NAV2,FMN2,PCDH9,DPP10,LSAMP,DST,TRPM3,ERBB4,RPS6KA2,AQP4,PPP2R2B |
2.383e-04 | -8.34 | right_lower_lobe | COSMIC cancer mutations | right_lower_lobe | 5692 | 29 | 16828 | 49 |
SLC25A18,PPP2R2B,CDH20,RYR3,SLC39A11,LIFR,SOX5,ADCY2,TNRC6A,ERBB4,PRKG1,NRG3,DTNA,MACF1,NAV2,SLC14A1,ARAP2,MGAT4C,NPAS3,DPP10,LSAMP,DCLK1,TRPM3,SORBS1,TRPS1,HPSE2,FMN2,CTNND2,NTM |
2.383e-04 | -8.34 | lung-right_lower_lobe-carcinoma-adenocarcinoma | COSMIC cancer mutations | lung-right_lower_lobe-carcinoma-adenocarcinoma | 5692 | 29 | 16828 | 49 |
ARAP2,MGAT4C,FMN2,CTNND2,NTM,HPSE2,TRPS1,SORBS1,TRPM3,LSAMP,DCLK1,NPAS3,DPP10,RYR3,SLC39A11,CDH20,PPP2R2B,SLC25A18,MACF1,SLC14A1,NAV2,DTNA,NRG3,PRKG1,TNRC6A,ERBB4,ADCY2,LIFR,SOX5 |
2.439e-04 | -8.32 | Doublecortin_dom | interpro domains | IPR003533 | 9 | 2 | 18521 | 49 |
DCLK1,DCLK2 |
2.468e-04 | -8.31 | PLEC | smart domains | SM00250 | 7 | 2 | 9717 | 34 |
MACF1,DST |
2.790e-04 | -8.18 | superficial_spreading | COSMIC cancer mutations | superficial_spreading | 1110 | 11 | 16828 | 49 |
LIFR,ADCY2,ERBB4,SORBS1,PRKG1,NTM,CTNND2,MACF1,MGAT4C,ARAP2,PPP2R2B |
2.829e-04 | -8.17 | Signalling by NGF | REACTOME pathways | R-HSA-166520 | 477 | 7 | 10285 | 29 |
TNRC6A,NRG3,ADCY2,RPS6KA2,CAMK2G,ERBB4,ABR |
2.833e-04 | -8.17 | carcinoid-endocrine_tumour | COSMIC cancer mutations | carcinoid-endocrine_tumour | 7752 | 35 | 16828 | 49 |
SOX5,SLC1A2,LIFR,DST,ERBB4,ADCY2,TNRC6A,CAMK2G,PRKG1,NRG3,NAV2,MACF1,SLC25A18,PPP2R2B,GLIS3,QKI,ABR,CDH20,SLC39A11,RYR3,WDR49,RFX4,DCLK2,BMPR1B,DPP10,PCDH9,DCLK1,LSAMP,TRPM3,TRPS1,HPSE2,CTNND2,FMN2,ARAP2,RPS6KA2 |
2.880e-04 | -8.15 | Pkinase | pfam domains | PF00069 | 347 | 6 | 17795 | 47 |
DCLK2,PRKG1,RPS6KA2,CAMK2G,DCLK1,TTN |
2.894e-04 | -8.15 | autonomic_ganglia-neuroblastoma | COSMIC cancer mutations | autonomic_ganglia-neuroblastoma | 3970 | 23 | 16828 | 49 |
PITPNC1,ARAP2,AQP4,PCDH9,NPAS3,DPP10,TRPS1,FMN2,CTNND2,GLIS3,WDR49,RYR3,RFX4,SLC1A2,IQCA1,CAMK2G,ERBB4,TNRC6A,ADCY2,PRKG1,MACF1,NAV2,HIF3A |
2.905e-04 | -8.14 | neuroblastoma | COSMIC cancer mutations | neuroblastoma | 3971 | 23 | 16828 | 49 |
SLC1A2,IQCA1,CAMK2G,ADCY2,TNRC6A,ERBB4,PRKG1,MACF1,NAV2,HIF3A,GLIS3,RYR3,WDR49,RFX4,PCDH9,NPAS3,DPP10,TRPS1,FMN2,CTNND2,PITPNC1,ARAP2,AQP4 |
2.977e-04 | -8.12 | ovary-carcinoma | COSMIC cancer mutations | ovary-carcinoma | 933 | 10 | 16828 | 49 |
DCLK1,BMPR1B,ERBB4,CAMK2G,DST,PPP2R2B,PRKG1,DCLK2,MACF1,RPS6KA2 |
3.044e-04 | -8.10 | Doublecortin_dom_sf | interpro domains | IPR036572 | 10 | 2 | 18521 | 49 |
DCLK1,DCLK2 |
3.085e-04 | -8.08 | adenoid_cystic_carcinoma | COSMIC cancer mutations | adenoid_cystic_carcinoma | 1123 | 11 | 16828 | 49 |
LIFR,DCLK1,MGAT4C,ARAP2,ERBB4,CAMK2G,RYR3,PRKG1,NAV2,RPS6KA2,CTNND2 |
3.129e-04 | -8.07 | angiosarcoma | COSMIC cancer mutations | angiosarcoma | 2192 | 16 | 16828 | 49 |
HPSE2,NAV2,FMN2,CTNND2,PRKG1,NRG3,ERBB4,ADCY2,PCDH9,SOX5,SLC1A2,LSAMP,RYR3,SLC39A11,PPP2R2B,CDH20 |
3.129e-04 | -8.07 | soft_tissue-blood_vessel-angiosarcoma | COSMIC cancer mutations | soft_tissue-blood_vessel-angiosarcoma | 2192 | 16 | 16828 | 49 |
SLC39A11,RYR3,PPP2R2B,CDH20,PRKG1,NRG3,NAV2,HPSE2,CTNND2,FMN2,SOX5,SLC1A2,PCDH9,LSAMP,ADCY2,ERBB4 |
3.267e-04 | -8.03 | YES1 (YES proto-oncogene 1, Src family tyrosine kinase) | protein interactions | 7525 | 364 | 6 | 19454 | 50 |
ERBB4,MSI2,CAMK2G,GFAP,SLC14A1,RPS6KA2 |
3.289e-04 | -8.02 | ovary-carcinoma-mucinous_carcinoma | COSMIC cancer mutations | ovary-carcinoma-mucinous_carcinoma | 456 | 7 | 16828 | 49 |
BMPR1B,PRKG1,DCLK1,RPS6KA2,ERBB4,DCLK2,CAMK2G |
3.318e-04 | -8.01 | autonomic_ganglia | COSMIC cancer mutations | autonomic_ganglia | 4005 | 23 | 16828 | 49 |
TRPS1,CTNND2,FMN2,DPP10,PCDH9,NPAS3,AQP4,PITPNC1,ARAP2,PRKG1,HIF3A,NAV2,MACF1,IQCA1,SLC1A2,ADCY2,ERBB4,TNRC6A,CAMK2G,RFX4,RYR3,WDR49,GLIS3 |
3.377e-04 | -7.99 | mucinous_carcinoma | COSMIC cancer mutations | mucinous_carcinoma | 458 | 7 | 16828 | 49 |
RPS6KA2,DCLK2,ERBB4,CAMK2G,BMPR1B,PRKG1,DCLK1 |
3.407e-04 | -7.98 | PI3K events in ERBB4 signaling | REACTOME pathways | R-HSA-1250342 | 10 | 2 | 10285 | 29 |
ERBB4,NRG3 |
3.409e-04 | -7.98 | plasma membrane | cellular component | GO:0005886 | 5538 | 26 | 19108 | 49 |
RYR3,SLC39A11,NRG3,TRPM3,SLC14A1,LIFR,PCDH9,DTNA,CTNND2,LSAMP,NTM,DCLK1,SLC1A2,MACF1,ADCY2,DPP10,SORBS1,AQP4,ERBB4,PRKG1,FMN2,DST,HPSE2,BMPR1B,CDH20,HIF3A |
3.456e-04 | -7.97 | blood_vessel | COSMIC cancer mutations | blood_vessel | 2211 | 16 | 16828 | 49 |
ERBB4,ADCY2,PCDH9,SOX5,SLC1A2,LSAMP,HPSE2,NAV2,FMN2,CTNND2,PRKG1,NRG3,PPP2R2B,CDH20,RYR3,SLC39A11 |
3.471e-04 | -7.97 | serous_carcinoma | COSMIC cancer mutations | serous_carcinoma | 10987 | 43 | 16828 | 49 |
IQCA1,SOX5,CAMK2G,NRG3,PRKG1,MSI2,NAV2,QKI,GLIS3,SLC39A11,DCLK2,DCLK1,LSAMP,PCDH9,CTNND2,FMN2,RPS6KA2,SLC1A2,LIFR,ADCY2,ERBB4,TNRC6A,DST,GFAP,DTNA,MACF1,ABR,CDH20,PPP2R2B,WDR49,RYR3,DPP10,BMPR1B,NPAS3,SORBS1,TRPM3,TRPS1,NTM,PTGDS,DAAM2,HPSE2,MGAT4C,ARAP2 |
3.484e-04 | -7.96 | salivary_gland | COSMIC cancer mutations | salivary_gland | 1139 | 11 | 16828 | 49 |
CTNND2,NAV2,PRKG1,ERBB4,CAMK2G,DCLK1,LIFR,RPS6KA2,RYR3,MGAT4C,ARAP2 |
3.653e-04 | -7.91 | ovary-carcinoma-endometrioid_carcinoma | COSMIC cancer mutations | ovary-carcinoma-endometrioid_carcinoma | 464 | 7 | 16828 | 49 |
BMPR1B,PRKG1,DCLK1,RPS6KA2,ERBB4,DCLK2,CAMK2G |
3.664e-04 | -7.91 | Doublecortin domain | gene3d domains | 3.10.20.230 | 9 | 2 | 14470 | 47 |
DCLK1,DCLK2 |
3.669e-04 | -7.91 | YWHAH (tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein eta) | protein interactions | 7533 | 1083 | 10 | 19454 | 50 |
DCLK1,NAV2,ARAP2,SORBS1,FMN2,MACF1,PITPNC1,DCLK2,CAMK2G,DST |
3.727e-04 | -7.89 | DC | prosite domains | PS50309 | 9 | 2 | 12186 | 40 |
DCLK2,DCLK1 |
3.766e-04 | -7.88 | soft_tissue | COSMIC cancer mutations | soft_tissue | 5828 | 29 | 16828 | 49 |
MACF1,NAV2,NRG3,PRKG1,CAMK2G,ADCY2,TNRC6A,ERBB4,DST,SLC1A2,SOX5,RYR3,SLC39A11,CDH20,PPP2R2B,GLIS3,FMN2,CTNND2,HPSE2,TRPS1,SORBS1,TRPM3,LSAMP,DCLK1,PCDH9,NPAS3,DPP10,AQP4,ARAP2 |
3.844e-04 | -7.86 | L-aspartate transmembrane transport | biological process | GO:0070778 | 11 | 2 | 18204 | 49 |
SLC1A2,SLC25A18 |
3.906e-04 | -7.85 | regulation of chondrocyte differentiation | biological process | GO:0032330 | 53 | 3 | 18204 | 49 |
SOX5,BMPR1B,TRPS1 |
4.018e-04 | -7.82 | ear | COSMIC cancer mutations | ear | 624 | 8 | 16828 | 49 |
DPP10,LIFR,NPAS3,TNRC6A,MGAT4C,PRKG1,SLC14A1,RPS6KA2 |
4.044e-04 | -7.81 | mucosal | COSMIC cancer mutations | mucosal | 2009 | 15 | 16828 | 49 |
WDR49,ABR,MGAT4C,ARAP2,PPP2R2B,NRG3,CTNND2,FMN2,NAV2,DCLK1,BMPR1B,PCDH9,LIFR,ERBB4,SORBS1 |
4.044e-04 | -7.81 | skin-mucosal-malignant_melanoma | COSMIC cancer mutations | skin-mucosal-malignant_melanoma | 2009 | 15 | 16828 | 49 |
NRG3,NAV2,FMN2,CTNND2,LIFR,PCDH9,BMPR1B,DCLK1,SORBS1,ERBB4,WDR49,ARAP2,PPP2R2B,MGAT4C,ABR |
4.163e-04 | -7.78 | protein serine kinase activity | molecular function | GO:0106310 | 362 | 6 | 18094 | 49 |
DCLK2,DCLK1,CAMK2G,RPS6KA2,PRKG1,TTN |
4.201e-04 | -7.77 | Transmembrane transport of small molecules | REACTOME pathways | R-HSA-382551 | 677 | 8 | 10285 | 29 |
RYR3,SLC1A2,CAMK2G,SLC14A1,ADCY2,AQP4,SLC25A18,TRPM3 |
4.213e-04 | -7.77 | DCX | smart domains | SM00537 | 9 | 2 | 9717 | 34 |
DCLK1,DCLK2 |
4.467e-04 | -7.71 | skin-scalp-malignant_melanoma | COSMIC cancer mutations | skin-scalp-malignant_melanoma | 634 | 8 | 16828 | 49 |
DCLK1,ERBB4,CAMK2G,SORBS1,PPP2R2B,NTM,FMN2,RPS6KA2 |
4.618e-04 | -7.68 | PROTEIN_KINASE_ST | prosite domains | PS00108 | 308 | 6 | 12186 | 40 |
RPS6KA2,CAMK2G,PRKG1,DCLK2,DCLK1,BMPR1B |
4.667e-04 | -7.67 | phosphotransferase activity, alcohol group as acceptor | molecular function | GO:0016773 | 686 | 8 | 18094 | 49 |
BMPR1B,DCLK2,CAMK2G,TTN,PRKG1,DCLK1,RPS6KA2,ERBB4 |
4.778e-04 | -7.65 | sarcolemma | cellular component | GO:0042383 | 142 | 4 | 19108 | 49 |
DTNA,AQP4,PRKG1,RYR3 |
5.195e-04 | -7.56 | cell periphery | cellular component | GO:0071944 | 6020 | 27 | 19108 | 49 |
NAV2,HPSE2,CDH20,HIF3A,BMPR1B,SORBS1,AQP4,ERBB4,DPP10,ADCY2,MACF1,FMN2,DST,PRKG1,CTNND2,LSAMP,NTM,SLC1A2,DCLK1,LIFR,TRPM3,SLC14A1,SLC39A11,NRG3,RYR3,DTNA,PCDH9 |
5.849e-04 | -7.44 | lung-carcinoid-endocrine_tumour | COSMIC cancer mutations | lung-carcinoid-endocrine_tumour | 502 | 7 | 16828 | 49 |
DCLK2,ERBB4,CAMK2G,RPS6KA2,DCLK1,BMPR1B,PRKG1 |
5.874e-04 | -7.44 | ERBB2 Activates PTK6 Signaling | REACTOME pathways | R-HSA-8847993 | 13 | 2 | 10285 | 29 |
NRG3,ERBB4 |
6.126e-04 | -7.40 | ovary-carcinoma-clear_cell_carcinoma | COSMIC cancer mutations | ovary-carcinoma-clear_cell_carcinoma | 665 | 8 | 16828 | 49 |
DCLK2,RPS6KA2,PRKG1,ERBB4,CAMK2G,DCLK1,BMPR1B,LIFR |
6.212e-04 | -7.38 | NGF signalling via TRKA from the plasma membrane | REACTOME pathways | R-HSA-187037 | 387 | 6 | 10285 | 29 |
ERBB4,CAMK2G,NRG3,TNRC6A,ADCY2,RPS6KA2 |
6.276e-04 | -7.37 | lung-carcinoid-endocrine_tumour-atypical | COSMIC cancer mutations | lung-carcinoid-endocrine_tumour-atypical | 508 | 7 | 16828 | 49 |
DCLK2,RPS6KA2,PRKG1,CAMK2G,ERBB4,DCLK1,BMPR1B |
6.372e-04 | -7.36 | clear_cell_carcinoma | COSMIC cancer mutations | clear_cell_carcinoma | 669 | 8 | 16828 | 49 |
CAMK2G,ERBB4,LIFR,BMPR1B,DCLK1,RPS6KA2,DCLK2,PRKG1 |
6.401e-04 | -7.35 | brain development | biological process | GO:0007420 | 724 | 8 | 18204 | 49 |
ERBB4,NRG3,SLC1A2,DCLK2,RFX4,PCDH9,DCLK1,PRKG1 |
6.403e-04 | -7.35 | L-glutamate transmembrane transporter activity | molecular function | GO:0005313 | 14 | 2 | 18094 | 49 |
SLC1A2,SLC25A18 |
6.697e-04 | -7.31 | phosphorylation | biological process | GO:0016310 | 729 | 8 | 18204 | 49 |
DCLK2,RPS6KA2,ERBB4,CAMK2G,BMPR1B,TTN,PRKG1,DCLK1 |
6.754e-04 | -7.30 | large_cell_carcinoma | COSMIC cancer mutations | large_cell_carcinoma | 849 | 9 | 16828 | 49 |
DCLK1,LIFR,BMPR1B,DPP10,CAMK2G,ERBB4,PRKG1,DCLK2,RPS6KA2 |
6.754e-04 | -7.30 | lung-carcinoma-large_cell_carcinoma | COSMIC cancer mutations | lung-carcinoma-large_cell_carcinoma | 849 | 9 | 16828 | 49 |
PRKG1,RPS6KA2,DCLK2,LIFR,BMPR1B,DPP10,DCLK1,CAMK2G,ERBB4 |
6.805e-04 | -7.29 | atypical | COSMIC cancer mutations | atypical | 515 | 7 | 16828 | 49 |
DCLK1,PRKG1,BMPR1B,CAMK2G,DCLK2,ERBB4,RPS6KA2 |
6.841e-04 | -7.29 | SHC1 events in ERBB4 signaling | REACTOME pathways | R-HSA-1250347 | 14 | 2 | 10285 | 29 |
NRG3,ERBB4 |
6.844e-04 | -7.29 | neurogenesis | biological process | GO:0022008 | 1334 | 11 | 18204 | 49 |
ERBB4,GFAP,NAV2,DCLK2,NTM,PRKG1,DCLK1,CTNND2,QKI,BMPR1B,SOX5 |
6.850e-04 | -7.29 | scalp | COSMIC cancer mutations | scalp | 2110 | 15 | 16828 | 49 |
PPP2R2B,RPS6KA2,DCLK1,LSAMP,SOX5,CAMK2G,ERBB4,SORBS1,DST,GFAP,PRKG1,TRPS1,FMN2,NTM,MACF1 |
6.998e-04 | -7.26 | YWHAB (tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein beta) | protein interactions | 7529 | 965 | 9 | 19454 | 50 |
DCLK2,PITPNC1,DST,CAMK2G,DCLK1,ARAP2,NAV2,SORBS1,MACF1 |
7.014e-04 | -7.26 | FH2 | pfam domains | PF02181 | 15 | 2 | 17795 | 47 |
DAAM2,FMN2 |
7.043e-04 | -7.26 | FH2_Formin_sf | interpro domains | IPR042201 | 15 | 2 | 18521 | 49 |
FMN2,DAAM2 |
7.043e-04 | -7.26 | FH2_Formin | interpro domains | IPR015425 | 15 | 2 | 18521 | 49 |
DAAM2,FMN2 |
7.348e-04 | -7.22 | CH | pfam domains | PF00307 | 67 | 3 | 17795 | 47 |
DST,MACF1,NAV2 |
7.616e-04 | -7.18 | kinase activity | molecular function | GO:0016301 | 739 | 8 | 18094 | 49 |
BMPR1B,DCLK2,CAMK2G,PRKG1,TTN,DCLK1,ERBB4,RPS6KA2 |
7.643e-04 | -7.18 | anatomical structure development | biological process | GO:0048856 | 5207 | 25 | 18204 | 49 |
HIF3A,CDH20,QKI,TRPS1,TNRC6A,NTM,DCLK2,CTNND2,GFAP,FMN2,SLC1A2,RFX4,LSAMP,CAMK2G,BMPR1B,SOX5,MSI2,TTN,NRG3,PCDH9,DAAM2,DCLK1,PRKG1,ERBB4,NAV2 |
7.686e-04 | -7.17 | adenoma | COSMIC cancer mutations | adenoma | 2873 | 18 | 16828 | 49 |
BMPR1B,SOX5,LIFR,NPAS3,PCDH9,TRPM3,DST,ERBB4,ADCY2,PRKG1,HPSE2,MACF1,CTNND2,HIF3A,CDH20,RYR3,WDR49,DCLK2 |
7.879e-04 | -7.15 | ERBB2 Regulates Cell Motility | REACTOME pathways | R-HSA-6785631 | 15 | 2 | 10285 | 29 |
NRG3,ERBB4 |
8.340e-04 | -7.09 | haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm-plasma_cell_myeloma | COSMIC cancer mutations | haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm-plasma_cell_myeloma | 1263 | 11 | 16828 | 49 |
ABR,ADCY2,MACF1,RPS6KA2,HPSE2,FMN2,CTNND2,NTM,RYR3,TRPS1,NRG3 |
8.340e-04 | -7.09 | plasma_cell_myeloma | COSMIC cancer mutations | plasma_cell_myeloma | 1263 | 11 | 16828 | 49 |
MACF1,HPSE2,RPS6KA2,FMN2,CTNND2,NTM,RYR3,TRPS1,NRG3,ABR,ADCY2 |
8.541e-04 | -7.07 | telencephalon development | biological process | GO:0021537 | 276 | 5 | 18204 | 49 |
ERBB4,NRG3,SLC1A2,DCLK2,RFX4 |
8.793e-04 | -7.04 | YWHAG (tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein gamma) | protein interactions | 7532 | 1211 | 10 | 19454 | 50 |
DCLK1,ARAP2,NAV2,SORBS1,MACF1,FMN2,PITPNC1,DCLK2,CAMK2G,DST |
8.989e-04 | -7.01 | PI3K events in ERBB2 signaling | REACTOME pathways | R-HSA-1963642 | 16 | 2 | 10285 | 29 |
ERBB4,NRG3 |
8.989e-04 | -7.01 | GRB2 events in ERBB2 signaling | REACTOME pathways | R-HSA-1963640 | 16 | 2 | 10285 | 29 |
ERBB4,NRG3 |
9.010e-04 | -7.01 | upper_aerodigestive_tract-pharynx-carcinoma-squamous_cell_carcinoma | COSMIC cancer mutations | upper_aerodigestive_tract-pharynx-carcinoma-squamous_cell_carcinoma | 1485 | 12 | 16828 | 49 |
RYR3,WDR49,DST,SORBS1,NPAS3,PCDH9,SLC14A1,DAAM2,MACF1,FMN2,NRG3,DTNA |
9.736e-04 | -6.93 | upper_aerodigestive_tract-larynx-carcinoma-squamous_cell_carcinoma | COSMIC cancer mutations | upper_aerodigestive_tract-larynx-carcinoma-squamous_cell_carcinoma | 1946 | 14 | 16828 | 49 |
BMPR1B,SOX5,PCDH9,NPAS3,DST,TNRC6A,ERBB4,DAAM2,MACF1,HPSE2,FMN2,MGAT4C,SLC39A11,RYR3 |
9.835e-04 | -6.92 | larynx | COSMIC cancer mutations | larynx | 1948 | 14 | 16828 | 49 |
SLC39A11,RYR3,MGAT4C,FMN2,DAAM2,HPSE2,MACF1,TNRC6A,ERBB4,DST,BMPR1B,SOX5,PCDH9,NPAS3 |
9.860e-04 | -6.92 | cell junction assembly | biological process | GO:0034329 | 285 | 5 | 18204 | 49 |
CDH20,NRG3,ERBB4,DST,SORBS1 |
9.890e-04 | -6.92 | head development | biological process | GO:0060322 | 774 | 8 | 18204 | 49 |
ERBB4,PCDH9,SLC1A2,NRG3,RFX4,DCLK2,DCLK1,PRKG1 |
9.985e-04 | -6.91 | regulation of cartilage development | biological process | GO:0061035 | 73 | 3 | 18204 | 49 |
TRPS1,SOX5,BMPR1B |
1.022e-03 | -6.89 | Htt (huntingtin) | protein interactions | 15194 | 77 | 3 | 19454 | 50 |
LSAMP,GFAP,NTM |
1.055e-03 | -6.85 | PPP1R9B (protein phosphatase 1 regulatory subunit 9B) | protein interactions | 84687 | 175 | 4 | 19454 | 50 |
RPS6KA2,DCLK2,NAV2,DCLK1 |
1.055e-03 | -6.85 | Formin, FH2 domain | gene3d domains | 1.20.58.2220 | 15 | 2 | 14470 | 47 |
FMN2,DAAM2 |
1.061e-03 | -6.85 | ANKRD40 (ankyrin repeat domain 40) | protein interactions | 91369 | 78 | 3 | 19454 | 50 |
MSI2,SLC25A18,SOX5 |
1.066e-03 | -6.84 | lung-left_upper_lobe-carcinoma-adenocarcinoma | COSMIC cancer mutations | lung-left_upper_lobe-carcinoma-adenocarcinoma | 556 | 7 | 16828 | 49 |
CTNND2,RYR3,PRKG1,TRPS1,ADCY2,ERBB4,LIFR |
1.069e-03 | -6.84 | acidic amino acid transmembrane transporter activity | molecular function | GO:0015172 | 18 | 2 | 18094 | 49 |
SLC1A2,SLC25A18 |
1.074e-03 | -6.84 | FH2 | prosite domains | PS51444 | 15 | 2 | 12186 | 40 |
DAAM2,FMN2 |
1.075e-03 | -6.84 | nodular | COSMIC cancer mutations | nodular | 1515 | 12 | 16828 | 49 |
NPAS3,ERBB4,TNRC6A,CTNND2,HIF3A,FMN2,MACF1,CDH20,GLIS3,ARAP2,WDR49,DCLK2 |
1.075e-03 | -6.84 | actin binding | molecular function | GO:0003779 | 434 | 6 | 18094 | 49 |
MACF1,FMN2,SORBS1,DST,DAAM2,TTN |
1.077e-03 | -6.83 | OSM (oncostatin M) | protein interactions | 5008 | 19 | 2 | 19454 | 50 |
TRPM3,LIFR |
1.089e-03 | -6.82 | left_upper_lobe | COSMIC cancer mutations | left_upper_lobe | 558 | 7 | 16828 | 49 |
TRPS1,RYR3,PRKG1,CTNND2,LIFR,ADCY2,ERBB4 |
1.135e-03 | -6.78 | PAS | pfam domains | PF00989 | 19 | 2 | 17795 | 47 |
HIF3A,NPAS3 |
1.139e-03 | -6.78 | PAS_fold | interpro domains | IPR013767 | 19 | 2 | 18521 | 49 |
NPAS3,HIF3A |
1.162e-03 | -6.76 | S_TKc | smart domains | SM00220 | 348 | 6 | 9717 | 34 |
DCLK1,CAMK2G,RPS6KA2,BMPR1B,PRKG1,DCLK2 |
1.165e-03 | -6.76 | lung-carcinoma-squamous_cell_carcinoma | COSMIC cancer mutations | lung-carcinoma-squamous_cell_carcinoma | 14664 | 49 | 16828 | 49 |
CTNND2,FMN2,DCLK1,LSAMP,PCDH9,AQP4,RPS6KA2,PITPNC1,NRG3,MSI2,PRKG1,HIF3A,NAV2,SLC14A1,IQCA1,SOX5,CAMK2G,RFX4,SLC39A11,DCLK2,SLC25A18,QKI,GLIS3,TRPS1,NTM,DAAM2,PTGDS,HPSE2,DPP10,BMPR1B,NPAS3,SORBS1,TRPM3,MGAT4C,ARAP2,GFAP,DTNA,MACF1,SLC1A2,LIFR,ERBB4,ADCY2,TNRC6A,DST,WDR49,RYR3,ABR,CDH20,PPP2R2B |
1.172e-03 | -6.75 | C11orf52 (chromosome 11 open reading frame 52) | protein interactions | 91894 | 310 | 5 | 19454 | 50 |
DST,DTNA,FMN2,MACF1,ARAP2 |
1.179e-03 | -6.74 | cartilage condensation | biological process | GO:0001502 | 19 | 2 | 18204 | 49 |
SOX5,BMPR1B |
1.193e-03 | -6.73 | water transmembrane transporter activity | molecular function | GO:0005372 | 19 | 2 | 18094 | 49 |
SLC14A1,AQP4 |
1.201e-03 | -6.72 | breast-carcinoma-basal_(triple-negative)_carcinoma | COSMIC cancer mutations | breast-carcinoma-basal_(triple-negative)_carcinoma | 2981 | 18 | 16828 | 49 |
DST,TRPM3,ADCY2,ERBB4,DPP10,BMPR1B,LIFR,NPAS3,NAV2,MACF1,NTM,FMN2,HIF3A,PRKG1,MSI2,NRG3,PPP2R2B,RPS6KA2 |
1.201e-03 | -6.72 | basal_(triple-negative)_carcinoma | COSMIC cancer mutations | basal_(triple-negative)_carcinoma | 2981 | 18 | 16828 | 49 |
LIFR,NPAS3,DPP10,BMPR1B,ERBB4,ADCY2,DST,TRPM3,NRG3,PRKG1,MSI2,FMN2,HIF3A,NTM,MACF1,NAV2,PPP2R2B,RPS6KA2 |
1.210e-03 | -6.72 | dicarboxylic acid transport | biological process | GO:0006835 | 78 | 3 | 18204 | 49 |
SLC25A18,GFAP,SLC1A2 |
1.213e-03 | -6.71 | FH2 | smart domains | SM00498 | 15 | 2 | 9717 | 34 |
FMN2,DAAM2 |
1.220e-03 | -6.71 | PRPH (peripherin) | protein interactions | 5630 | 182 | 4 | 19454 | 50 |
TNRC6A,PPP2R2B,GFAP,SORBS1 |
1.222e-03 | -6.71 | skin-head_neck-malignant_melanoma-superficial_spreading | COSMIC cancer mutations | skin-head_neck-malignant_melanoma-superficial_spreading | 923 | 9 | 16828 | 49 |
ERBB4,ADCY2,PPP2R2B,ARAP2,SORBS1,MGAT4C,LIFR,CTNND2,MACF1 |
1.284e-03 | -6.66 | CH_dom | interpro domains | IPR001715 | 81 | 3 | 18521 | 49 |
DST,MACF1,NAV2 |
1.307e-03 | -6.64 | positive regulation of chondrocyte differentiation | biological process | GO:0032332 | 20 | 2 | 18204 | 49 |
BMPR1B,SOX5 |
1.318e-03 | -6.63 | TENM1 (teneurin transmembrane protein 1) | protein interactions | 10178 | 21 | 2 | 19454 | 50 |
MACF1,SORBS1 |
1.331e-03 | -6.62 | CH_dom_sf | interpro domains | IPR036872 | 82 | 3 | 18521 | 49 |
DST,NAV2,MACF1 |
1.357e-03 | -6.60 | plasma membrane bounded cell projection | cellular component | GO:0120025 | 2285 | 14 | 19108 | 49 |
CTNND2,IQCA1,GFAP,SLC1A2,BMPR1B,AQP4,MACF1,ADCY2,FMN2,DTNA,ABR,PCDH9,DST,CAMK2G |
1.443e-03 | -6.54 | cell aggregation | biological process | GO:0098743 | 21 | 2 | 18204 | 49 |
SOX5,BMPR1B |
1.491e-03 | -6.51 | lobular_carcinoma | COSMIC cancer mutations | lobular_carcinoma | 763 | 8 | 16828 | 49 |
RPS6KA2,DCLK2,PRKG1,ERBB4,CAMK2G,CDH20,BMPR1B,DCLK1 |
1.491e-03 | -6.51 | breast-carcinoma-lobular_carcinoma | COSMIC cancer mutations | breast-carcinoma-lobular_carcinoma | 763 | 8 | 16828 | 49 |
ERBB4,CDH20,CAMK2G,DCLK1,BMPR1B,DCLK2,RPS6KA2,PRKG1 |
1.530e-03 | -6.48 | urinary_tract-bladder-carcinoma | COSMIC cancer mutations | urinary_tract-bladder-carcinoma | 14050 | 48 | 16828 | 49 |
SLC39A11,RFX4,DCLK2,SLC25A18,GLIS3,QKI,MSI2,PRKG1,NRG3,SLC14A1,NAV2,HIF3A,SOX5,IQCA1,CAMK2G,RPS6KA2,PITPNC1,CTNND2,FMN2,PCDH9,DCLK1,LSAMP,WDR49,RYR3,PPP2R2B,ABR,CDH20,GFAP,DTNA,MACF1,SLC1A2,LIFR,DST,ERBB4,ADCY2,TNRC6A,MGAT4C,ARAP2,TRPS1,DAAM2,PTGDS,HPSE2,NTM,BMPR1B,DPP10,NPAS3,TRPM3,SORBS1 |
1.541e-03 | -6.48 | CH | smart domains | SM00033 | 66 | 3 | 9717 | 34 |
DST,NAV2,MACF1 |
1.548e-03 | -6.47 | SFN (stratifin) | protein interactions | 2810 | 671 | 7 | 19454 | 50 |
DST,PPP2R2B,FMN2,MACF1,NAV2,ARAP2,SORBS1 |
1.571e-03 | -6.46 | ATP binding | molecular function | GO:0005524 | 1467 | 11 | 18094 | 49 |
IQCA1,TTN,ERBB4,BMPR1B,NAV2,CAMK2G,DCLK2,ADCY2,PRKG1,RPS6KA2,DCLK1 |
1.581e-03 | -6.45 | cytoskeleton organization | biological process | GO:0007010 | 1251 | 10 | 18204 | 49 |
DST,IQCA1,MACF1,DCLK2,PRKG1,DAAM2,GFAP,FMN2,TTN,SORBS1 |
1.582e-03 | -6.45 | Rbm38 (RNA binding motif protein 38) | protein interactions | 56190 | 23 | 2 | 19454 | 50 |
MSI2,QKI |
1.582e-03 | -6.45 | TIMM10B (translocase of inner mitochondrial membrane 10B) | protein interactions | 26515 | 23 | 2 | 19454 | 50 |
MSI2,HPSE2 |
1.584e-03 | -6.45 | protein kinase A signaling | biological process | GO:0010737 | 22 | 2 | 18204 | 49 |
TTN,PRKG1 |
1.620e-03 | -6.43 | OCLN (occludin) | protein interactions | 100506658 | 495 | 6 | 19454 | 50 |
RPS6KA2,MACF1,FMN2,DTNA,DST,ARAP2 |
1.648e-03 | -6.41 | stomach-carcinoma | COSMIC cancer mutations | stomach-carcinoma | 439 | 6 | 16828 | 49 |
PRKG1,BMPR1B,DCLK1,RPS6KA2,CAMK2G,ERBB4 |
1.674e-03 | -6.39 | Actinin_actin-bd_CS | interpro domains | IPR001589 | 23 | 2 | 18521 | 49 |
MACF1,DST |
1.675e-03 | -6.39 | central_nervous_system-medulla-primitive_neuroectodermal_tumour-medulloblastoma-classic | COSMIC cancer mutations | central_nervous_system-medulla-primitive_neuroectodermal_tumour-medulloblastoma-classic | 14773 | 49 | 16828 | 49 |
SLC39A11,RFX4,DCLK2,SLC25A18,QKI,GLIS3,PRKG1,MSI2,NRG3,SLC14A1,NAV2,HIF3A,SOX5,IQCA1,CAMK2G,RPS6KA2,AQP4,PITPNC1,FMN2,CTNND2,PCDH9,LSAMP,DCLK1,RYR3,WDR49,PPP2R2B,ABR,CDH20,GFAP,DTNA,MACF1,LIFR,SLC1A2,DST,ADCY2,ERBB4,TNRC6A,ARAP2,MGAT4C,TRPS1,HPSE2,PTGDS,DAAM2,NTM,NPAS3,DPP10,BMPR1B,TRPM3,SORBS1 |
1.675e-03 | -6.39 | central_nervous_system-medulla-primitive_neuroectodermal_tumour-medulloblastoma-desmoplastic | COSMIC cancer mutations | central_nervous_system-medulla-primitive_neuroectodermal_tumour-medulloblastoma-desmoplastic | 14773 | 49 | 16828 | 49 |
PPP2R2B,CDH20,ABR,WDR49,RYR3,SLC1A2,LIFR,DST,ADCY2,TNRC6A,ERBB4,DTNA,GFAP,MACF1,MGAT4C,ARAP2,BMPR1B,DPP10,NPAS3,TRPM3,SORBS1,TRPS1,PTGDS,DAAM2,HPSE2,NTM,SLC25A18,QKI,GLIS3,SLC39A11,RFX4,DCLK2,SOX5,IQCA1,CAMK2G,PRKG1,MSI2,NRG3,SLC14A1,NAV2,HIF3A,PITPNC1,RPS6KA2,AQP4,PCDH9,LSAMP,DCLK1,CTNND2,FMN2 |
1.675e-03 | -6.39 | central_nervous_system-medulla-primitive_neuroectodermal_tumour-medulloblastoma | COSMIC cancer mutations | central_nervous_system-medulla-primitive_neuroectodermal_tumour-medulloblastoma | 14773 | 49 | 16828 | 49 |
ERBB4,ADCY2,TNRC6A,DST,SLC1A2,LIFR,MACF1,GFAP,DTNA,ABR,CDH20,PPP2R2B,WDR49,RYR3,TRPM3,SORBS1,BMPR1B,DPP10,NPAS3,NTM,PTGDS,DAAM2,HPSE2,TRPS1,MGAT4C,ARAP2,CAMK2G,IQCA1,SOX5,HIF3A,SLC14A1,NAV2,NRG3,PRKG1,MSI2,GLIS3,QKI,SLC25A18,DCLK2,RFX4,SLC39A11,LSAMP,DCLK1,PCDH9,CTNND2,FMN2,PITPNC1,AQP4,RPS6KA2 |
1.675e-03 | -6.39 | central_nervous_system-medulla-primitive_neuroectodermal_tumour-medulloblastoma-large_cell | COSMIC cancer mutations | central_nervous_system-medulla-primitive_neuroectodermal_tumour-medulloblastoma-large_cell | 14773 | 49 | 16828 | 49 |
ARAP2,MGAT4C,SORBS1,TRPM3,NPAS3,DPP10,BMPR1B,HPSE2,DAAM2,PTGDS,NTM,TRPS1,PPP2R2B,CDH20,ABR,WDR49,RYR3,DST,ERBB4,TNRC6A,ADCY2,LIFR,SLC1A2,MACF1,GFAP,DTNA,PITPNC1,RPS6KA2,AQP4,PCDH9,DCLK1,LSAMP,FMN2,CTNND2,GLIS3,QKI,SLC25A18,DCLK2,SLC39A11,RFX4,CAMK2G,SOX5,IQCA1,SLC14A1,NAV2,HIF3A,PRKG1,MSI2,NRG3 |
1.681e-03 | -6.39 | classic | COSMIC cancer mutations | classic | 14774 | 49 | 16828 | 49 |
SORBS1,TRPM3,NPAS3,BMPR1B,DPP10,HPSE2,DAAM2,PTGDS,NTM,TRPS1,ARAP2,MGAT4C,DST,TNRC6A,ADCY2,ERBB4,LIFR,SLC1A2,MACF1,GFAP,DTNA,PPP2R2B,ABR,CDH20,RYR3,WDR49,PCDH9,DCLK1,LSAMP,FMN2,CTNND2,PITPNC1,RPS6KA2,AQP4,CAMK2G,SOX5,IQCA1,NAV2,SLC14A1,HIF3A,PRKG1,MSI2,NRG3,GLIS3,QKI,SLC25A18,DCLK2,SLC39A11,RFX4 |
1.704e-03 | -6.38 | medulla | COSMIC cancer mutations | medulla | 14778 | 49 | 16828 | 49 |
DST,ADCY2,TNRC6A,ERBB4,LIFR,SLC1A2,MACF1,GFAP,DTNA,PPP2R2B,ABR,CDH20,RYR3,WDR49,SORBS1,TRPM3,NPAS3,DPP10,BMPR1B,HPSE2,PTGDS,DAAM2,NTM,TRPS1,ARAP2,MGAT4C,CAMK2G,SOX5,IQCA1,SLC14A1,NAV2,HIF3A,PRKG1,MSI2,NRG3,QKI,GLIS3,SLC25A18,DCLK2,SLC39A11,RFX4,PCDH9,LSAMP,DCLK1,FMN2,CTNND2,PITPNC1,RPS6KA2,AQP4 |
1.709e-03 | -6.37 | desmoplastic | COSMIC cancer mutations | desmoplastic | 14779 | 49 | 16828 | 49 |
PITPNC1,AQP4,RPS6KA2,DCLK1,LSAMP,PCDH9,CTNND2,FMN2,SLC25A18,GLIS3,QKI,RFX4,SLC39A11,DCLK2,IQCA1,SOX5,CAMK2G,NRG3,MSI2,PRKG1,HIF3A,SLC14A1,NAV2,MGAT4C,ARAP2,BMPR1B,DPP10,NPAS3,SORBS1,TRPM3,TRPS1,NTM,PTGDS,DAAM2,HPSE2,CDH20,ABR,PPP2R2B,RYR3,WDR49,SLC1A2,LIFR,ADCY2,ERBB4,TNRC6A,DST,DTNA,GFAP,MACF1 |
1.712e-03 | -6.37 | SHC1 events in ERBB2 signaling | REACTOME pathways | R-HSA-1250196 | 22 | 2 | 10285 | 29 |
NRG3,ERBB4 |
1.762e-03 | -6.34 | DMRTB1 (DMRT like family B with proline rich C-terminal 1) | protein interactions | 63948 | 93 | 3 | 19454 | 50 |
MSI2,QKI,TNRC6A |
1.774e-03 | -6.33 | bone-humerus-other-chondroblastoma | COSMIC cancer mutations | bone-humerus-other-chondroblastoma | 301 | 5 | 16828 | 49 |
FMN2,ADCY2,PPP2R2B,PRKG1,SOX5 |
1.816e-03 | -6.31 | Spectrin | pfam domains | PF00435 | 24 | 2 | 17795 | 47 |
MACF1,DST |
1.823e-03 | -6.31 | Spectrin_repeat | interpro domains | IPR002017 | 24 | 2 | 18521 | 49 |
MACF1,DST |
1.854e-03 | -6.29 | bladder | COSMIC cancer mutations | bladder | 14112 | 48 | 16828 | 49 |
SLC25A18,GLIS3,QKI,RFX4,SLC39A11,DCLK2,IQCA1,SOX5,CAMK2G,NRG3,PRKG1,MSI2,HIF3A,NAV2,SLC14A1,PITPNC1,RPS6KA2,LSAMP,DCLK1,PCDH9,FMN2,CTNND2,CDH20,ABR,PPP2R2B,WDR49,RYR3,LIFR,SLC1A2,ERBB4,ADCY2,TNRC6A,DST,GFAP,DTNA,MACF1,ARAP2,MGAT4C,NPAS3,BMPR1B,DPP10,SORBS1,TRPM3,TRPS1,NTM,HPSE2,DAAM2,PTGDS |
1.854e-03 | -6.29 | urinary_tract | COSMIC cancer mutations | urinary_tract | 14112 | 48 | 16828 | 49 |
NRG3,MSI2,PRKG1,HIF3A,SLC14A1,NAV2,IQCA1,SOX5,CAMK2G,RFX4,SLC39A11,DCLK2,SLC25A18,QKI,GLIS3,CTNND2,FMN2,DCLK1,LSAMP,PCDH9,RPS6KA2,PITPNC1,GFAP,DTNA,MACF1,SLC1A2,LIFR,ERBB4,ADCY2,TNRC6A,DST,RYR3,WDR49,CDH20,ABR,PPP2R2B,TRPS1,NTM,DAAM2,PTGDS,HPSE2,BMPR1B,DPP10,NPAS3,SORBS1,TRPM3,MGAT4C,ARAP2 |
1.856e-03 | -6.29 | multicellular organismal process | biological process | GO:0032501 | 6177 | 27 | 18204 | 49 |
PCDH9,NRG3,DCLK1,PRKG1,DAAM2,ERBB4,NAV2,PTGDS,CAMK2G,LSAMP,SLC1A2,RFX4,MSI2,BMPR1B,SOX5,TTN,NTM,DCLK2,CTNND2,GFAP,RYR3,HIF3A,AQP4,QKI,DTNA,CDH20,TRPS1 |
1.874e-03 | -6.28 | haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm-acute_lymphoblastic_leukaemia | COSMIC cancer mutations | haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm-acute_lymphoblastic_leukaemia | 2081 | 14 | 16828 | 49 |
DCLK1,BMPR1B,SOX5,ERBB4,ADCY2,CAMK2G,GFAP,DTNA,TRPS1,PRKG1,DAAM2,SLC25A18,DCLK2,RPS6KA2 |
1.913e-03 | -6.26 | human chr2q37.2-q37.3 | chromosome location | human chr2q37.2-q37.3 | 1 | 1 | 26134 | 50 |
IQCA1 |
1.913e-03 | -6.26 | human chr10q11.23-q21.1 | chromosome location | human chr10q11.23-q21.1 | 1 | 1 | 26134 | 50 |
PRKG1 |
1.913e-03 | -6.26 | human chr9q21.12-q21.13 | chromosome location | human chr9q21.12-q21.13 | 1 | 1 | 26134 | 50 |
TRPM3 |
1.913e-03 | -6.26 | human chr15q13.3-q14 | chromosome location | human chr15q13.3-q14 | 1 | 1 | 26134 | 50 |
RYR3 |
1.913e-03 | -6.26 | human chr12q21.31-q21.32 | chromosome location | human chr12q21.31-q21.32 | 1 | 1 | 26134 | 50 |
MGAT4C |
1.913e-03 | -6.26 | human chr17q24.3-q25.1 | chromosome location | human chr17q24.3-q25.1 | 1 | 1 | 26134 | 50 |
SLC39A11 |
1.913e-03 | -6.26 | human chr4q31.23-q31.3 | chromosome location | human chr4q31.23-q31.3 | 1 | 1 | 26134 | 50 |
DCLK2 |
1.945e-03 | -6.24 | protein tetramerization | biological process | GO:0051262 | 92 | 3 | 18204 | 49 |
AQP4,TRPM3,RYR3 |
1.957e-03 | -6.24 | bone-femur-other-chondroblastoma | COSMIC cancer mutations | bone-femur-other-chondroblastoma | 183 | 4 | 16828 | 49 |
NRG3,RYR3,PCDH9,SLC39A11 |
1.964e-03 | -6.23 | PRNP (prion protein (Kanno blood group)) | protein interactions | 5621 | 1118 | 9 | 19454 | 50 |
MSI2,AQP4,CAMK2G,TRPM3,SORBS1,LSAMP,QKI,MACF1,TRPS1 |
1.984e-03 | -6.22 | breast-carcinoma-ductal_carcinoma | COSMIC cancer mutations | breast-carcinoma-ductal_carcinoma | 14824 | 49 | 16828 | 49 |
HIF3A,NAV2,SLC14A1,NRG3,PRKG1,MSI2,CAMK2G,IQCA1,SOX5,DCLK2,RFX4,SLC39A11,QKI,GLIS3,SLC25A18,CTNND2,FMN2,DCLK1,LSAMP,PCDH9,AQP4,RPS6KA2,PITPNC1,MACF1,DTNA,GFAP,ADCY2,ERBB4,TNRC6A,DST,SLC1A2,LIFR,WDR49,RYR3,ABR,CDH20,PPP2R2B,NTM,DAAM2,PTGDS,HPSE2,TRPS1,TRPM3,SORBS1,DPP10,BMPR1B,NPAS3,MGAT4C,ARAP2 |
2.006e-03 | -6.21 | intermediate filament cytoskeleton organization | biological process | GO:0045104 | 93 | 3 | 18204 | 49 |
GFAP,DST,MACF1 |
2.022e-03 | -6.20 | Calcium signaling pathway | KEGG pathways | hsa04020 | 181 | 4 | 7161 | 22 |
ADCY2,CAMK2G,RYR3,ERBB4 |
2.022e-03 | -6.20 | Calcium signaling pathway | KEGG pathways | ko04020 | 181 | 4 | 7161 | 22 |
ERBB4,RYR3,ADCY2,CAMK2G |
2.047e-03 | -6.19 | MED27 (mediator complex subunit 27) | protein interactions | 9442 | 98 | 3 | 19454 | 50 |
SOX5,QKI,TNRC6A |
2.047e-03 | -6.19 | L-glutamate transmembrane transport | biological process | GO:0015813 | 25 | 2 | 18204 | 49 |
SLC1A2,SLC25A18 |
2.069e-03 | -6.18 | intermediate filament-based process | biological process | GO:0045103 | 94 | 3 | 18204 | 49 |
MACF1,GFAP,DST |
2.112e-03 | -6.16 | ErbB signaling pathway | KEGG pathways | ko04012 | 85 | 3 | 7161 | 22 |
NRG3,CAMK2G,ERBB4 |
2.112e-03 | -6.16 | ErbB signaling pathway | KEGG pathways | hsa04012 | 85 | 3 | 7161 | 22 |
NRG3,CAMK2G,ERBB4 |
2.127e-03 | -6.15 | large_cell | COSMIC cancer mutations | large_cell | 14845 | 49 | 16828 | 49 |
SOX5,IQCA1,CAMK2G,MSI2,PRKG1,NRG3,SLC14A1,NAV2,HIF3A,SLC25A18,QKI,GLIS3,SLC39A11,RFX4,DCLK2,PCDH9,LSAMP,DCLK1,CTNND2,FMN2,PITPNC1,RPS6KA2,AQP4,SLC1A2,LIFR,DST,ERBB4,ADCY2,TNRC6A,DTNA,GFAP,MACF1,PPP2R2B,ABR,CDH20,WDR49,RYR3,BMPR1B,DPP10,NPAS3,SORBS1,TRPM3,TRPS1,DAAM2,PTGDS,HPSE2,NTM,MGAT4C,ARAP2 |
2.137e-03 | -6.15 | Calponin-like domain | gene3d domains | 1.10.418.10 | 79 | 3 | 14470 | 47 |
DST,MACF1,NAV2 |
2.161e-03 | -6.14 | cell projection | cellular component | GO:0042995 | 2398 | 14 | 19108 | 49 |
BMPR1B,SLC1A2,GFAP,CTNND2,IQCA1,CAMK2G,FMN2,ABR,DTNA,PCDH9,DST,ADCY2,MACF1,AQP4 |
2.176e-03 | -6.13 | adenyl ribonucleotide binding | molecular function | GO:0032559 | 1528 | 11 | 18094 | 49 |
RPS6KA2,DCLK1,PRKG1,ADCY2,CAMK2G,DCLK2,BMPR1B,NAV2,ERBB4,TTN,IQCA1 |
2.181e-03 | -6.13 | MBNL2 (muscleblind like splicing regulator 2) | protein interactions | 10150 | 27 | 2 | 19454 | 50 |
MSI2,QKI |
2.181e-03 | -6.13 | ANKRD1 (ankyrin repeat domain 1) | protein interactions | 27063 | 27 | 2 | 19454 | 50 |
TTN,DST |
2.185e-03 | -6.13 | LYN (LYN proto-oncogene, Src family tyrosine kinase) | protein interactions | 4067 | 713 | 7 | 19454 | 50 |
ERBB4,MSI2,ARAP2,FMN2,MACF1,DST,DTNA |
2.198e-03 | -6.12 | follicular_lymphoma | COSMIC cancer mutations | follicular_lymphoma | 1209 | 10 | 16828 | 49 |
PRKG1,NRG3,HPSE2,CTNND2,AQP4,PCDH9,SOX5,DPP10,LSAMP,ADCY2 |
2.262e-03 | -6.09 | amino acid transmembrane transport | biological process | GO:0003333 | 97 | 3 | 18204 | 49 |
SLC1A2,GFAP,SLC25A18 |
2.342e-03 | -6.06 | CH | prosite domains | PS50021 | 81 | 3 | 12186 | 40 |
DST,MACF1,NAV2 |
2.419e-03 | -6.02 | Muscle contraction | REACTOME pathways | R-HSA-397014 | 204 | 4 | 10285 | 29 |
TTN,SORBS1,RYR3,CAMK2G |
2.487e-03 | -6.00 | Salivary secretion | KEGG pathways | hsa04970 | 90 | 3 | 7161 | 22 |
ADCY2,RYR3,PRKG1 |
2.487e-03 | -6.00 | Salivary secretion | KEGG pathways | ko04970 | 90 | 3 | 7161 | 22 |
PRKG1,RYR3,ADCY2 |
2.495e-03 | -5.99 | upper_aerodigestive_tract-head_neck-carcinoma-squamous_cell_carcinoma | COSMIC cancer mutations | upper_aerodigestive_tract-head_neck-carcinoma-squamous_cell_carcinoma | 9263 | 37 | 16828 | 49 |
TRPM3,SORBS1,DCLK1,LSAMP,PCDH9,BMPR1B,FMN2,CTNND2,HPSE2,DAAM2,PTGDS,TRPS1,MGAT4C,PITPNC1,RPS6KA2,CAMK2G,ERBB4,ADCY2,TNRC6A,DST,IQCA1,LIFR,SOX5,HIF3A,MACF1,NAV2,MSI2,PRKG1,ABR,CDH20,PPP2R2B,QKI,GLIS3,DCLK2,WDR49,RYR3,SLC39A11 |
2.535e-03 | -5.98 | signaling | biological process | GO:0023052 | 4968 | 23 | 18204 | 49 |
ADCY2,ARAP2,NRG3,MACF1,ABR,DST,DAAM2,PRKG1,DCLK1,ERBB4,SLC1A2,CAMK2G,PITPNC1,BMPR1B,RPS6KA2,TTN,DCLK2,CTNND2,FMN2,LIFR,RYR3,DTNA,SORBS1 |
2.545e-03 | -5.97 | ACTININ_2 | prosite domains | PS00020 | 23 | 2 | 12186 | 40 |
MACF1,DST |
2.545e-03 | -5.97 | ACTININ_1 | prosite domains | PS00019 | 23 | 2 | 12186 | 40 |
MACF1,DST |
2.564e-03 | -5.97 | H zone | cellular component | GO:0031673 | 1 | 1 | 19108 | 49 |
DST |
2.566e-03 | -5.97 | water transport | biological process | GO:0006833 | 28 | 2 | 18204 | 49 |
SLC14A1,AQP4 |
2.570e-03 | -5.96 | IML3 (Iml3p) | protein interactions | 852404 | 1 | 1 | 19454 | 50 |
GFAP |
2.570e-03 | -5.96 | 1700006A11Rik (RIKEN cDNA 1700006A11 gene) | protein interactions | 71824 | 1 | 1 | 19454 | 50 |
BMPR1B |
2.570e-03 | -5.96 | AGO4 (Argonaute family protein) | protein interactions | 817246 | 1 | 1 | 19454 | 50 |
TNRC6A |
2.570e-03 | -5.96 | Lztr1 (leucine-zipper-like transcriptional regulator, 1) | protein interactions | 66863 | 1 | 1 | 19454 | 50 |
BMPR1B |
2.570e-03 | -5.96 | Hipk3 (homeodomain interacting protein kinase 3) | protein interactions | 15259 | 1 | 1 | 19454 | 50 |
GLIS3 |
2.570e-03 | -5.96 | Isl1 (ISL1 transcription factor, LIM/homeodomain) | protein interactions | 16392 | 1 | 1 | 19454 | 50 |
GLIS3 |
2.570e-03 | -5.96 | Dcaf7 (DDB1 and CUL4 associated factor 7) | protein interactions | 71833 | 1 | 1 | 19454 | 50 |
BMPR1B |
2.570e-03 | -5.96 | EB1a (microtubule end binding protein EB1A) | protein interactions | 823923 | 1 | 1 | 19454 | 50 |
DST |
2.570e-03 | -5.96 | mal3 (EB1 family Mal3) | protein interactions | 2542123 | 1 | 1 | 19454 | 50 |
DST |
2.570e-03 | -5.96 | Agtrap (angiotensin II, type I receptor-associated protein) | protein interactions | 11610 | 1 | 1 | 19454 | 50 |
PITPNC1 |
2.603e-03 | -5.95 | MAPRE3 (microtubule associated protein RP/EB family member 3) | protein interactions | 22924 | 224 | 4 | 19454 | 50 |
DST,MACF1,DCLK1,NAV2 |
2.641e-03 | -5.94 | STAR_dimer | pfam domains | PF16544 | 1 | 1 | 17795 | 47 |
QKI |
2.641e-03 | -5.94 | Quaking_NLS | pfam domains | PF16551 | 1 | 1 | 17795 | 47 |
QKI |
2.641e-03 | -5.94 | LIFR_N | pfam domains | PF18207 | 1 | 1 | 17795 | 47 |
LIFR |
2.641e-03 | -5.94 | PKcGMP_CC | pfam domains | PF16808 | 1 | 1 | 17795 | 47 |
PRKG1 |
2.641e-03 | -5.94 | Titin_Z | pfam domains | PF09042 | 1 | 1 | 17795 | 47 |
TTN |
2.641e-03 | -5.94 | PPAK | pfam domains | PF02818 | 1 | 1 | 17795 | 47 |
TTN |
2.645e-03 | -5.94 | tibia | COSMIC cancer mutations | tibia | 836 | 8 | 16828 | 49 |
MACF1,CTNND2,PRKG1,QKI,TRPM3,DST,LSAMP,DCLK1 |
2.646e-03 | -5.93 | RSK3_STKc | interpro domains | IPR042766 | 1 | 1 | 18521 | 49 |
RPS6KA2 |
2.646e-03 | -5.93 | LIFR_N | interpro domains | IPR040901 | 1 | 1 | 18521 | 49 |
LIFR |
2.646e-03 | -5.93 | PKcGMP_CC | interpro domains | IPR031831 | 1 | 1 | 18521 | 49 |
PRKG1 |
2.646e-03 | -5.93 | SORBS1_SH3 | interpro domains | IPR035606 | 1 | 1 | 18521 | 49 |
SORBS1 |
2.646e-03 | -5.93 | SORBS1_SH3_1 | interpro domains | IPR035610 | 1 | 1 | 18521 | 49 |
SORBS1 |
2.646e-03 | -5.93 | TRPS1 | interpro domains | IPR028440 | 1 | 1 | 18521 | 49 |
TRPS1 |
2.646e-03 | -5.93 | STAR_dimer | interpro domains | IPR032377 | 1 | 1 | 18521 | 49 |
QKI |
2.646e-03 | -5.93 | Titin_Z_rpt | interpro domains | IPR015129 | 1 | 1 | 18521 | 49 |
TTN |
2.646e-03 | -5.93 | TNRC6A_RRM | interpro domains | IPR034924 | 1 | 1 | 18521 | 49 |
TNRC6A |
2.646e-03 | -5.93 | Quaking_NLS | interpro domains | IPR032367 | 1 | 1 | 18521 | 49 |
QKI |
2.646e-03 | -5.93 | SORBS1_SH3_2 | interpro domains | IPR035611 | 1 | 1 | 18521 | 49 |
SORBS1 |
2.646e-03 | -5.93 | PPAK_motif | interpro domains | IPR004168 | 1 | 1 | 18521 | 49 |
TTN |
2.646e-03 | -5.93 | ABR_PH | interpro domains | IPR037865 | 1 | 1 | 18521 | 49 |
ABR |
2.692e-03 | -5.92 | directional guidance of interneurons involved in migration from the subpallium to the cortex | biological process | GO:0021840 | 1 | 1 | 18204 | 49 |
NRG3 |
2.692e-03 | -5.92 | chemorepulsion involved in interneuron migration from the subpallium to the cortex | biological process | GO:0021842 | 1 | 1 | 18204 | 49 |
NRG3 |
2.692e-03 | -5.92 | homologous chromosome movement towards spindle pole in meiosis I anaphase | biological process | GO:0051758 | 1 | 1 | 18204 | 49 |
FMN2 |
2.698e-03 | -5.92 | FKBP1A (FKBP prolyl isomerase 1A) | protein interactions | 2280 | 108 | 3 | 19454 | 50 |
ERBB4,MSI2,RYR3 |
2.708e-03 | -5.91 | internal N(7)-methylguanine-containing RNA reader activity | molecular function | GO:0160089 | 1 | 1 | 18094 | 49 |
QKI |
2.709e-03 | -5.91 | large_intestine-caecum-carcinoma-adenocarcinoma | COSMIC cancer mutations | large_intestine-caecum-carcinoma-adenocarcinoma | 14236 | 48 | 16828 | 49 |
PITPNC1,AQP4,RPS6KA2,LSAMP,DCLK1,PCDH9,FMN2,CTNND2,GLIS3,QKI,SLC25A18,DCLK2,RFX4,SLC39A11,CAMK2G,IQCA1,SOX5,HIF3A,NAV2,SLC14A1,NRG3,PRKG1,ARAP2,MGAT4C,TRPM3,SORBS1,NPAS3,BMPR1B,DPP10,NTM,HPSE2,DAAM2,PTGDS,TRPS1,CDH20,ABR,PPP2R2B,RYR3,WDR49,TNRC6A,ADCY2,ERBB4,DST,LIFR,SLC1A2,MACF1,GFAP,DTNA |
2.724e-03 | -5.91 | transferase activity, transferring phosphorus-containing groups | molecular function | GO:0016772 | 903 | 8 | 18094 | 49 |
ERBB4,RPS6KA2,CAMK2G,DCLK1,DCLK2,TTN,PRKG1,BMPR1B |
2.752e-03 | -5.90 | Downstream signal transduction | REACTOME pathways | R-HSA-186763 | 352 | 5 | 10285 | 29 |
ERBB4,CAMK2G,NRG3,TNRC6A,ADCY2 |
2.784e-03 | -5.88 | amino acid:monoatomic cation symporter activity | molecular function | GO:0005416 | 29 | 2 | 18094 | 49 |
SLC25A18,SLC1A2 |
2.809e-03 | -5.87 | caecum | COSMIC cancer mutations | caecum | 14248 | 48 | 16828 | 49 |
RYR3,WDR49,ABR,CDH20,PPP2R2B,DTNA,GFAP,MACF1,SLC1A2,LIFR,ERBB4,ADCY2,TNRC6A,DST,MGAT4C,ARAP2,TRPS1,NTM,PTGDS,DAAM2,HPSE2,BMPR1B,DPP10,NPAS3,SORBS1,TRPM3,RFX4,SLC39A11,DCLK2,SLC25A18,GLIS3,QKI,NRG3,PRKG1,HIF3A,SLC14A1,NAV2,IQCA1,SOX5,CAMK2G,AQP4,RPS6KA2,PITPNC1,CTNND2,FMN2,LSAMP,DCLK1,PCDH9 |
2.845e-03 | -5.86 | Spectrin/alpha-actinin | interpro domains | IPR018159 | 30 | 2 | 18521 | 49 |
MACF1,DST |
2.853e-03 | -5.86 | cell communication | biological process | GO:0007154 | 5010 | 23 | 18204 | 49 |
ERBB4,DAAM2,PRKG1,DCLK1,ADCY2,ARAP2,NRG3,MACF1,ABR,DST,TTN,RPS6KA2,PITPNC1,BMPR1B,SLC1A2,CAMK2G,LIFR,FMN2,CTNND2,DCLK2,SORBS1,DTNA,RYR3 |
2.890e-03 | -5.85 | DAP12 signaling | REACTOME pathways | R-HSA-2424491 | 356 | 5 | 10285 | 29 |
ADCY2,TNRC6A,NRG3,CAMK2G,ERBB4 |
2.916e-03 | -5.84 | cell junction organization | biological process | GO:0034330 | 532 | 6 | 18204 | 49 |
ERBB4,DST,CDH20,NRG3,CTNND2,SORBS1 |
2.934e-03 | -5.83 | inorganic molecular entity transmembrane transporter activity | molecular function | GO:0015318 | 714 | 7 | 18094 | 49 |
SLC39A11,AQP4,SLC1A2,RYR3,TRPM3,SLC25A18,SLC14A1 |
2.942e-03 | -5.83 | L-glutamate import | biological process | GO:0051938 | 30 | 2 | 18204 | 49 |
SLC25A18,SLC1A2 |
2.973e-03 | -5.82 | CREB phosphorylation through the activation of Ras | REACTOME pathways | R-HSA-442742 | 29 | 2 | 10285 | 29 |
CAMK2G,RPS6KA2 |
3.026e-03 | -5.80 | Transmission across Chemical Synapses | REACTOME pathways | R-HSA-112315 | 217 | 4 | 10285 | 29 |
CAMK2G,SLC1A2,ADCY2,RPS6KA2 |
3.132e-03 | -5.77 | acute_lymphoblastic_leukaemia | COSMIC cancer mutations | acute_lymphoblastic_leukaemia | 2197 | 14 | 16828 | 49 |
CAMK2G,ERBB4,ADCY2,DCLK1,SOX5,BMPR1B,DAAM2,DTNA,GFAP,PRKG1,TRPS1,SLC25A18,DCLK2,RPS6KA2 |
3.180e-03 | -5.75 | Downregulation of ERBB2 signaling | REACTOME pathways | R-HSA-8863795 | 30 | 2 | 10285 | 29 |
NRG3,ERBB4 |
3.182e-03 | -5.75 | Signaling by EGFR | REACTOME pathways | R-HSA-177929 | 364 | 5 | 10285 | 29 |
ERBB4,CAMK2G,ADCY2,NRG3,TNRC6A |
3.204e-03 | -5.74 | cervix-carcinoma-squamous_cell_carcinoma | COSMIC cancer mutations | cervix-carcinoma-squamous_cell_carcinoma | 11789 | 43 | 16828 | 49 |
HIF3A,NAV2,MACF1,DTNA,NRG3,PRKG1,TNRC6A,ERBB4,ADCY2,DST,IQCA1,SLC1A2,SOX5,LIFR,DCLK2,RFX4,SLC39A11,RYR3,WDR49,CDH20,ABR,GLIS3,QKI,PPP2R2B,SLC25A18,NTM,CTNND2,FMN2,DAAM2,HPSE2,TRPS1,TRPM3,SORBS1,LSAMP,DCLK1,BMPR1B,DPP10,PCDH9,NPAS3,RPS6KA2,MGAT4C,ARAP2,PITPNC1 |
3.212e-03 | -5.74 | cell junction | cellular component | GO:0030054 | 2224 | 13 | 19108 | 49 |
CTNND2,QKI,CDH20,RPS6KA2,SLC1A2,DCLK1,SORBS1,ERBB4,NRG3,DTNA,ABR,DST,PCDH9 |
3.237e-03 | -5.73 | cervix | COSMIC cancer mutations | cervix | 11793 | 43 | 16828 | 49 |
PCDH9,DCLK1,LSAMP,CTNND2,FMN2,PITPNC1,RPS6KA2,SOX5,IQCA1,NAV2,HIF3A,PRKG1,NRG3,QKI,GLIS3,SLC25A18,DCLK2,SLC39A11,RFX4,TRPM3,SORBS1,DPP10,BMPR1B,NPAS3,DAAM2,HPSE2,NTM,TRPS1,MGAT4C,ARAP2,DST,ERBB4,ADCY2,TNRC6A,SLC1A2,LIFR,MACF1,DTNA,PPP2R2B,CDH20,ABR,WDR49,RYR3 |
3.248e-03 | -5.73 | - | gene3d domains | 6.10.250.880 | 1 | 1 | 14470 | 47 |
ERBB4 |
3.248e-03 | -5.73 | - | gene3d domains | 1.20.5.4010 | 1 | 1 | 14470 | 47 |
QKI |
3.249e-03 | -5.73 | NTM (neurotrimin) | protein interactions | 50863 | 33 | 2 | 19454 | 50 |
LSAMP,NTM |
3.252e-03 | -5.73 | AQUAPORIN4 | prints domains | PR02016 | 1 | 1 | 5227 | 17 |
AQP4 |
3.270e-03 | -5.72 | developmental process | biological process | GO:0032502 | 5716 | 25 | 18204 | 49 |
CTNND2,DCLK2,NTM,FMN2,GFAP,HIF3A,TRPS1,TNRC6A,CDH20,QKI,DAAM2,PRKG1,DCLK1,NRG3,PCDH9,NAV2,ERBB4,SOX5,BMPR1B,MSI2,RFX4,SLC1A2,CAMK2G,LSAMP,TTN |
3.336e-03 | -5.70 | GJA1 (gap junction protein alpha 1) | protein interactions | 2697 | 572 | 6 | 19454 | 50 |
ARAP2,ERBB4,DTNA,PCDH9,DST,MACF1 |
3.344e-03 | -5.70 | positive regulation of cartilage development | biological process | GO:0061036 | 32 | 2 | 18204 | 49 |
BMPR1B,SOX5 |
3.349e-03 | -5.70 | oesophagus-middle_third-carcinoma-squamous_cell_carcinoma | COSMIC cancer mutations | oesophagus-middle_third-carcinoma-squamous_cell_carcinoma | 3531 | 19 | 16828 | 49 |
NRG3,GFAP,FMN2,CTNND2,MACF1,HPSE2,NAV2,IQCA1,PCDH9,SOX5,DPP10,ADCY2,TNRC6A,TRPM3,DST,RYR3,SLC39A11,RPS6KA2,ARAP2 |
3.352e-03 | -5.70 | intermediate filament cytoskeleton | cellular component | GO:0045111 | 241 | 4 | 19108 | 49 |
DTNA,DST,MACF1,GFAP |
3.371e-03 | -5.69 | middle_third | COSMIC cancer mutations | middle_third | 3533 | 19 | 16828 | 49 |
TNRC6A,ADCY2,DST,TRPM3,IQCA1,SOX5,DPP10,PCDH9,CTNND2,FMN2,NAV2,HPSE2,MACF1,NRG3,GFAP,ARAP2,RPS6KA2,SLC39A11,RYR3 |
3.376e-03 | -5.69 | generation of neurons | biological process | GO:0048699 | 1158 | 9 | 18204 | 49 |
ERBB4,GFAP,DCLK2,NTM,PRKG1,CTNND2,DCLK1,SOX5,BMPR1B |
3.390e-03 | -5.69 | PAS | smart domains | SM00091 | 25 | 2 | 9717 | 34 |
HIF3A,NPAS3 |
3.400e-03 | -5.68 | regulation of gliogenesis | biological process | GO:0014013 | 112 | 3 | 18204 | 49 |
QKI,GFAP,DAAM2 |
3.442e-03 | -5.67 | adenyl nucleotide binding | molecular function | GO:0030554 | 1620 | 11 | 18094 | 49 |
ADCY2,TTN,PRKG1,ERBB4,RPS6KA2,DCLK1,BMPR1B,NAV2,IQCA1,CAMK2G,DCLK2 |
3.454e-03 | -5.67 | DAP12 interactions | REACTOME pathways | R-HSA-2172127 | 371 | 5 | 10285 | 29 |
CAMK2G,ERBB4,TNRC6A,NRG3,ADCY2 |
3.465e-03 | -5.67 | TTC3 (tetratricopeptide repeat domain 3) | protein interactions | 7267 | 118 | 3 | 19454 | 50 |
TTN,DST,DAAM2 |
3.486e-03 | -5.66 | dendrite development | biological process | GO:0016358 | 113 | 3 | 18204 | 49 |
PRKG1,DCLK1,CTNND2 |
3.499e-03 | -5.66 | DELLA | smart domains | SM01129 | 1 | 1 | 9717 | 34 |
MACF1 |
3.531e-03 | -5.65 | central_nervous_system-cerebellum-glioma-astrocytoma_Grade_I | COSMIC cancer mutations | central_nervous_system-cerebellum-glioma-astrocytoma_Grade_I | 105 | 3 | 16828 | 49 |
PRKG1,NRG3,QKI |
3.548e-03 | -5.64 | skin-trunk-malignant_melanoma-nodular | COSMIC cancer mutations | skin-trunk-malignant_melanoma-nodular | 1291 | 10 | 16828 | 49 |
NPAS3,GLIS3,ARAP2,ERBB4,TNRC6A,CDH20,MACF1,CTNND2,DCLK2,HIF3A |
3.619e-03 | -5.62 | haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm-NK-T_cell_lymphoma | COSMIC cancer mutations | haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm-NK-T_cell_lymphoma | 217 | 4 | 16828 | 49 |
NAV2,MGAT4C,DTNA,RFX4 |
3.644e-03 | -5.61 | PAS | interpro domains | IPR000014 | 34 | 2 | 18521 | 49 |
NPAS3,HIF3A |
3.644e-03 | -5.61 | PAS-like_dom_sf | interpro domains | IPR035965 | 34 | 2 | 18521 | 49 |
NPAS3,HIF3A |
3.656e-03 | -5.61 | thyroid-carcinoma | COSMIC cancer mutations | thyroid-carcinoma | 4126 | 21 | 16828 | 49 |
AQP4,RYR3,WDR49,ARAP2,GLIS3,ABR,NAV2,MACF1,CTNND2,HIF3A,TRPS1,PRKG1,DTNA,TRPM3,DST,ADCY2,ERBB4,SOX5,PCDH9,LIFR,LSAMP |
3.658e-03 | -5.61 | Signaling by PDGF | REACTOME pathways | R-HSA-186797 | 376 | 5 | 10285 | 29 |
CAMK2G,ERBB4,TNRC6A,NRG3,ADCY2 |
3.803e-03 | -5.57 | anion binding | molecular function | GO:0043168 | 2412 | 14 | 18094 | 49 |
IQCA1,PITPNC1,TTN,ERBB4,BMPR1B,NAV2,DCLK2,PTGDS,ARAP2,CAMK2G,PRKG1,ADCY2,DCLK1,RPS6KA2 |
3.857e-03 | -5.56 | C1QTNF9 (C1q and TNF related 9) | protein interactions | 338872 | 36 | 2 | 19454 | 50 |
DST,TTN |
3.897e-03 | -5.55 | skin-arm-malignant_melanoma | COSMIC cancer mutations | skin-arm-malignant_melanoma | 1308 | 10 | 16828 | 49 |
ERBB4,SORBS1,TRPM3,ARAP2,DPP10,NPAS3,NTM,NAV2,MACF1,TRPS1 |
4.032e-03 | -5.51 | haematopoietic_and_lymphoid_tissue | COSMIC cancer mutations | haematopoietic_and_lymphoid_tissue | 14368 | 48 | 16828 | 49 |
SORBS1,TRPM3,DPP10,BMPR1B,NPAS3,DAAM2,HPSE2,NTM,TRPS1,MGAT4C,ARAP2,DST,ERBB4,ADCY2,TNRC6A,SLC1A2,LIFR,MACF1,GFAP,DTNA,PPP2R2B,ABR,CDH20,WDR49,RYR3,PCDH9,DCLK1,LSAMP,CTNND2,FMN2,PITPNC1,RPS6KA2,AQP4,CAMK2G,SOX5,IQCA1,SLC14A1,NAV2,HIF3A,PRKG1,MSI2,NRG3,QKI,GLIS3,SLC25A18,DCLK2,SLC39A11,RFX4 |
4.071e-03 | -5.50 | MAGI2 (membrane associated guanylate kinase, WW and PDZ domain containing 2) | protein interactions | 9863 | 37 | 2 | 19454 | 50 |
CTNND2,ERBB4 |
4.071e-03 | -5.50 | TH (tyrosine hydroxylase) | protein interactions | 7054 | 37 | 2 | 19454 | 50 |
CAMK2G,DAAM2 |
4.073e-03 | -5.50 | SOCS6 (suppressor of cytokine signaling 6) | protein interactions | 9306 | 125 | 3 | 19454 | 50 |
DST,BMPR1B,ERBB4 |
4.117e-03 | -5.49 | NK-T_cell_lymphoma | COSMIC cancer mutations | NK-T_cell_lymphoma | 225 | 4 | 16828 | 49 |
RFX4,DTNA,NAV2,MGAT4C |
4.127e-03 | -5.49 | striated muscle contraction | biological process | GO:0006941 | 120 | 3 | 18204 | 49 |
RYR3,DTNA,TTN |
4.258e-03 | -5.46 | EPB41L4A (erythrocyte membrane protein band 4.1 like 4A) | protein interactions | 64097 | 127 | 3 | 19454 | 50 |
MACF1,DTNA,DST |
4.290e-03 | -5.45 | Pcbp1 (poly(rC) binding protein 1) | protein interactions | 23983 | 38 | 2 | 19454 | 50 |
QKI,MSI2 |
4.312e-03 | -5.45 | PAS | prosite domains | PS50112 | 30 | 2 | 12186 | 40 |
HIF3A,NPAS3 |
4.413e-03 | -5.42 | arm | COSMIC cancer mutations | arm | 1331 | 10 | 16828 | 49 |
DPP10,NPAS3,SORBS1,TRPM3,ARAP2,ERBB4,TRPS1,NAV2,MACF1,NTM |
4.448e-03 | -5.42 | central_nervous_system-brainstem-glioma-oligoastrocytoma_Grade_III | COSMIC cancer mutations | central_nervous_system-brainstem-glioma-oligoastrocytoma_Grade_III | 114 | 3 | 16828 | 49 |
SOX5,SLC1A2,RYR3 |
4.451e-03 | -5.41 | cardiac muscle hypertrophy | biological process | GO:0003300 | 37 | 2 | 18204 | 49 |
PRKG1,TTN |
4.451e-03 | -5.41 | positive regulation of glucose import | biological process | GO:0046326 | 37 | 2 | 18204 | 49 |
SLC1A2,SORBS1 |
4.451e-03 | -5.41 | negative regulation of protein localization to nucleus | biological process | GO:1900181 | 37 | 2 | 18204 | 49 |
DCLK1,DCLK2 |
4.493e-03 | -5.41 | A band | cellular component | GO:0031672 | 39 | 2 | 19108 | 49 |
TTN,DST |
4.494e-03 | -5.41 | DIRAS3 (DIRAS family GTPase 3) | protein interactions | 9077 | 261 | 4 | 19454 | 50 |
MACF1,FMN2,DTNA,DST |
4.512e-03 | -5.40 | Z disc | cellular component | GO:0030018 | 130 | 3 | 19108 | 49 |
DST,TTN,RYR3 |
4.515e-03 | -5.40 | MYBPC2 (myosin binding protein C2) | protein interactions | 4606 | 39 | 2 | 19454 | 50 |
TTN,DST |
4.548e-03 | -5.39 | SPEC | smart domains | SM00150 | 29 | 2 | 9717 | 34 |
DST,MACF1 |
4.576e-03 | -5.39 | haematopoietic_neoplasm | COSMIC cancer mutations | haematopoietic_neoplasm | 11082 | 41 | 16828 | 49 |
TRPM3,BMPR1B,DPP10,PCDH9,NPAS3,LSAMP,DCLK1,DAAM2,HPSE2,CTNND2,NTM,FMN2,ARAP2,RPS6KA2,DST,ERBB4,ADCY2,TNRC6A,CAMK2G,SOX5,SLC1A2,LIFR,IQCA1,NAV2,SLC14A1,MACF1,HIF3A,PRKG1,MSI2,GFAP,DTNA,NRG3,QKI,GLIS3,PPP2R2B,CDH20,DCLK2,SLC39A11,RYR3,WDR49,RFX4 |
4.691e-03 | -5.36 | fluid transport | biological process | GO:0042044 | 38 | 2 | 18204 | 49 |
SLC14A1,AQP4 |
4.691e-03 | -5.36 | amino acid import across plasma membrane | biological process | GO:0089718 | 38 | 2 | 18204 | 49 |
SLC1A2,GFAP |
4.691e-03 | -5.36 | striated muscle hypertrophy | biological process | GO:0014897 | 38 | 2 | 18204 | 49 |
PRKG1,TTN |
4.768e-03 | -5.35 | EF-hand-dom_pair | interpro domains | IPR011992 | 258 | 4 | 18521 | 49 |
MACF1,RYR3,DST,DTNA |
4.810e-03 | -5.34 | Post NMDA receptor activation events | REACTOME pathways | R-HSA-438064 | 37 | 2 | 10285 | 29 |
RPS6KA2,CAMK2G |
4.852e-03 | -5.33 | cellular process | biological process | GO:0009987 | 14996 | 47 | 18204 | 49 |
DCLK2,LIFR,FMN2,GFAP,HPSE2,PPP2R2B,TNRC6A,SLC14A1,PRKG1,ABR,MACF1,NRG3,ADCY2,ERBB4,BMPR1B,PITPNC1,SOX5,RFX4,TTN,RPS6KA2,CTNND2,MGAT4C,SLC25A18,NTM,AQP4,GLIS3,HIF3A,RYR3,SORBS1,DPP10,QKI,CDH20,DTNA,DCLK1,DAAM2,PCDH9,DST,ARAP2,SLC39A11,PTGDS,NAV2,MSI2,IQCA1,CAMK2G,LSAMP,TRPM3,SLC1A2 |
4.858e-03 | -5.33 | humerus | COSMIC cancer mutations | humerus | 546 | 6 | 16828 | 49 |
PRKG1,SOX5,HIF3A,FMN2,ADCY2,PPP2R2B |
4.929e-03 | -5.31 | protein complex oligomerization | biological process | GO:0051259 | 256 | 4 | 18204 | 49 |
AQP4,TRPM3,SLC1A2,RYR3 |
4.936e-03 | -5.31 | cellular response to alkaloid | biological process | GO:0071312 | 39 | 2 | 18204 | 49 |
SLC1A2,RYR3 |
4.945e-03 | -5.31 | ARL4C (ADP ribosylation factor like GTPase 4C) | protein interactions | 10123 | 134 | 3 | 19454 | 50 |
PCDH9,ARAP2,TTN |
4.988e-03 | -5.30 | upper_aerodigestive_tract-head_neck-carcinoma-adenoid_cystic_carcinoma | COSMIC cancer mutations | upper_aerodigestive_tract-head_neck-carcinoma-adenoid_cystic_carcinoma | 383 | 5 | 16828 | 49 |
LIFR,DCLK1,RPS6KA2,CAMK2G,ERBB4 |
4.988e-03 | -5.30 | salivary_gland-carcinoma | COSMIC cancer mutations | salivary_gland-carcinoma | 383 | 5 | 16828 | 49 |
CAMK2G,ERBB4,RPS6KA2,DCLK1,LIFR |
4.988e-03 | -5.30 | upper_aerodigestive_tract-carcinoma | COSMIC cancer mutations | upper_aerodigestive_tract-carcinoma | 383 | 5 | 16828 | 49 |
LIFR,DCLK1,RPS6KA2,CAMK2G,ERBB4 |
4.988e-03 | -5.30 | upper_aerodigestive_tract-lymph_node-carcinoma-adenoid_cystic_carcinoma | COSMIC cancer mutations | upper_aerodigestive_tract-lymph_node-carcinoma-adenoid_cystic_carcinoma | 383 | 5 | 16828 | 49 |
DCLK1,LIFR,ERBB4,CAMK2G,RPS6KA2 |
4.988e-03 | -5.30 | upper_aerodigestive_tract-mouth-carcinoma-adenoid_cystic_carcinoma | COSMIC cancer mutations | upper_aerodigestive_tract-mouth-carcinoma-adenoid_cystic_carcinoma | 383 | 5 | 16828 | 49 |
LIFR,DCLK1,RPS6KA2,ERBB4,CAMK2G |
5.049e-03 | -5.29 | Myo1c (myosin IC) | protein interactions | 17913 | 135 | 3 | 19454 | 50 |
TRPS1,CAMK2G,DST |
5.049e-03 | -5.29 | NTRK2 (neurotrophic receptor tyrosine kinase 2) | protein interactions | 4915 | 135 | 3 | 19454 | 50 |
ERBB4,DTNA,DST |
5.085e-03 | -5.28 | PIP3 activates AKT signaling | REACTOME pathways | R-HSA-1257604 | 125 | 3 | 10285 | 29 |
ERBB4,NRG3,TNRC6A |
5.098e-03 | -5.28 | I-set | pfam domains | PF07679 | 132 | 3 | 17795 | 47 |
TTN,LSAMP,NTM |
5.131e-03 | -5.27 | haematopoietic_and_lymphoid_tissue-abdomen-lymphoid_neoplasm-diffuse_large_B_cell_lymphoma | COSMIC cancer mutations | haematopoietic_and_lymphoid_tissue-abdomen-lymphoid_neoplasm-diffuse_large_B_cell_lymphoma | 120 | 3 | 16828 | 49 |
DST,CTNND2,FMN2 |
5.133e-03 | -5.27 | Ig_I-set | interpro domains | IPR013098 | 132 | 3 | 18521 | 49 |
NTM,TTN,LSAMP |
5.134e-03 | -5.27 | Kdm4c (lysine (K)-specific demethylase 4C) | protein interactions | 76804 | 2 | 1 | 19454 | 50 |
GLIS3 |
5.134e-03 | -5.27 | ORF43 (ORF43) | protein interactions | 4961497 | 2 | 1 | 19454 | 50 |
DAAM2 |
5.134e-03 | -5.27 | cdh11.S (cadherin 11 S homeolog) | protein interactions | 100337621 | 2 | 1 | 19454 | 50 |
ERBB4 |
5.134e-03 | -5.27 | TRIM39-RPP21 (TRIM39-RPP21 readthrough) | protein interactions | 202658 | 2 | 1 | 19454 | 50 |
PRKG1 |
5.134e-03 | -5.27 | URA1 (dihydroorotate dehydrogenase) | protein interactions | 853664 | 2 | 1 | 19454 | 50 |
GFAP |
5.134e-03 | -5.27 | Ppp3cc (protein phosphatase 3, catalytic subunit, gamma isoform) | protein interactions | 19057 | 2 | 1 | 19454 | 50 |
BMPR1B |
5.134e-03 | -5.27 | Zmym2 (zinc finger, MYM-type 2) | protein interactions | 76007 | 2 | 1 | 19454 | 50 |
GLIS3 |
5.134e-03 | -5.27 | Mknk2 (MAP kinase-interacting serine/threonine kinase 2) | protein interactions | 17347 | 2 | 1 | 19454 | 50 |
BMPR1B |
5.134e-03 | -5.27 | Bcr (BCR activator of RhoGEF and GTPase) | protein interactions | 110279 | 2 | 1 | 19454 | 50 |
BMPR1B |
5.134e-03 | -5.27 | Fkbp1b (FK506 binding protein 1b) | protein interactions | 14226 | 2 | 1 | 19454 | 50 |
BMPR1B |
5.134e-03 | -5.27 | Bmpr2 (bone morphogenetic protein receptor type 2) | protein interactions | 12168 | 2 | 1 | 19454 | 50 |
BMPR1B |
5.134e-03 | -5.27 | Fkbp1a (FK506 binding protein 1a) | protein interactions | 14225 | 2 | 1 | 19454 | 50 |
BMPR1B |
5.134e-03 | -5.27 | EST1 (Est1p) | protein interactions | 850934 | 2 | 1 | 19454 | 50 |
NAV2 |
5.134e-03 | -5.27 | Sh3kbp1 (SH3-domain kinase binding protein 1) | protein interactions | 58194 | 2 | 1 | 19454 | 50 |
BMPR1B |
5.134e-03 | -5.27 | Irf7 (interferon regulatory factor 7) | protein interactions | 54123 | 2 | 1 | 19454 | 50 |
BMPR1B |
5.134e-03 | -5.27 | Klhl1 (kelch-like 1) | protein interactions | 93688 | 2 | 1 | 19454 | 50 |
BMPR1B |
5.134e-03 | -5.27 | Fbxo34 (F-box protein 34) | protein interactions | 78938 | 2 | 1 | 19454 | 50 |
BMPR1B |
5.187e-03 | -5.26 | muscle hypertrophy | biological process | GO:0014896 | 40 | 2 | 18204 | 49 |
PRKG1,TTN |
5.271e-03 | -5.25 | carboxylic acid transmembrane transport | biological process | GO:1905039 | 131 | 3 | 18204 | 49 |
SLC1A2,GFAP,SLC25A18 |
5.276e-03 | -5.24 | LIFR_D2 | pfam domains | PF17971 | 2 | 1 | 17795 | 47 |
LIFR |
5.276e-03 | -5.24 | LIF-R_Ig-like | pfam domains | PF21177 | 2 | 1 | 17795 | 47 |
LIFR |
5.276e-03 | -5.24 | UT | pfam domains | PF03253 | 2 | 1 | 17795 | 47 |
SLC14A1 |
5.276e-03 | -5.24 | Bcr-Abl_Oligo | pfam domains | PF09036 | 2 | 1 | 17795 | 47 |
ABR |
5.276e-03 | -5.24 | Glyco_hydro_79n | pfam domains | PF03662 | 2 | 1 | 17795 | 47 |
HPSE2 |
5.284e-03 | -5.24 | cGMP_dep_kinase | interpro domains | IPR002374 | 2 | 1 | 18521 | 49 |
PRKG1 |
5.284e-03 | -5.24 | Bcr-Abl_oncoprot_oligo | interpro domains | IPR015123 | 2 | 1 | 18521 | 49 |
ABR |
5.284e-03 | -5.24 | MSI_RRM2 | interpro domains | IPR034126 | 2 | 1 | 18521 | 49 |
MSI2 |
5.284e-03 | -5.24 | LIF-R-like_Ig-like | interpro domains | IPR048497 | 2 | 1 | 18521 | 49 |
LIFR |
5.284e-03 | -5.24 | Abr/Bcr | interpro domains | IPR037769 | 2 | 1 | 18521 | 49 |
ABR |
5.284e-03 | -5.24 | DCX_chordates | interpro domains | IPR017302 | 2 | 1 | 18521 | 49 |
DCLK1 |
5.284e-03 | -5.24 | Bcr-Abl_oncoprot_oligo_sf | interpro domains | IPR036481 | 2 | 1 | 18521 | 49 |
ABR |
5.284e-03 | -5.24 | Urea_transporter | interpro domains | IPR004937 | 2 | 1 | 18521 | 49 |
SLC14A1 |
5.284e-03 | -5.24 | Formin_Cappuccino_subfam | interpro domains | IPR001265 | 2 | 1 | 18521 | 49 |
FMN2 |
5.284e-03 | -5.24 | Distrobrevin | interpro domains | IPR017432 | 2 | 1 | 18521 | 49 |
DTNA |
5.284e-03 | -5.24 | STKc_cGK | interpro domains | IPR035014 | 2 | 1 | 18521 | 49 |
PRKG1 |
5.284e-03 | -5.24 | LIFR_D2 | interpro domains | IPR040817 | 2 | 1 | 18521 | 49 |
LIFR |
5.284e-03 | -5.24 | Glyco_hydro_79 | interpro domains | IPR005199 | 2 | 1 | 18521 | 49 |
HPSE2 |
5.356e-03 | -5.23 | lung-middle_lobe-carcinoma-adenocarcinoma | COSMIC cancer mutations | lung-middle_lobe-carcinoma-adenocarcinoma | 1368 | 10 | 16828 | 49 |
TNRC6A,ERBB4,TRPM3,DCLK1,PCDH9,CTNND2,HPSE2,MACF1,RYR3,WDR49 |
5.376e-03 | -5.23 | myofibroblast contraction | biological process | GO:1990764 | 2 | 1 | 18204 | 49 |
QKI |
5.376e-03 | -5.23 | negative regulation of 3'-UTR-mediated mRNA stabilization | biological process | GO:1905869 | 2 | 1 | 18204 | 49 |
QKI |
5.376e-03 | -5.23 | negative regulation of inositol phosphate biosynthetic process | biological process | GO:0010920 | 2 | 1 | 18204 | 49 |
PRKG1 |
5.376e-03 | -5.23 | establishment of planar polarity involved in nephron morphogenesis | biological process | GO:0072046 | 2 | 1 | 18204 | 49 |
ERBB4 |
5.383e-03 | -5.22 | amino acid transport | biological process | GO:0006865 | 132 | 3 | 18204 | 49 |
SLC25A18,SLC1A2,GFAP |
5.386e-03 | -5.22 | membrane | cellular component | GO:0016020 | 9220 | 33 | 19108 | 49 |
CAMK2G,DTNA,PCDH9,TRPM3,SLC14A1,SLC25A18,SLC39A11,RYR3,NRG3,LIFR,DCLK1,PTGDS,SLC1A2,PPP2R2B,GFAP,NTM,LSAMP,CTNND2,PRKG1,ABR,DST,FMN2,DPP10,ADCY2,MACF1,ERBB4,AQP4,SORBS1,BMPR1B,HIF3A,CDH20,MGAT4C,HPSE2 |
5.409e-03 | -5.22 | heparanase activity | molecular function | GO:0030305 | 2 | 1 | 18094 | 49 |
HPSE2 |
5.409e-03 | -5.22 | cGMP-dependent protein kinase activity | molecular function | GO:0004692 | 2 | 1 | 18094 | 49 |
PRKG1 |
5.409e-03 | -5.22 | leukemia inhibitory factor receptor activity | molecular function | GO:0004923 | 2 | 1 | 18094 | 49 |
LIFR |
5.432e-03 | -5.22 | GAB1 signalosome | REACTOME pathways | R-HSA-180292 | 128 | 3 | 10285 | 29 |
ERBB4,TNRC6A,NRG3 |
5.432e-03 | -5.22 | PI3K/AKT activation | REACTOME pathways | R-HSA-198203 | 128 | 3 | 10285 | 29 |
ERBB4,NRG3,TNRC6A |
5.440e-03 | -5.21 | sarcoplasmic reticulum membrane | cellular component | GO:0033017 | 43 | 2 | 19108 | 49 |
RYR3,CAMK2G |
5.443e-03 | -5.21 | cell-substrate junction assembly | biological process | GO:0007044 | 41 | 2 | 18204 | 49 |
DST,SORBS1 |
5.462e-03 | -5.21 | lung-carcinoma-adenocarcinoma | COSMIC cancer mutations | lung-carcinoma-adenocarcinoma | 15133 | 49 | 16828 | 49 |
WDR49,RYR3,ABR,CDH20,PPP2R2B,GFAP,DTNA,MACF1,LIFR,SLC1A2,ERBB4,ADCY2,TNRC6A,DST,ARAP2,MGAT4C,TRPS1,NTM,HPSE2,DAAM2,PTGDS,NPAS3,DPP10,BMPR1B,SORBS1,TRPM3,RFX4,SLC39A11,DCLK2,SLC25A18,QKI,GLIS3,NRG3,PRKG1,MSI2,HIF3A,SLC14A1,NAV2,IQCA1,SOX5,CAMK2G,AQP4,RPS6KA2,PITPNC1,FMN2,CTNND2,DCLK1,LSAMP,PCDH9 |
5.501e-03 | -5.20 | growth | biological process | GO:0040007 | 424 | 5 | 18204 | 49 |
BMPR1B,DCLK1,PRKG1,SLC1A2,ERBB4 |
5.501e-03 | -5.20 | developmental growth | biological process | GO:0048589 | 424 | 5 | 18204 | 49 |
DCLK1,PRKG1,BMPR1B,ERBB4,SLC1A2 |
5.535e-03 | -5.20 | salivary_gland-parotid-carcinoma-adenoid_cystic_carcinoma | COSMIC cancer mutations | salivary_gland-parotid-carcinoma-adenoid_cystic_carcinoma | 561 | 6 | 16828 | 49 |
RPS6KA2,ERBB4,CAMK2G,RYR3,LIFR,DCLK1 |
5.601e-03 | -5.18 | Oocyte meiosis | KEGG pathways | ko04114 | 120 | 3 | 7161 | 22 |
CAMK2G,ADCY2,RPS6KA2 |
5.601e-03 | -5.18 | Oocyte meiosis | KEGG pathways | hsa04114 | 120 | 3 | 7161 | 22 |
RPS6KA2,ADCY2,CAMK2G |
5.625e-03 | -5.18 | haematopoietic_and_lymphoid_tissue-lymph_node-lymphoid_neoplasm-diffuse_large_B_cell_lymphoma | COSMIC cancer mutations | haematopoietic_and_lymphoid_tissue-lymph_node-lymphoid_neoplasm-diffuse_large_B_cell_lymphoma | 748 | 7 | 16828 | 49 |
DPP10,SOX5,ARAP2,DTNA,TRPS1,PRKG1,CTNND2 |
5.717e-03 | -5.16 | SH2D1A (SH2 domain containing 1A) | protein interactions | 4068 | 44 | 2 | 19454 | 50 |
CAMK2G,ERBB4 |
5.729e-03 | -5.16 | organic acid transmembrane transport | biological process | GO:1903825 | 135 | 3 | 18204 | 49 |
SLC1A2,GFAP,SLC25A18 |
5.739e-03 | -5.16 | - | gene3d domains | 1.20.58.60 | 35 | 2 | 14470 | 47 |
DST,MACF1 |
5.752e-03 | -5.16 | middle_lobe | COSMIC cancer mutations | middle_lobe | 1382 | 10 | 16828 | 49 |
WDR49,RYR3,HPSE2,MACF1,CTNND2,PCDH9,DCLK1,TRPM3,ERBB4,TNRC6A |
5.755e-03 | -5.16 | clear_cell_renal_cell_carcinoma | COSMIC cancer mutations | clear_cell_renal_cell_carcinoma | 13924 | 47 | 16828 | 49 |
DAAM2,PTGDS,HPSE2,TRPS1,TRPM3,SORBS1,DPP10,BMPR1B,NPAS3,MGAT4C,ARAP2,MACF1,DTNA,GFAP,DST,TNRC6A,ADCY2,ERBB4,SLC1A2,LIFR,WDR49,RYR3,PPP2R2B,ABR,CDH20,CTNND2,FMN2,PCDH9,DCLK1,LSAMP,RPS6KA2,AQP4,PITPNC1,SLC14A1,NAV2,HIF3A,MSI2,PRKG1,NRG3,CAMK2G,SOX5,IQCA1,DCLK2,SLC39A11,QKI,GLIS3,SLC25A18 |
5.755e-03 | -5.16 | kidney-carcinoma-clear_cell_renal_cell_carcinoma | COSMIC cancer mutations | kidney-carcinoma-clear_cell_renal_cell_carcinoma | 13924 | 47 | 16828 | 49 |
TRPS1,PTGDS,DAAM2,HPSE2,BMPR1B,DPP10,NPAS3,SORBS1,TRPM3,MGAT4C,ARAP2,GFAP,DTNA,MACF1,SLC1A2,LIFR,ADCY2,ERBB4,TNRC6A,DST,RYR3,WDR49,CDH20,ABR,PPP2R2B,CTNND2,FMN2,LSAMP,DCLK1,PCDH9,AQP4,RPS6KA2,PITPNC1,NRG3,MSI2,PRKG1,HIF3A,NAV2,SLC14A1,IQCA1,SOX5,CAMK2G,SLC39A11,DCLK2,SLC25A18,GLIS3,QKI |
5.771e-03 | -5.15 | stomach-carcinoma-adenocarcinoma | COSMIC cancer mutations | stomach-carcinoma-adenocarcinoma | 15150 | 49 | 16828 | 49 |
BMPR1B,DPP10,NPAS3,TRPM3,SORBS1,TRPS1,PTGDS,DAAM2,HPSE2,NTM,MGAT4C,ARAP2,SLC1A2,LIFR,DST,ADCY2,ERBB4,TNRC6A,GFAP,DTNA,MACF1,PPP2R2B,ABR,CDH20,RYR3,WDR49,PCDH9,LSAMP,DCLK1,CTNND2,FMN2,PITPNC1,RPS6KA2,AQP4,SOX5,IQCA1,CAMK2G,MSI2,PRKG1,NRG3,SLC14A1,NAV2,HIF3A,SLC25A18,GLIS3,QKI,SLC39A11,RFX4,DCLK2 |
5.775e-03 | -5.15 | YWHAQ (tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein theta) | protein interactions | 10971 | 1076 | 8 | 19454 | 50 |
DCLK2,DST,SORBS1,TTN,NAV2,DCLK1,ARAP2,MACF1 |
5.776e-03 | -5.15 | right_upper_lobe | COSMIC cancer mutations | right_upper_lobe | 10376 | 39 | 16828 | 49 |
DCLK2,RYR3,WDR49,RFX4,PPP2R2B,GLIS3,ABR,CDH20,SLC25A18,MACF1,NAV2,HIF3A,PRKG1,NRG3,GFAP,DTNA,DST,ERBB4,ADCY2,TNRC6A,LIFR,SOX5,SLC1A2,IQCA1,ARAP2,MGAT4C,PITPNC1,HPSE2,FMN2,CTNND2,NTM,TRPS1,TRPM3,SORBS1,NPAS3,PCDH9,BMPR1B,DCLK1,LSAMP |
5.776e-03 | -5.15 | lung-right_upper_lobe-carcinoma-adenocarcinoma | COSMIC cancer mutations | lung-right_upper_lobe-carcinoma-adenocarcinoma | 10376 | 39 | 16828 | 49 |
SLC25A18,CDH20,ABR,GLIS3,PPP2R2B,RFX4,RYR3,WDR49,DCLK2,IQCA1,SLC1A2,SOX5,LIFR,TNRC6A,ADCY2,ERBB4,DST,NRG3,GFAP,DTNA,PRKG1,HIF3A,NAV2,MACF1,PITPNC1,MGAT4C,ARAP2,LSAMP,DCLK1,BMPR1B,NPAS3,PCDH9,TRPM3,SORBS1,TRPS1,NTM,CTNND2,FMN2,HPSE2 |
5.784e-03 | -5.15 | NS-malignant_melanoma | COSMIC cancer mutations | NS-malignant_melanoma | 3420 | 18 | 16828 | 49 |
ADCY2,ERBB4,TRPM3,DCLK1,PCDH9,LIFR,CTNND2,FMN2,DAAM2,NAV2,MACF1,NRG3,MGAT4C,GLIS3,PITPNC1,RPS6KA2,RFX4,WDR49 |
5.793e-03 | -5.15 | Role of LAT2/NTAL/LAB on calcium mobilization | REACTOME pathways | R-HSA-2730905 | 131 | 3 | 10285 | 29 |
ERBB4,TNRC6A,NRG3 |
5.875e-03 | -5.14 | bone | COSMIC cancer mutations | bone | 8157 | 33 | 16828 | 49 |
ARAP2,PTGDS,DAAM2,HPSE2,CTNND2,FMN2,TRPS1,TRPM3,SORBS1,PCDH9,NPAS3,LSAMP,DCLK1,DCLK2,SLC39A11,RYR3,GLIS3,QKI,PPP2R2B,ABR,NAV2,MACF1,HIF3A,PRKG1,NRG3,DTNA,DST,ERBB4,TNRC6A,ADCY2,CAMK2G,SOX5,LIFR |
5.880e-03 | -5.14 | Activation of NMDA receptor upon glutamate binding and postsynaptic events | REACTOME pathways | R-HSA-442755 | 41 | 2 | 10285 | 29 |
RPS6KA2,CAMK2G |
5.885e-03 | -5.14 | central_nervous_system-brain-glioma-oligodendroglioma_Grade_III | COSMIC cancer mutations | central_nervous_system-brain-glioma-oligodendroglioma_Grade_III | 249 | 4 | 16828 | 49 |
GLIS3,MACF1,MGAT4C,NAV2 |
5.908e-03 | -5.13 | signal transduction | biological process | GO:0007165 | 4637 | 21 | 18204 | 49 |
PITPNC1,BMPR1B,RYR3,TTN,SORBS1,DTNA,RPS6KA2,DAAM2,PRKG1,DCLK1,CTNND2,DCLK2,ADCY2,NRG3,ARAP2,ABR,MACF1,DST,LIFR,ERBB4,FMN2 |
5.952e-03 | -5.12 | actin filament-based process | biological process | GO:0030029 | 616 | 6 | 18204 | 49 |
SORBS1,TTN,QKI,FMN2,PRKG1,DAAM2 |
5.974e-03 | -5.12 | cell-substrate junction organization | biological process | GO:0150115 | 43 | 2 | 18204 | 49 |
DST,SORBS1 |
5.994e-03 | -5.12 | I band | cellular component | GO:0031674 | 144 | 3 | 19108 | 49 |
TTN,RYR3,DST |
6.032e-03 | -5.11 | intracellular signal transduction | biological process | GO:0035556 | 1505 | 10 | 18204 | 49 |
TTN,RPS6KA2,FMN2,DCLK1,PRKG1,NRG3,ADCY2,DCLK2,RYR3,ABR |
6.037e-03 | -5.11 | Calml3 (calmodulin-like 3) | protein interactions | 70405 | 144 | 3 | 19454 | 50 |
MACF1,CAMK2G,DST |
6.126e-03 | -5.10 | neuron projection | cellular component | GO:0043005 | 1331 | 9 | 19108 | 49 |
ABR,DTNA,DST,SLC1A2,PCDH9,BMPR1B,CAMK2G,CTNND2,ADCY2 |
6.220e-03 | -5.08 | DCTN1 (dynactin subunit 1) | protein interactions | 1639 | 457 | 5 | 19454 | 50 |
MACF1,DST,TTN,DCLK2,DCLK1 |
6.224e-03 | -5.08 | cellular component organization | biological process | GO:0016043 | 5636 | 24 | 18204 | 49 |
CDH20,SORBS1,RYR3,AQP4,HPSE2,GFAP,FMN2,DCLK2,CTNND2,TTN,SLC1A2,TRPM3,RFX4,IQCA1,BMPR1B,PITPNC1,ERBB4,NAV2,NRG3,DST,MACF1,DAAM2,DCLK1,PRKG1 |
6.234e-03 | -5.08 | CLIP4 (CAP-Gly domain containing linker protein family member 4) | protein interactions | 79745 | 46 | 2 | 19454 | 50 |
TTN,DST |
6.247e-03 | -5.08 | positive regulation of glucose transmembrane transport | biological process | GO:0010828 | 44 | 2 | 18204 | 49 |
SLC1A2,SORBS1 |
6.272e-03 | -5.07 | PARD3 (par-3 family cell polarity regulator) | protein interactions | 56288 | 287 | 4 | 19454 | 50 |
DTNA,DST,SORBS1,TTN |
6.288e-03 | -5.07 | basal plasma membrane | cellular component | GO:0009925 | 288 | 4 | 19108 | 49 |
ERBB4,DST,AQP4,SLC14A1 |
6.348e-03 | -5.06 | VASP (vasodilator stimulated phosphoprotein) | protein interactions | 7408 | 288 | 4 | 19454 | 50 |
SORBS1,TNRC6A,FMN2,PRKG1 |
6.384e-03 | -5.05 | parotid | COSMIC cancer mutations | parotid | 578 | 6 | 16828 | 49 |
CAMK2G,ERBB4,RPS6KA2,DCLK1,RYR3,LIFR |
6.453e-03 | -5.04 | Vasopressin regulates renal water homeostasis via Aquaporins | REACTOME pathways | R-HSA-432040 | 43 | 2 | 10285 | 29 |
ADCY2,AQP4 |
6.486e-03 | -5.04 | - | gene3d domains | 6.20.350.10 | 2 | 1 | 14470 | 47 |
RYR3 |
6.486e-03 | -5.04 | Bcr-Abl oncoprotein oligomerisation domain | gene3d domains | 4.10.280.30 | 2 | 1 | 14470 | 47 |
ABR |
6.495e-03 | -5.04 | FORMIN | prints domains | PR00828 | 2 | 1 | 5227 | 17 |
FMN2 |
6.495e-03 | -5.04 | CGMPKINASE | prints domains | PR00104 | 2 | 1 | 5227 | 17 |
PRKG1 |
6.500e-03 | -5.04 | PTGER4 (prostaglandin E receptor 4) | protein interactions | 5734 | 47 | 2 | 19454 | 50 |
DST,CTNND2 |
6.527e-03 | -5.03 | acidic amino acid transport | biological process | GO:0015800 | 45 | 2 | 18204 | 49 |
SLC25A18,SLC1A2 |
6.599e-03 | -5.02 | SOX2 (SRY-box transcription factor 2) | protein interactions | 6657 | 1342 | 9 | 19454 | 50 |
MACF1,TRPS1,QKI,TNRC6A,LSAMP,NAV2,GLIS3,MSI2,SOX5 |
6.812e-03 | -4.99 | regulation of oligodendrocyte differentiation | biological process | GO:0048713 | 46 | 2 | 18204 | 49 |
DAAM2,QKI |
6.870e-03 | -4.98 | uveal_tract | COSMIC cancer mutations | uveal_tract | 587 | 6 | 16828 | 49 |
CTNND2,MACF1,ADCY2,TNRC6A,TRPM3,PCDH9 |
6.881e-03 | -4.98 | TNIK (TRAF2 and NCK interacting kinase) | protein interactions | 23043 | 151 | 3 | 19454 | 50 |
DST,MACF1,PRKG1 |
6.939e-03 | -4.97 | haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm-follicular_lymphoma | COSMIC cancer mutations | haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm-follicular_lymphoma | 981 | 8 | 16828 | 49 |
PRKG1,NRG3,HPSE2,CTNND2,PCDH9,SOX5,LSAMP,ADCY2 |
7.049e-03 | -4.95 | FBLIM1 (filamin binding LIM protein 1) | protein interactions | 54751 | 49 | 2 | 19454 | 50 |
DCLK2,DCLK1 |
7.119e-03 | -4.94 | oligoastrocytoma_Grade_III | COSMIC cancer mutations | oligoastrocytoma_Grade_III | 263 | 4 | 16828 | 49 |
SOX5,SLC1A2,WDR49,RYR3 |
7.404e-03 | -4.91 | large_intestine-adenoma | COSMIC cancer mutations | large_intestine-adenoma | 266 | 4 | 16828 | 49 |
CDH20,SOX5,RYR3,LIFR |
7.446e-03 | -4.90 | PAS domain | gene3d domains | 3.30.450.20 | 40 | 2 | 14470 | 47 |
HIF3A,NPAS3 |
7.585e-03 | -4.88 | oesophagus-lower_third-carcinoma-squamous_cell_carcinoma | COSMIC cancer mutations | oesophagus-lower_third-carcinoma-squamous_cell_carcinoma | 3507 | 18 | 16828 | 49 |
RYR3,DCLK2,DPP10,NPAS3,LIFR,PCDH9,ADCY2,TNRC6A,ERBB4,DST,TRPM3,PRKG1,CTNND2,FMN2,DAAM2,NAV2,MACF1,HPSE2 |
7.592e-03 | -4.88 | haematopoietic_and_lymphoid_tissue-small_intestine-lymphoid_neoplasm-enteropathy_type_T_cell_lymphoma | COSMIC cancer mutations | haematopoietic_and_lymphoid_tissue-small_intestine-lymphoid_neoplasm-enteropathy_type_T_cell_lymphoma | 45 | 2 | 16828 | 49 |
MGAT4C,MACF1 |
7.592e-03 | -4.88 | enteropathy_type_T_cell_lymphoma | COSMIC cancer mutations | enteropathy_type_T_cell_lymphoma | 45 | 2 | 16828 | 49 |
MACF1,MGAT4C |
7.631e-03 | -4.88 | human chr8q23.3 | chromosome location | human chr8q23.3 | 4 | 1 | 26134 | 50 |
TRPS1 |
7.691e-03 | -4.87 | Lrrc7 (leucine rich repeat containing 7) | protein interactions | 117284 | 3 | 1 | 19454 | 50 |
CAMK2G |
7.691e-03 | -4.87 | NRG3 (neuregulin 3) | protein interactions | 10718 | 3 | 1 | 19454 | 50 |
ERBB4 |
7.691e-03 | -4.87 | Spop (speckle-type BTB/POZ protein) | protein interactions | 20747 | 3 | 1 | 19454 | 50 |
GLIS3 |
7.691e-03 | -4.87 | Smad6 (SMAD family member 6) | protein interactions | 17130 | 3 | 1 | 19454 | 50 |
BMPR1B |
7.691e-03 | -4.87 | Usp45 (ubiquitin specific petidase 45) | protein interactions | 77593 | 3 | 1 | 19454 | 50 |
BMPR1B |
7.691e-03 | -4.87 | QRFPR (pyroglutamylated RFamide peptide receptor) | protein interactions | 84109 | 3 | 1 | 19454 | 50 |
NTM |
7.691e-03 | -4.87 | Rap2a (RAS related protein 2a) | protein interactions | 76108 | 3 | 1 | 19454 | 50 |
BMPR1B |
7.691e-03 | -4.87 | Stk35 (serine/threonine kinase 35) | protein interactions | 67333 | 3 | 1 | 19454 | 50 |
BMPR1B |
7.691e-03 | -4.87 | Chn1 (chimerin 1) | protein interactions | 108699 | 3 | 1 | 19454 | 50 |
BMPR1B |
7.691e-03 | -4.87 | Fbxw5 (F-box and WD-40 domain protein 5) | protein interactions | 30839 | 3 | 1 | 19454 | 50 |
BMPR1B |
7.691e-03 | -4.87 | EBLN1 (endogenous Bornavirus like nucleoprotein 1) | protein interactions | 340900 | 3 | 1 | 19454 | 50 |
TTN |
7.691e-03 | -4.87 | Plekhb1 (pleckstrin homology domain containing, family B (evectins) member 1) | protein interactions | 27276 | 3 | 1 | 19454 | 50 |
BMPR1B |
7.691e-03 | -4.87 | Hk2 (hexokinase 2) | protein interactions | 25059 | 3 | 1 | 19454 | 50 |
PTGDS |
7.691e-03 | -4.87 | Atg16l1 (autophagy related 16 like 1) | protein interactions | 77040 | 3 | 1 | 19454 | 50 |
BMPR1B |
7.700e-03 | -4.87 | astrocytoma_Grade_I | COSMIC cancer mutations | astrocytoma_Grade_I | 139 | 3 | 16828 | 49 |
QKI,PRKG1,NRG3 |
7.720e-03 | -4.86 | endometrium-carcinoma-serous_carcinoma | COSMIC cancer mutations | endometrium-carcinoma-serous_carcinoma | 1442 | 10 | 16828 | 49 |
TRPS1,RYR3,WDR49,CTNND2,FMN2,LSAMP,DST,SORBS1,TRPM3,ARAP2 |
7.736e-03 | -4.86 | neuron differentiation | biological process | GO:0030182 | 1081 | 8 | 18204 | 49 |
DCLK2,NTM,BMPR1B,PRKG1,CTNND2,DCLK1,ERBB4,GFAP |
7.742e-03 | -4.86 | neuron development | biological process | GO:0048666 | 859 | 7 | 18204 | 49 |
BMPR1B,CTNND2,DCLK1,PRKG1,NTM,DCLK2,GFAP |
7.749e-03 | -4.86 | purine ribonucleoside triphosphate binding | molecular function | GO:0035639 | 1804 | 11 | 18094 | 49 |
IQCA1,TTN,ERBB4,BMPR1B,NAV2,CAMK2G,DCLK2,ADCY2,PRKG1,RPS6KA2,DCLK1 |
7.815e-03 | -4.85 | Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell | REACTOME pathways | R-HSA-112314 | 146 | 3 | 10285 | 29 |
ADCY2,RPS6KA2,CAMK2G |
7.847e-03 | -4.85 | basal part of cell | cellular component | GO:0045178 | 307 | 4 | 19108 | 49 |
SLC14A1,DST,AQP4,ERBB4 |
7.903e-03 | -4.84 | RR_TM4-6 | pfam domains | PF06459 | 3 | 1 | 17795 | 47 |
RYR3 |
7.903e-03 | -4.84 | TM_ErbB1 | pfam domains | PF21314 | 3 | 1 | 17795 | 47 |
ERBB4 |
7.903e-03 | -4.84 | Ago_hook | pfam domains | PF10427 | 3 | 1 | 17795 | 47 |
TNRC6A |
7.903e-03 | -4.84 | Sorb | pfam domains | PF02208 | 3 | 1 | 17795 | 47 |
SORBS1 |
7.903e-03 | -4.84 | RyR | pfam domains | PF02026 | 3 | 1 | 17795 | 47 |
RYR3 |
7.903e-03 | -4.84 | TNRC6-PABC_bdg | pfam domains | PF16608 | 3 | 1 | 17795 | 47 |
TNRC6A |
7.903e-03 | -4.84 | HIF-1 | pfam domains | PF11413 | 3 | 1 | 17795 | 47 |
HIF3A |
7.903e-03 | -4.84 | RYDR_Jsol | pfam domains | PF21119 | 3 | 1 | 17795 | 47 |
RYR3 |
7.909e-03 | -4.84 | SH2B2 (SH2B adaptor protein 2) | protein interactions | 10603 | 52 | 2 | 19454 | 50 |
SORBS1,ERBB4 |
7.909e-03 | -4.84 | AMHR2 (anti-Mullerian hormone receptor type 2) | protein interactions | 269 | 52 | 2 | 19454 | 50 |
RPS6KA2,BMPR1B |
7.916e-03 | -4.84 | SPRY1_RyR | interpro domains | IPR035761 | 3 | 1 | 18521 | 49 |
RYR3 |
7.916e-03 | -4.84 | Neuregulin | interpro domains | IPR040180 | 3 | 1 | 18521 | 49 |
NRG3 |
7.916e-03 | -4.84 | Ryan_recept | interpro domains | IPR013333 | 3 | 1 | 18521 | 49 |
RYR3 |
7.916e-03 | -4.84 | Ryanrecept_TM4-6 | interpro domains | IPR009460 | 3 | 1 | 18521 | 49 |
RYR3 |
7.916e-03 | -4.84 | SPRY2_RyR | interpro domains | IPR035764 | 3 | 1 | 18521 | 49 |
RYR3 |
7.916e-03 | -4.84 | RYDR_Jsol | interpro domains | IPR048581 | 3 | 1 | 18521 | 49 |
RYR3 |
7.916e-03 | -4.84 | TM_ErbB1 | interpro domains | IPR049328 | 3 | 1 | 18521 | 49 |
ERBB4 |
7.916e-03 | -4.84 | RhoGAP_ARAP | interpro domains | IPR037858 | 3 | 1 | 18521 | 49 |
ARAP2 |
7.916e-03 | -4.84 | SoHo_dom | interpro domains | IPR003127 | 3 | 1 | 18521 | 49 |
SORBS1 |
7.916e-03 | -4.84 | TNRC6_PABC-bd | interpro domains | IPR032226 | 3 | 1 | 18521 | 49 |
TNRC6A |
7.916e-03 | -4.84 | HIF_alpha-like | interpro domains | IPR021537 | 3 | 1 | 18521 | 49 |
HIF3A |
7.916e-03 | -4.84 | Ryanodine_rcpt | interpro domains | IPR003032 | 3 | 1 | 18521 | 49 |
RYR3 |
7.916e-03 | -4.84 | Argonaute_hook_dom | interpro domains | IPR019486 | 3 | 1 | 18521 | 49 |
TNRC6A |
7.916e-03 | -4.84 | SPRY3_RyR | interpro domains | IPR035762 | 3 | 1 | 18521 | 49 |
RYR3 |
7.916e-03 | -4.84 | Nav/unc-53 | interpro domains | IPR039041 | 3 | 1 | 18521 | 49 |
NAV2 |
7.928e-03 | -4.84 | DTNBP1 (dystrobrevin binding protein 1) | protein interactions | 84062 | 159 | 3 | 19454 | 50 |
MACF1,DTNA,DST |
7.984e-03 | -4.83 | eye | COSMIC cancer mutations | eye | 606 | 6 | 16828 | 49 |
TNRC6A,ADCY2,TRPM3,PCDH9,CTNND2,MACF1 |
8.021e-03 | -4.83 | YWHAZ (tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein zeta) | protein interactions | 7534 | 1138 | 8 | 19454 | 50 |
MACF1,DCLK1,NAV2,ARAP2,SORBS1,CAMK2G,DST,PITPNC1 |
8.054e-03 | -4.82 | cysteine transmembrane transport | biological process | GO:1903712 | 3 | 1 | 18204 | 49 |
SLC1A2 |
8.054e-03 | -4.82 | formin-nucleated actin cable assembly | biological process | GO:0070649 | 3 | 1 | 18204 | 49 |
FMN2 |
8.054e-03 | -4.82 | mammary placode formation | biological process | GO:0060596 | 3 | 1 | 18204 | 49 |
NRG3 |
8.054e-03 | -4.82 | meiotic chromosome movement towards spindle pole | biological process | GO:0016344 | 3 | 1 | 18204 | 49 |
FMN2 |
8.054e-03 | -4.82 | striated muscle myosin thick filament assembly | biological process | GO:0071688 | 3 | 1 | 18204 | 49 |
TTN |
8.054e-03 | -4.82 | vagus nerve development | biological process | GO:0021564 | 3 | 1 | 18204 | 49 |
NAV2 |
8.054e-03 | -4.82 | cysteine transport | biological process | GO:0042883 | 3 | 1 | 18204 | 49 |
SLC1A2 |
8.054e-03 | -4.82 | positive regulation of Schwann cell proliferation | biological process | GO:0010625 | 3 | 1 | 18204 | 49 |
GFAP |
8.054e-03 | -4.82 | formin-nucleated actin cable organization | biological process | GO:0110009 | 3 | 1 | 18204 | 49 |
FMN2 |
8.054e-03 | -4.82 | central nervous system morphogenesis | biological process | GO:0021551 | 3 | 1 | 18204 | 49 |
ERBB4 |
8.054e-03 | -4.82 | skeletal muscle myosin thick filament assembly | biological process | GO:0030241 | 3 | 1 | 18204 | 49 |
TTN |
8.054e-03 | -4.82 | Schwann cell proliferation | biological process | GO:0014010 | 3 | 1 | 18204 | 49 |
GFAP |
8.054e-03 | -4.82 | sarcomerogenesis | biological process | GO:0048769 | 3 | 1 | 18204 | 49 |
TTN |
8.103e-03 | -4.82 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity | molecular function | GO:0008454 | 3 | 1 | 18094 | 49 |
MGAT4C |
8.103e-03 | -4.82 | prostaglandin-D synthase activity | molecular function | GO:0004667 | 3 | 1 | 18094 | 49 |
PTGDS |
8.103e-03 | -4.82 | oncostatin-M receptor activity | molecular function | GO:0004924 | 3 | 1 | 18094 | 49 |
LIFR |
8.103e-03 | -4.82 | cysteine transmembrane transporter activity | molecular function | GO:0033229 | 3 | 1 | 18094 | 49 |
SLC1A2 |
8.103e-03 | -4.82 | urea channel activity | molecular function | GO:0015265 | 3 | 1 | 18094 | 49 |
SLC14A1 |
8.103e-03 | -4.82 | neuregulin receptor activity | molecular function | GO:0038131 | 3 | 1 | 18094 | 49 |
ERBB4 |
8.103e-03 | -4.82 | epidermal growth factor receptor activity | molecular function | GO:0005006 | 3 | 1 | 18094 | 49 |
ERBB4 |
8.267e-03 | -4.80 | muscle system process | biological process | GO:0003012 | 297 | 4 | 18204 | 49 |
RYR3,DTNA,PRKG1,TTN |
8.343e-03 | -4.79 | DSCAM (DS cell adhesion molecule) | protein interactions | 1826 | 162 | 3 | 19454 | 50 |
MACF1,DST,GFAP |
8.434e-03 | -4.78 | MAPK family signaling cascades | REACTOME pathways | R-HSA-5683057 | 290 | 4 | 10285 | 29 |
ERBB4,CAMK2G,NRG3,TNRC6A |
8.523e-03 | -4.77 | YWHAE (tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein epsilon) | protein interactions | 7531 | 1150 | 8 | 19454 | 50 |
DCLK2,CAMK2G,DST,SORBS1,DCLK1,NAV2,ARAP2,MACF1 |
8.604e-03 | -4.76 | cell motility | biological process | GO:0048870 | 1101 | 8 | 18204 | 49 |
CDH20,ERBB4,FMN2,NRG3,DST,DAAM2,DCLK1,PRKG1 |
8.986e-03 | -4.71 | Signaling by ERBB2 | REACTOME pathways | R-HSA-1227986 | 51 | 2 | 10285 | 29 |
NRG3,ERBB4 |
9.212e-03 | -4.69 | oesophagus-carcinoma-adenocarcinoma | COSMIC cancer mutations | oesophagus-carcinoma-adenocarcinoma | 13112 | 45 | 16828 | 49 |
CTNND2,FMN2,LSAMP,DCLK1,PCDH9,AQP4,RPS6KA2,NRG3,PRKG1,HIF3A,NAV2,IQCA1,SOX5,CAMK2G,RFX4,SLC39A11,DCLK2,SLC25A18,GLIS3,QKI,TRPS1,NTM,DAAM2,PTGDS,HPSE2,DPP10,BMPR1B,NPAS3,SORBS1,TRPM3,MGAT4C,ARAP2,GFAP,MACF1,SLC1A2,LIFR,TNRC6A,ADCY2,ERBB4,DST,RYR3,WDR49,ABR,CDH20,PPP2R2B |
9.231e-03 | -4.69 | ACTA1 (actin alpha 1, skeletal muscle) | protein interactions | 58 | 321 | 4 | 19454 | 50 |
SORBS1,TTN,DTNA,MACF1 |
9.268e-03 | -4.68 | Adrenergic signaling in cardiomyocytes | KEGG pathways | ko04261 | 144 | 3 | 7161 | 22 |
ADCY2,CAMK2G,PPP2R2B |
9.268e-03 | -4.68 | Adrenergic signaling in cardiomyocytes | KEGG pathways | hsa04261 | 144 | 3 | 7161 | 22 |
PPP2R2B,CAMK2G,ADCY2 |
9.312e-03 | -4.68 | AGC-kinase_C | interpro domains | IPR000961 | 55 | 2 | 18521 | 49 |
RPS6KA2,PRKG1 |
9.329e-03 | -4.67 | Aquaporin-mediated transport | REACTOME pathways | R-HSA-445717 | 52 | 2 | 10285 | 29 |
AQP4,ADCY2 |
9.361e-03 | -4.67 | PIAS2 (protein inhibitor of activated STAT 2) | protein interactions | 9063 | 169 | 3 | 19454 | 50 |
NAV2,SOX5,GFAP |
9.564e-03 | -4.65 | side of membrane | cellular component | GO:0098552 | 715 | 6 | 19108 | 49 |
DTNA,LSAMP,LIFR,NTM,AQP4,GFAP |
9.713e-03 | -4.63 | - | gene3d domains | 1.10.490.160 | 3 | 1 | 14470 | 47 |
RYR3 |
9.727e-03 | -4.63 | PGNDSYNTHASE | prints domains | PR01254 | 3 | 1 | 5227 | 17 |
PTGDS |
9.727e-03 | -4.63 | RYANODINER | prints domains | PR00795 | 3 | 1 | 5227 | 17 |
RYR3 |
9.763e-03 | -4.63 | CILK1 (ciliogenesis associated kinase 1) | protein interactions | 22858 | 58 | 2 | 19454 | 50 |
CAMK2G,MSI2 |
9.816e-03 | -4.62 | SOHO | prosite domains | PS50831 | 3 | 1 | 12186 | 40 |
SORBS1 |
9.929e-03 | -4.61 | import across plasma membrane | biological process | GO:0098739 | 165 | 3 | 18204 | 49 |
SLC1A2,GFAP,SLC39A11 |
9.962e-03 | -4.61 | thyroid-carcinoma-medullary_carcinoma | COSMIC cancer mutations | thyroid-carcinoma-medullary_carcinoma | 290 | 4 | 16828 | 49 |
SLC1A2,PRKG1,GFAP,NRG3 |
9.962e-03 | -4.61 | medullary_carcinoma | COSMIC cancer mutations | medullary_carcinoma | 290 | 4 | 16828 | 49 |
NRG3,GFAP,PRKG1,SLC1A2 |
1.009e-02 | -4.60 | ADAM17 (ADAM metallopeptidase domain 17) | protein interactions | 6868 | 59 | 2 | 19454 | 50 |
ERBB4,CAMK2G |
1.010e-02 | -4.59 | purine ribonucleotide binding | molecular function | GO:0032555 | 1871 | 11 | 18094 | 49 |
BMPR1B,NAV2,IQCA1,CAMK2G,DCLK2,PRKG1,ADCY2,TTN,RPS6KA2,ERBB4,DCLK1 |
1.023e-02 | -4.58 | MAPT (microtubule associated protein tau) | protein interactions | 4137 | 948 | 7 | 19454 | 50 |
PPP2R2B,LSAMP,NTM,CTNND2,DCLK1,SORBS1,SLC1A2 |
1.024e-02 | -4.58 | Ubr5 (ubiquitin protein ligase E3 component n-recognin 5) | protein interactions | 117060 | 4 | 1 | 19454 | 50 |
TNRC6A |
1.024e-02 | -4.58 | Ctbp2 (C-terminal binding protein 2) | protein interactions | 13017 | 4 | 1 | 19454 | 50 |
TRPS1 |
1.024e-02 | -4.58 | Dnaja1 (DnaJ heat shock protein family (Hsp40) member A1) | protein interactions | 15502 | 4 | 1 | 19454 | 50 |
GLIS3 |
1.024e-02 | -4.58 | Nkiras1 (NFKB inhibitor interacting Ras-like protein 1) | protein interactions | 69721 | 4 | 1 | 19454 | 50 |
BMPR1B |
1.024e-02 | -4.58 | Rhebl1 (Ras homolog enriched in brain like 1) | protein interactions | 69159 | 4 | 1 | 19454 | 50 |
BMPR1B |
1.024e-02 | -4.58 | Cdk14 (cyclin dependent kinase 14) | protein interactions | 18647 | 4 | 1 | 19454 | 50 |
BMPR1B |
1.024e-02 | -4.58 | CALML4 (calmodulin like 4) | protein interactions | 91860 | 4 | 1 | 19454 | 50 |
CAMK2G |
1.024e-02 | -4.58 | Ilkap (integrin-linked kinase-associated serine/threonine phosphatase 2C) | protein interactions | 67444 | 4 | 1 | 19454 | 50 |
BMPR1B |
1.024e-02 | -4.58 | Srgap1 (SLIT-ROBO Rho GTPase activating protein 1) | protein interactions | 117600 | 4 | 1 | 19454 | 50 |
BMPR1B |
1.024e-02 | -4.58 | Arhgef6 (Rac/Cdc42 guanine nucleotide exchange factor 6) | protein interactions | 73341 | 4 | 1 | 19454 | 50 |
BMPR1B |
1.024e-02 | -4.58 | Naa20 (N(alpha)-acetyltransferase 20, NatB catalytic subunit) | protein interactions | 67877 | 4 | 1 | 19454 | 50 |
BMPR1B |
1.024e-02 | -4.58 | IER5L (immediate early response 5 like) | protein interactions | 389792 | 4 | 1 | 19454 | 50 |
PPP2R2B |
1.026e-02 | -4.58 | kidney-carcinoma-papillary_renal_cell_carcinoma | COSMIC cancer mutations | kidney-carcinoma-papillary_renal_cell_carcinoma | 6364 | 27 | 16828 | 49 |
PRKG1,NRG3,MACF1,NAV2,LIFR,SOX5,IQCA1,DST,CAMK2G,ADCY2,ERBB4,TNRC6A,RYR3,RFX4,DCLK2,ABR,HPSE2,FMN2,NTM,CTNND2,DPP10,BMPR1B,DCLK1,TRPM3,RPS6KA2,PITPNC1,ARAP2 |
1.026e-02 | -4.58 | papillary_renal_cell_carcinoma | COSMIC cancer mutations | papillary_renal_cell_carcinoma | 6364 | 27 | 16828 | 49 |
NAV2,MACF1,PRKG1,NRG3,DST,TNRC6A,ERBB4,ADCY2,CAMK2G,SOX5,LIFR,IQCA1,DCLK2,RYR3,RFX4,ABR,HPSE2,NTM,CTNND2,FMN2,TRPM3,DPP10,BMPR1B,DCLK1,RPS6KA2,ARAP2,PITPNC1 |
1.032e-02 | -4.57 | cellular component organization or biogenesis | biological process | GO:0071840 | 5850 | 24 | 18204 | 49 |
TTN,BMPR1B,PITPNC1,RFX4,SLC1A2,TRPM3,IQCA1,NAV2,ERBB4,DAAM2,PRKG1,DCLK1,NRG3,MACF1,DST,SORBS1,CDH20,AQP4,RYR3,HPSE2,FMN2,GFAP,CTNND2,DCLK2 |
1.046e-02 | -4.56 | Sorb | smart domains | SM00459 | 3 | 1 | 9717 | 34 |
SORBS1 |
1.052e-02 | -4.55 | TRPM_tetra | pfam domains | PF16519 | 4 | 1 | 17795 | 47 |
TRPM3 |
1.052e-02 | -4.55 | CaMKII_AD | pfam domains | PF08332 | 4 | 1 | 17795 | 47 |
CAMK2G |
1.052e-02 | -4.55 | Glyco_transf_54 | pfam domains | PF04666 | 4 | 1 | 17795 | 47 |
MGAT4C |
1.054e-02 | -4.55 | PP2A_PR55 | interpro domains | IPR000009 | 4 | 1 | 18521 | 49 |
PPP2R2B |
1.054e-02 | -4.55 | RSK_N | interpro domains | IPR041906 | 4 | 1 | 18521 | 49 |
RPS6KA2 |
1.054e-02 | -4.55 | PP2A_PR55_CS | interpro domains | IPR018067 | 4 | 1 | 18521 | 49 |
PPP2R2B |
1.054e-02 | -4.55 | TRPM_tetra | interpro domains | IPR032415 | 4 | 1 | 18521 | 49 |
TRPM3 |
1.054e-02 | -4.55 | Tyr_kinase_EGF/ERB/XmrK_rcpt | interpro domains | IPR016245 | 4 | 1 | 18521 | 49 |
ERBB4 |
1.054e-02 | -4.55 | TRPM_tetra_sf | interpro domains | IPR037162 | 4 | 1 | 18521 | 49 |
TRPM3 |
1.054e-02 | -4.55 | Ca/CaM-dep_prot_kinase-assoc | interpro domains | IPR013543 | 4 | 1 | 18521 | 49 |
CAMK2G |
1.054e-02 | -4.55 | Glyco_transf_54 | interpro domains | IPR006759 | 4 | 1 | 18521 | 49 |
MGAT4C |
1.072e-02 | -4.54 | leukemia inhibitory factor signaling pathway | biological process | GO:0048861 | 4 | 1 | 18204 | 49 |
LIFR |
1.072e-02 | -4.54 | ovarian cumulus expansion | biological process | GO:0001550 | 4 | 1 | 18204 | 49 |
BMPR1B |
1.072e-02 | -4.54 | myosin filament assembly | biological process | GO:0031034 | 4 | 1 | 18204 | 49 |
TTN |
1.072e-02 | -4.54 | malate-aspartate shuttle | biological process | GO:0043490 | 4 | 1 | 18204 | 49 |
SLC25A18 |
1.072e-02 | -4.54 | regulation of systemic arterial blood pressure by baroreceptor feedback | biological process | GO:0003025 | 4 | 1 | 18204 | 49 |
NAV2 |
1.072e-02 | -4.54 | negative regulation of germ cell proliferation | biological process | GO:1905937 | 4 | 1 | 18204 | 49 |
PTGDS |
1.072e-02 | -4.54 | cardiac muscle tissue regeneration | biological process | GO:0061026 | 4 | 1 | 18204 | 49 |
ERBB4 |
1.072e-02 | -4.54 | oncostatin-M-mediated signaling pathway | biological process | GO:0038165 | 4 | 1 | 18204 | 49 |
LIFR |
1.072e-02 | -4.54 | negative regulation of male germ cell proliferation | biological process | GO:2000255 | 4 | 1 | 18204 | 49 |
PTGDS |
1.072e-02 | -4.54 | positive regulation of mesenchymal stem cell differentiation | biological process | GO:2000741 | 4 | 1 | 18204 | 49 |
SOX5 |
1.074e-02 | -4.53 | Oxytocin signaling pathway | KEGG pathways | ko04921 | 152 | 3 | 7161 | 22 |
CAMK2G,ADCY2,RYR3 |
1.074e-02 | -4.53 | Oxytocin signaling pathway | KEGG pathways | hsa04921 | 152 | 3 | 7161 | 22 |
RYR3,CAMK2G,ADCY2 |
1.076e-02 | -4.53 | Ion homeostasis | REACTOME pathways | R-HSA-5578775 | 56 | 2 | 10285 | 29 |
RYR3,CAMK2G |
1.077e-02 | -4.53 | transport | biological process | GO:0006810 | 3615 | 17 | 18204 | 49 |
SLC39A11,PTGDS,GFAP,FMN2,ERBB4,DCLK1,SLC25A18,DST,MACF1,QKI,SLC14A1,PITPNC1,AQP4,CAMK2G,RYR3,SLC1A2,TRPM3 |
1.078e-02 | -4.53 | ribonucleotide binding | molecular function | GO:0032553 | 1888 | 11 | 18094 | 49 |
ERBB4,TTN,IQCA1,DCLK1,RPS6KA2,ADCY2,PRKG1,DCLK2,CAMK2G,BMPR1B,NAV2 |
1.079e-02 | -4.53 | ciliary neurotrophic factor receptor activity | molecular function | GO:0004897 | 4 | 1 | 18094 | 49 |
LIFR |
1.079e-02 | -4.53 | ryanodine-sensitive calcium-release channel activity | molecular function | GO:0005219 | 4 | 1 | 18094 | 49 |
RYR3 |
1.095e-02 | -4.51 | tat (Tat) | protein interactions | 155871 | 1718 | 10 | 19454 | 50 |
PRKG1,RYR3,SLC14A1,SLC1A2,BMPR1B,SORBS1,PPP2R2B,CAMK2G,GFAP,ADCY2 |
1.098e-02 | -4.51 | bone-tibia-Ewings_sarcoma-peripheral_primitive_neuroectodermal_tumour | COSMIC cancer mutations | bone-tibia-Ewings_sarcoma-peripheral_primitive_neuroectodermal_tumour | 649 | 6 | 16828 | 49 |
PRKG1,MACF1,DCLK1,DST,TRPM3,QKI |
1.098e-02 | -4.51 | primitive_neuroectodermal_tumour-medulloblastoma | COSMIC cancer mutations | primitive_neuroectodermal_tumour-medulloblastoma | 15350 | 49 | 16828 | 49 |
NRG3,PRKG1,MSI2,HIF3A,NAV2,SLC14A1,IQCA1,SOX5,CAMK2G,RFX4,SLC39A11,DCLK2,SLC25A18,GLIS3,QKI,CTNND2,FMN2,LSAMP,DCLK1,PCDH9,AQP4,RPS6KA2,PITPNC1,GFAP,DTNA,MACF1,SLC1A2,LIFR,ADCY2,ERBB4,TNRC6A,DST,RYR3,WDR49,ABR,CDH20,PPP2R2B,TRPS1,NTM,DAAM2,PTGDS,HPSE2,BMPR1B,DPP10,NPAS3,TRPM3,SORBS1,MGAT4C,ARAP2 |
1.100e-02 | -4.51 | PHF21A (PHD finger protein 21A) | protein interactions | 51317 | 338 | 4 | 19454 | 50 |
TRPS1,TNRC6A,CAMK2G,DST |
1.104e-02 | -4.51 | EZR (ezrin) | protein interactions | 7430 | 526 | 5 | 19454 | 50 |
DTNA,DST,MACF1,SORBS1,ABR |
1.108e-02 | -4.50 | protein phosphorylation | biological process | GO:0006468 | 503 | 5 | 18204 | 49 |
ERBB4,RPS6KA2,PRKG1,DCLK1,BMPR1B |
1.110e-02 | -4.50 | ZKSCAN1 (zinc finger with KRAB and SCAN domains 1) | protein interactions | 7586 | 62 | 2 | 19454 | 50 |
QKI,PRKG1 |
1.113e-02 | -4.50 | cell migration | biological process | GO:0016477 | 921 | 7 | 18204 | 49 |
DCLK1,PRKG1,DAAM2,FMN2,ERBB4,NRG3,CDH20 |
1.118e-02 | -4.49 | parathyroid-carcinoma | COSMIC cancer mutations | parathyroid-carcinoma | 300 | 4 | 16828 | 49 |
TRPS1,RYR3,PRKG1,MACF1 |
1.123e-02 | -4.49 | Astrocytic Glutamate-Glutamine Uptake And Metabolism | REACTOME pathways | R-HSA-210455 | 4 | 1 | 10285 | 29 |
SLC1A2 |
1.123e-02 | -4.49 | Neurotransmitter uptake and Metabolism In Glial Cells | REACTOME pathways | R-HSA-112313 | 4 | 1 | 10285 | 29 |
SLC1A2 |
1.137e-02 | -4.48 | regulation of glucose import | biological process | GO:0046324 | 60 | 2 | 18204 | 49 |
SLC1A2,SORBS1 |
1.137e-02 | -4.48 | protein homotetramerization | biological process | GO:0051289 | 60 | 2 | 18204 | 49 |
RYR3,AQP4 |
1.138e-02 | -4.48 | head_neck | COSMIC cancer mutations | head_neck | 15361 | 49 | 16828 | 49 |
PPP2R2B,CDH20,ABR,RYR3,WDR49,LIFR,SLC1A2,DST,TNRC6A,ERBB4,ADCY2,DTNA,GFAP,MACF1,ARAP2,MGAT4C,NPAS3,DPP10,BMPR1B,TRPM3,SORBS1,TRPS1,HPSE2,PTGDS,DAAM2,NTM,SLC25A18,GLIS3,QKI,SLC39A11,RFX4,DCLK2,SOX5,IQCA1,CAMK2G,MSI2,PRKG1,NRG3,NAV2,SLC14A1,HIF3A,PITPNC1,RPS6KA2,AQP4,PCDH9,DCLK1,LSAMP,FMN2,CTNND2 |
1.143e-02 | -4.47 | human chr14q13.1 | chromosome location | human chr14q13.1 | 6 | 1 | 26134 | 50 |
NPAS3 |
1.156e-02 | -4.46 | EF-hand | gene3d domains | 1.10.238.10 | 272 | 4 | 14470 | 47 |
DST,DTNA,RYR3,MACF1 |
1.156e-02 | -4.46 | oligodendroglioma_Grade_III | COSMIC cancer mutations | oligodendroglioma_Grade_III | 303 | 4 | 16828 | 49 |
MGAT4C,NAV2,MACF1,GLIS3 |
1.160e-02 | -4.46 | synapse | cellular component | GO:0045202 | 1473 | 9 | 19108 | 49 |
DCLK1,SLC1A2,DTNA,ABR,RPS6KA2,QKI,NRG3,ERBB4,CTNND2 |
1.161e-02 | -4.46 | QKI (QKI, KH domain containing RNA binding) | protein interactions | 9444 | 183 | 3 | 19454 | 50 |
TNRC6A,QKI,MSI2 |
1.171e-02 | -4.45 | Regulation of lipolysis in adipocytes | KEGG pathways | hsa04923 | 54 | 2 | 7161 | 22 |
PRKG1,ADCY2 |
1.179e-02 | -4.44 | SYNC (syncoilin, intermediate filament protein) | protein interactions | 81493 | 64 | 2 | 19454 | 50 |
GFAP,DTNA |
1.179e-02 | -4.44 | VSX1 (visual system homeobox 1) | protein interactions | 30813 | 64 | 2 | 19454 | 50 |
DST,TRPS1 |
1.179e-02 | -4.44 | EVA1C (eva-1 homolog C) | protein interactions | 59271 | 64 | 2 | 19454 | 50 |
BMPR1B,PCDH9 |
1.182e-02 | -4.44 | central nervous system neuron differentiation | biological process | GO:0021953 | 176 | 3 | 18204 | 49 |
DCLK2,DCLK1,BMPR1B |
1.188e-02 | -4.43 | skin-head_neck-carcinoma-squamous_cell_carcinoma | COSMIC cancer mutations | skin-head_neck-carcinoma-squamous_cell_carcinoma | 14191 | 47 | 16828 | 49 |
SOX5,IQCA1,CAMK2G,PRKG1,NRG3,SLC14A1,NAV2,HIF3A,SLC25A18,GLIS3,QKI,SLC39A11,RFX4,DCLK2,PCDH9,LSAMP,DCLK1,CTNND2,FMN2,PITPNC1,RPS6KA2,AQP4,SLC1A2,LIFR,DST,ERBB4,ADCY2,TNRC6A,GFAP,DTNA,MACF1,PPP2R2B,CDH20,ABR,WDR49,RYR3,DPP10,BMPR1B,NPAS3,SORBS1,TRPM3,TRPS1,DAAM2,HPSE2,NTM,MGAT4C,ARAP2 |
1.209e-02 | -4.42 | kidney | COSMIC cancer mutations | kidney | 15380 | 49 | 16828 | 49 |
SOX5,IQCA1,CAMK2G,PRKG1,MSI2,NRG3,SLC14A1,NAV2,HIF3A,SLC25A18,QKI,GLIS3,SLC39A11,RFX4,DCLK2,PCDH9,LSAMP,DCLK1,FMN2,CTNND2,PITPNC1,RPS6KA2,AQP4,LIFR,SLC1A2,DST,TNRC6A,ERBB4,ADCY2,DTNA,GFAP,MACF1,PPP2R2B,ABR,CDH20,WDR49,RYR3,NPAS3,BMPR1B,DPP10,TRPM3,SORBS1,TRPS1,HPSE2,DAAM2,PTGDS,NTM,ARAP2,MGAT4C |
1.211e-02 | -4.41 | positive regulation of protein localization to plasma membrane | biological process | GO:1903078 | 62 | 2 | 18204 | 49 |
DPP10,SORBS1 |
1.223e-02 | -4.40 | astrocytoma_Grade_III | COSMIC cancer mutations | astrocytoma_Grade_III | 1544 | 10 | 16828 | 49 |
ERBB4,ADCY2,TNRC6A,TRPM3,NRG3,PRKG1,RYR3,HPSE2,DAAM2,NAV2 |
1.228e-02 | -4.40 | Signaling by BRAF and RAF fusions | REACTOME pathways | R-HSA-6802952 | 60 | 2 | 10285 | 29 |
MACF1,QKI |
1.239e-02 | -4.39 | adherens junction | cellular component | GO:0005912 | 188 | 3 | 19108 | 49 |
CDH20,SORBS1,CTNND2 |
1.250e-02 | -4.38 | cell adhesion | biological process | GO:0007155 | 942 | 7 | 18204 | 49 |
CDH20,SORBS1,NTM,PCDH9,LSAMP,DST,CTNND2 |
1.261e-02 | -4.37 | CDH1 (cadherin 1) | protein interactions | 999 | 757 | 6 | 19454 | 50 |
DST,MACF1,CTNND2,NAV2,SORBS1,TTN |
1.261e-02 | -4.37 | S_TK_X | smart domains | SM00133 | 49 | 2 | 9717 | 34 |
RPS6KA2,PRKG1 |
1.262e-02 | -4.37 | bone-pelvis-chondrosarcoma | COSMIC cancer mutations | bone-pelvis-chondrosarcoma | 311 | 4 | 16828 | 49 |
DCLK1,LSAMP,DAAM2,ERBB4 |
1.267e-02 | -4.37 | Ca2+ pathway | REACTOME pathways | R-HSA-4086398 | 61 | 2 | 10285 | 29 |
PRKG1,TNRC6A |
1.276e-02 | -4.36 | calcium- and calmodulin-dependent protein kinase complex | cellular component | GO:0005954 | 5 | 1 | 19108 | 49 |
CAMK2G |
1.278e-02 | -4.36 | RhoGAP | pfam domains | PF00620 | 65 | 2 | 17795 | 47 |
ARAP2,ABR |
1.279e-02 | -4.36 | CAMK2N2 (calcium/calmodulin dependent protein kinase II inhibitor 2) | protein interactions | 94032 | 5 | 1 | 19454 | 50 |
CAMK2G |
1.279e-02 | -4.36 | Wwp2 (WW domain containing E3 ubiquitin protein ligase 2) | protein interactions | 66894 | 5 | 1 | 19454 | 50 |
GLIS3 |
1.279e-02 | -4.36 | GANC (glucosidase alpha, neutral C) | protein interactions | 2595 | 5 | 1 | 19454 | 50 |
TTN |
1.279e-02 | -4.36 | TRPM6 (transient receptor potential cation channel subfamily M member 6) | protein interactions | 140803 | 5 | 1 | 19454 | 50 |
TRPM3 |
1.279e-02 | -4.36 | Cdk4 (cyclin dependent kinase 4) | protein interactions | 12567 | 5 | 1 | 19454 | 50 |
BMPR1B |
1.279e-02 | -4.36 | RVS161 (amphiphysin-like protein RVS161) | protein interactions | 850367 | 5 | 1 | 19454 | 50 |
GFAP |
1.279e-02 | -4.36 | Rhobtb1 (Rho-related BTB domain containing 1) | protein interactions | 69288 | 5 | 1 | 19454 | 50 |
BMPR1B |
1.279e-02 | -4.36 | RFX4 (regulatory factor X4) | protein interactions | 5992 | 5 | 1 | 19454 | 50 |
RFX4 |
1.279e-02 | -4.36 | SLC10A3 (solute carrier family 10 member 3) | protein interactions | 8273 | 5 | 1 | 19454 | 50 |
SORBS1 |
1.279e-02 | -4.36 | Hk3 (hexokinase 3) | protein interactions | 25060 | 5 | 1 | 19454 | 50 |
PTGDS |
1.279e-02 | -4.36 | Rab38 (RAB38, member RAS oncogene family) | protein interactions | 72433 | 5 | 1 | 19454 | 50 |
BMPR1B |
1.279e-02 | -4.36 | KY (kyphoscoliosis peptidase) | protein interactions | 339855 | 5 | 1 | 19454 | 50 |
TTN |
1.279e-02 | -4.36 | PTGER2 (prostaglandin E receptor 2) | protein interactions | 5732 | 5 | 1 | 19454 | 50 |
PTGDS |
1.279e-02 | -4.36 | NRG2 (neuregulin 2) | protein interactions | 9542 | 5 | 1 | 19454 | 50 |
ERBB4 |
1.279e-02 | -4.36 | Rab6b (RAB6B, member RAS oncogene family) | protein interactions | 270192 | 5 | 1 | 19454 | 50 |
BMPR1B |
1.279e-02 | -4.36 | DPP10 (dipeptidyl peptidase like 10) | protein interactions | 57628 | 5 | 1 | 19454 | 50 |
DPP10 |
1.279e-02 | -4.36 | PPP1R17 (protein phosphatase 1 regulatory subunit 17) | protein interactions | 10842 | 5 | 1 | 19454 | 50 |
PRKG1 |
1.279e-02 | -4.36 | Rhoj (ras homolog family member J) | protein interactions | 80837 | 5 | 1 | 19454 | 50 |
BMPR1B |
1.279e-02 | -4.36 | Rras2 (related RAS viral (r-ras) oncogene 2) | protein interactions | 66922 | 5 | 1 | 19454 | 50 |
BMPR1B |
1.283e-02 | -4.36 | RhoGAP_dom | interpro domains | IPR000198 | 65 | 2 | 18521 | 49 |
ABR,ARAP2 |
1.287e-02 | -4.35 | dendrite morphogenesis | biological process | GO:0048813 | 64 | 2 | 18204 | 49 |
CTNND2,DCLK1 |
1.287e-02 | -4.35 | actin filament bundle assembly | biological process | GO:0051017 | 64 | 2 | 18204 | 49 |
FMN2,SORBS1 |
1.293e-02 | -4.35 | TRPM, tetramerisation domain | gene3d domains | 1.20.5.1010 | 4 | 1 | 14470 | 47 |
TRPM3 |
1.295e-02 | -4.35 | PP2APR55 | prints domains | PR00600 | 4 | 1 | 5227 | 17 |
PPP2R2B |
1.298e-02 | -4.34 | TLE3 (TLE family member 3, transcriptional corepressor) | protein interactions | 7090 | 355 | 4 | 19454 | 50 |
TRPS1,TNRC6A,QKI,TTN |
1.302e-02 | -4.34 | pancreas-carcinoma | COSMIC cancer mutations | pancreas-carcinoma | 14770 | 48 | 16828 | 49 |
PPP2R2B,CDH20,ABR,RYR3,WDR49,SLC1A2,LIFR,DST,ADCY2,ERBB4,TNRC6A,GFAP,MACF1,MGAT4C,ARAP2,BMPR1B,DPP10,NPAS3,TRPM3,SORBS1,TRPS1,DAAM2,PTGDS,HPSE2,NTM,SLC25A18,GLIS3,QKI,SLC39A11,RFX4,DCLK2,SOX5,IQCA1,CAMK2G,MSI2,PRKG1,NRG3,SLC14A1,NAV2,HIF3A,PITPNC1,RPS6KA2,AQP4,PCDH9,DCLK1,LSAMP,CTNND2,FMN2 |
1.307e-02 | -4.34 | PR55_1 | prosite domains | PS01024 | 4 | 1 | 12186 | 40 |
PPP2R2B |
1.307e-02 | -4.34 | PR55_2 | prosite domains | PS01025 | 4 | 1 | 12186 | 40 |
PPP2R2B |
1.314e-02 | -4.33 | PH_19 | pfam domains | PF19057 | 5 | 1 | 17795 | 47 |
ABR |
1.314e-02 | -4.33 | Protocadherin | pfam domains | PF08374 | 5 | 1 | 17795 | 47 |
PCDH9 |
1.314e-02 | -4.33 | IP_trans | pfam domains | PF02121 | 5 | 1 | 17795 | 47 |
PITPNC1 |
1.316e-02 | -4.33 | PI_transfer | interpro domains | IPR001666 | 5 | 1 | 18521 | 49 |
PITPNC1 |
1.316e-02 | -4.33 | Protocadherin | interpro domains | IPR013585 | 5 | 1 | 18521 | 49 |
PCDH9 |
1.316e-02 | -4.33 | DCX/DCDC2-like | interpro domains | IPR049626 | 5 | 1 | 18521 | 49 |
DCLK1 |
1.316e-02 | -4.33 | BBP-like | interpro domains | IPR045071 | 5 | 1 | 18521 | 49 |
QKI |
1.323e-02 | -4.33 | CXADR (CXADR Ig-like cell adhesion molecule) | protein interactions | 1525 | 357 | 4 | 19454 | 50 |
DST,RPS6KA2,MACF1,SORBS1 |
1.330e-02 | -4.32 | cellular response to stimulus | biological process | GO:0051716 | 6307 | 25 | 18204 | 49 |
TTN,RPS6KA2,BMPR1B,PITPNC1,SLC1A2,ERBB4,DAAM2,DCLK1,PRKG1,ADCY2,NRG3,ARAP2,DST,ABR,MACF1,SORBS1,TNRC6A,DTNA,AQP4,RYR3,LIFR,GFAP,FMN2,CTNND2,DCLK2 |
1.332e-02 | -4.32 | human chr13q21.32 | chromosome location | human chr13q21.32 | 7 | 1 | 26134 | 50 |
PCDH9 |
1.339e-02 | -4.31 | ERBB2-ERBB4 signaling pathway | biological process | GO:0038135 | 5 | 1 | 18204 | 49 |
ERBB4 |
1.339e-02 | -4.31 | negative regulation of chondrocyte proliferation | biological process | GO:1902731 | 5 | 1 | 18204 | 49 |
BMPR1B |
1.339e-02 | -4.31 | ciliary neurotrophic factor-mediated signaling pathway | biological process | GO:0070120 | 5 | 1 | 18204 | 49 |
LIFR |
1.339e-02 | -4.31 | polar body extrusion after meiotic divisions | biological process | GO:0040038 | 5 | 1 | 18204 | 49 |
FMN2 |
1.339e-02 | -4.31 | glossopharyngeal nerve development | biological process | GO:0021563 | 5 | 1 | 18204 | 49 |
NAV2 |
1.339e-02 | -4.31 | myosin filament organization | biological process | GO:0031033 | 5 | 1 | 18204 | 49 |
TTN |
1.339e-02 | -4.31 | negative regulation of glutamate secretion | biological process | GO:0014050 | 5 | 1 | 18204 | 49 |
PRKG1 |
1.342e-02 | -4.31 | salivary_gland-carcinoma-adenoid_cystic_carcinoma | COSMIC cancer mutations | salivary_gland-carcinoma-adenoid_cystic_carcinoma | 488 | 5 | 16828 | 49 |
RYR3,PRKG1,CTNND2,MGAT4C,ARAP2 |
1.347e-02 | -4.31 | transforming growth factor beta receptor activity, type I | molecular function | GO:0005025 | 5 | 1 | 18094 | 49 |
BMPR1B |
1.347e-02 | -4.31 | high-affinity L-glutamate transmembrane transporter activity | molecular function | GO:0005314 | 5 | 1 | 18094 | 49 |
SLC1A2 |
1.347e-02 | -4.31 | glutamate:sodium symporter activity | molecular function | GO:0015501 | 5 | 1 | 18094 | 49 |
SLC1A2 |
1.359e-02 | -4.30 | cell development | biological process | GO:0048468 | 2236 | 12 | 18204 | 49 |
FMN2,ERBB4,GFAP,PRKG1,DCLK1,CTNND2,DCLK2,NTM,TTN,QKI,MSI2,BMPR1B |
1.364e-02 | -4.29 | cardiac muscle cell development | biological process | GO:0055013 | 66 | 2 | 18204 | 49 |
PRKG1,TTN |
1.364e-02 | -4.29 | L-alpha-amino acid transmembrane transport | biological process | GO:1902475 | 66 | 2 | 18204 | 49 |
SLC25A18,SLC1A2 |
1.364e-02 | -4.29 | ERBB signaling pathway | biological process | GO:0038127 | 66 | 2 | 18204 | 49 |
ERBB4,NRG3 |
1.367e-02 | -4.29 | neoplasm | COSMIC cancer mutations | neoplasm | 14787 | 48 | 16828 | 49 |
CTNND2,FMN2,DCLK1,LSAMP,PCDH9,AQP4,RPS6KA2,NRG3,PRKG1,MSI2,HIF3A,SLC14A1,NAV2,IQCA1,SOX5,CAMK2G,RFX4,SLC39A11,DCLK2,SLC25A18,QKI,GLIS3,TRPS1,NTM,DAAM2,PTGDS,HPSE2,DPP10,BMPR1B,NPAS3,SORBS1,TRPM3,MGAT4C,ARAP2,GFAP,DTNA,MACF1,SLC1A2,LIFR,ADCY2,ERBB4,TNRC6A,DST,WDR49,RYR3,ABR,CDH20,PPP2R2B |
1.380e-02 | -4.28 | L-amino acid transmembrane transporter activity | molecular function | GO:0015179 | 66 | 2 | 18094 | 49 |
SLC1A2,SLC25A18 |
1.398e-02 | -4.27 | AGC_KINASE_CTER | prosite domains | PS51285 | 55 | 2 | 12186 | 40 |
PRKG1,RPS6KA2 |
1.399e-02 | -4.27 | PTPDC1 (protein tyrosine phosphatase domain containing 1) | protein interactions | 138639 | 70 | 2 | 19454 | 50 |
ERBB4,PPP2R2B |
1.408e-02 | -4.26 | Signaling by SCF-KIT | REACTOME pathways | R-HSA-1433557 | 337 | 4 | 10285 | 29 |
TNRC6A,NRG3,CAMK2G,ERBB4 |
1.426e-02 | -4.25 | purine nucleotide binding | molecular function | GO:0017076 | 1964 | 11 | 18094 | 49 |
PRKG1,TTN,ADCY2,ERBB4,RPS6KA2,DCLK1,BMPR1B,NAV2,IQCA1,CAMK2G,DCLK2 |
1.431e-02 | -4.25 | Constitutive Signaling by Aberrant PI3K in Cancer | REACTOME pathways | R-HSA-2219530 | 65 | 2 | 10285 | 29 |
NRG3,ERBB4 |
1.437e-02 | -4.24 | AKR7L (aldo-keto reductase family 7 like (gene/pseudogene)) | protein interactions | 246181 | 71 | 2 | 19454 | 50 |
MACF1,DST |
1.444e-02 | -4.24 | actin filament bundle organization | biological process | GO:0061572 | 68 | 2 | 18204 | 49 |
SORBS1,FMN2 |
1.455e-02 | -4.23 | Corticotropin Activation of Cortisol Production | SMPDB pathways | SMP0000310 | 5 | 1 | 1369 | 4 |
ADCY2 |
1.491e-02 | -4.21 | DBN1 (drebrin 1) | protein interactions | 1627 | 370 | 4 | 19454 | 50 |
SOX5,DST,PPP2R2B,CAMK2G |
1.495e-02 | -4.20 | carbohydrate derivative binding | molecular function | GO:0097367 | 2251 | 12 | 18094 | 49 |
HPSE2,PRKG1,TTN,ADCY2,DCLK1,ERBB4,RPS6KA2,NAV2,BMPR1B,DCLK2,CAMK2G,IQCA1 |
1.503e-02 | -4.20 | acute_myeloid_leukaemia | COSMIC cancer mutations | acute_myeloid_leukaemia | 10418 | 38 | 16828 | 49 |
CDH20,PPP2R2B,GLIS3,QKI,RFX4,WDR49,RYR3,SLC39A11,CAMK2G,ERBB4,ADCY2,TNRC6A,DST,IQCA1,LIFR,SOX5,SLC1A2,HIF3A,MACF1,NAV2,SLC14A1,GFAP,NRG3,PRKG1,MSI2,ARAP2,RPS6KA2,TRPM3,DCLK1,LSAMP,NPAS3,PCDH9,DPP10,FMN2,CTNND2,NTM,HPSE2,DAAM2 |
1.503e-02 | -4.20 | haematopoietic_and_lymphoid_tissue-haematopoietic_neoplasm-acute_myeloid_leukaemia | COSMIC cancer mutations | haematopoietic_and_lymphoid_tissue-haematopoietic_neoplasm-acute_myeloid_leukaemia | 10418 | 38 | 16828 | 49 |
MSI2,PRKG1,GFAP,NRG3,SLC14A1,NAV2,MACF1,HIF3A,SLC1A2,SOX5,LIFR,IQCA1,DST,TNRC6A,ERBB4,ADCY2,CAMK2G,SLC39A11,WDR49,RYR3,RFX4,QKI,GLIS3,PPP2R2B,CDH20,DAAM2,HPSE2,NTM,CTNND2,FMN2,DPP10,PCDH9,NPAS3,DCLK1,LSAMP,TRPM3,RPS6KA2,ARAP2 |
1.516e-02 | -4.19 | Signaling by PTK6 | REACTOME pathways | R-HSA-8848021 | 67 | 2 | 10285 | 29 |
ERBB4,NRG3 |
1.526e-02 | -4.18 | transporter activity | molecular function | GO:0005215 | 1211 | 8 | 18094 | 49 |
AQP4,SLC39A11,SLC14A1,SLC25A18,TRPM3,PITPNC1,RYR3,SLC1A2 |
1.531e-02 | -4.18 | RBMS1 (RNA binding motif single stranded interacting protein 1) | protein interactions | 5937 | 203 | 3 | 19454 | 50 |
QKI,TNRC6A,MSI2 |
1.532e-02 | -4.18 | DAZ4 (deleted in azoospermia 4) | protein interactions | 57135 | 6 | 1 | 19454 | 50 |
QKI |
1.532e-02 | -4.18 | GDF6 (growth differentiation factor 6) | protein interactions | 392255 | 6 | 1 | 19454 | 50 |
BMPR1B |
1.532e-02 | -4.18 | LIF (LIF interleukin 6 family cytokine) | protein interactions | 3976 | 6 | 1 | 19454 | 50 |
LIFR |
1.532e-02 | -4.18 | Zbtb2 (zinc finger and BTB domain containing 2) | protein interactions | 381990 | 6 | 1 | 19454 | 50 |
SORBS1 |
1.532e-02 | -4.18 | LBX2 (ladybird homeobox 2) | protein interactions | 85474 | 6 | 1 | 19454 | 50 |
GFAP |
1.532e-02 | -4.18 | Fancl (Fanconi anemia, complementation group L) | protein interactions | 67030 | 6 | 1 | 19454 | 50 |
BMPR1B |
1.532e-02 | -4.18 | PBP2 (Pbp2p) | protein interactions | 852533 | 6 | 1 | 19454 | 50 |
QKI |
1.532e-02 | -4.18 | CIBAR2 (CBY1 interacting BAR domain containing 2) | protein interactions | 339145 | 6 | 1 | 19454 | 50 |
CAMK2G |
1.532e-02 | -4.18 | ANKDD1A (ankyrin repeat and death domain containing 1A) | protein interactions | 348094 | 6 | 1 | 19454 | 50 |
TTN |
1.532e-02 | -4.18 | ADCY1 (adenylate cyclase 1) | protein interactions | 107 | 6 | 1 | 19454 | 50 |
ADCY2 |
1.532e-02 | -4.18 | DRP2 (dystrophin related protein 2) | protein interactions | 1821 | 6 | 1 | 19454 | 50 |
DTNA |
1.532e-02 | -4.18 | NRG4 (neuregulin 4) | protein interactions | 145957 | 6 | 1 | 19454 | 50 |
ERBB4 |
1.532e-02 | -4.18 | Tiam2 (T cell lymphoma invasion and metastasis 2) | protein interactions | 24001 | 6 | 1 | 19454 | 50 |
DTNA |
1.532e-02 | -4.18 | Rhod (ras homolog family member D) | protein interactions | 11854 | 6 | 1 | 19454 | 50 |
BMPR1B |
1.532e-02 | -4.18 | SOX1 (SRY-box transcription factor 1) | protein interactions | 6656 | 6 | 1 | 19454 | 50 |
SOX5 |
1.532e-02 | -4.18 | SOX11 (SRY-box transcription factor 11) | protein interactions | 6664 | 6 | 1 | 19454 | 50 |
SOX5 |
1.532e-02 | -4.18 | Itch (itchy, E3 ubiquitin protein ligase) | protein interactions | 16396 | 6 | 1 | 19454 | 50 |
GLIS3 |
1.532e-02 | -4.18 | Map2k3 (mitogen-activated protein kinase kinase 3) | protein interactions | 26397 | 6 | 1 | 19454 | 50 |
BMPR1B |
1.532e-02 | -4.18 | TPPP3 (tubulin polymerization promoting protein family member 3) | protein interactions | 51673 | 6 | 1 | 19454 | 50 |
PPP2R2B |
1.533e-02 | -4.18 | protein homooligomerization | biological process | GO:0051260 | 194 | 3 | 18204 | 49 |
SLC1A2,RYR3,AQP4 |
1.546e-02 | -4.17 | actin cytoskeleton organization | biological process | GO:0030036 | 547 | 5 | 18204 | 49 |
FMN2,SORBS1,DAAM2,TTN,PRKG1 |
1.547e-02 | -4.17 | C20 prostanoid biosynthesis | BIOCYC pathways | HUMAN_PWY66-374 | 7 | 1 | 902 | 2 |
PTGDS |
1.547e-02 | -4.17 | C20 prostanoid biosynthesis | BIOCYC pathways | META_PWY66-374 | 7 | 1 | 902 | 2 |
PTGDS |
1.552e-02 | -4.17 | INPPL1 (inositol polyphosphate phosphatase like 1) | protein interactions | 3636 | 204 | 3 | 19454 | 50 |
ARAP2,SORBS1,ERBB4 |
1.554e-02 | -4.16 | TEC (tec protein tyrosine kinase) | protein interactions | 7006 | 74 | 2 | 19454 | 50 |
MSI2,ERBB4 |
1.561e-02 | -4.16 | intermediate filament | cellular component | GO:0005882 | 205 | 3 | 19108 | 49 |
DST,GFAP,MACF1 |
1.575e-02 | -4.15 | GF_recep_IV | pfam domains | PF14843 | 6 | 1 | 17795 | 47 |
ERBB4 |
1.575e-02 | -4.15 | RYDR_ITPR | pfam domains | PF01365 | 6 | 1 | 17795 | 47 |
RYR3 |
1.575e-02 | -4.15 | EF-hand_3 | pfam domains | PF09069 | 6 | 1 | 17795 | 47 |
DTNA |
1.575e-02 | -4.15 | RIH_assoc | pfam domains | PF08454 | 6 | 1 | 17795 | 47 |
RYR3 |
1.575e-02 | -4.15 | Adcy_cons_dom | pfam domains | PF06327 | 6 | 1 | 17795 | 47 |
ADCY2 |
1.575e-02 | -4.15 | THB | pfam domains | PF18362 | 6 | 1 | 17795 | 47 |
TTN |
1.575e-02 | -4.15 | DPPIV_N | pfam domains | PF00930 | 6 | 1 | 17795 | 47 |
DPP10 |
1.575e-02 | -4.15 | Ins145_P3_rec | pfam domains | PF08709 | 6 | 1 | 17795 | 47 |
RYR3 |
1.575e-02 | -4.15 | EF-hand_2 | pfam domains | PF09068 | 6 | 1 | 17795 | 47 |
DTNA |
1.577e-02 | -4.15 | Adcy_conserved_dom | interpro domains | IPR009398 | 6 | 1 | 18521 | 49 |
ADCY2 |
1.577e-02 | -4.15 | RIH_assoc-dom | interpro domains | IPR013662 | 6 | 1 | 18521 | 49 |
RYR3 |
1.577e-02 | -4.15 | Ins145_P3_rcpt | interpro domains | IPR014821 | 6 | 1 | 18521 | 49 |
RYR3 |
1.577e-02 | -4.15 | Ribosomal_S6_kinase_II | interpro domains | IPR016239 | 6 | 1 | 18521 | 49 |
RPS6KA2 |
1.577e-02 | -4.15 | Ryanodine_IP3_receptor | interpro domains | IPR015925 | 6 | 1 | 18521 | 49 |
RYR3 |
1.577e-02 | -4.15 | GF_recep_IV | interpro domains | IPR032778 | 6 | 1 | 18521 | 49 |
ERBB4 |
1.577e-02 | -4.15 | RIH_dom | interpro domains | IPR000699 | 6 | 1 | 18521 | 49 |
RYR3 |
1.577e-02 | -4.15 | RyR/IP3R_RIH_dom_sf | interpro domains | IPR035910 | 6 | 1 | 18521 | 49 |
RYR3 |
1.577e-02 | -4.15 | EF-hand_dom_typ2 | interpro domains | IPR015154 | 6 | 1 | 18521 | 49 |
DTNA |
1.577e-02 | -4.15 | MyBP-C_THB | interpro domains | IPR040849 | 6 | 1 | 18521 | 49 |
TTN |
1.577e-02 | -4.15 | Peptidase_S9B_N | interpro domains | IPR002469 | 6 | 1 | 18521 | 49 |
DPP10 |
1.577e-02 | -4.15 | GLI-like | interpro domains | IPR043359 | 6 | 1 | 18521 | 49 |
GLIS3 |
1.577e-02 | -4.15 | EF-hand_dom_typ1 | interpro domains | IPR015153 | 6 | 1 | 18521 | 49 |
DTNA |
1.583e-02 | -4.15 | Neuronal System | REACTOME pathways | R-HSA-112316 | 349 | 4 | 10285 | 29 |
RPS6KA2,ADCY2,CAMK2G,SLC1A2 |
1.594e-02 | -4.14 | TXNL4A (thioredoxin like 4A) | protein interactions | 10907 | 75 | 2 | 19454 | 50 |
QKI,TNRC6A |
1.600e-02 | -4.13 | other | COSMIC cancer mutations | other | 14843 | 48 | 16828 | 49 |
DCLK2,RFX4,SLC39A11,GLIS3,QKI,SLC25A18,HIF3A,NAV2,SLC14A1,NRG3,MSI2,PRKG1,CAMK2G,IQCA1,SOX5,AQP4,RPS6KA2,FMN2,CTNND2,DCLK1,LSAMP,PCDH9,RYR3,WDR49,CDH20,ABR,PPP2R2B,MACF1,GFAP,DTNA,ERBB4,TNRC6A,ADCY2,DST,LIFR,SLC1A2,ARAP2,MGAT4C,NTM,HPSE2,DAAM2,PTGDS,TRPS1,TRPM3,SORBS1,NPAS3,DPP10,BMPR1B |
1.604e-02 | -4.13 | intracellular water homeostasis | biological process | GO:0009992 | 6 | 1 | 18204 | 49 |
AQP4 |
1.604e-02 | -4.13 | fused antrum stage | biological process | GO:0048165 | 6 | 1 | 18204 | 49 |
BMPR1B |
1.604e-02 | -4.13 | L-aspartate import across plasma membrane | biological process | GO:0140009 | 6 | 1 | 18204 | 49 |
SLC1A2 |
1.604e-02 | -4.13 | asymmetric neuroblast division | biological process | GO:0055059 | 6 | 1 | 18204 | 49 |
SOX5 |
1.604e-02 | -4.13 | mammary gland formation | biological process | GO:0060592 | 6 | 1 | 18204 | 49 |
NRG3 |
1.604e-02 | -4.13 | relaxation of vascular associated smooth muscle | biological process | GO:0060087 | 6 | 1 | 18204 | 49 |
PRKG1 |
1.604e-02 | -4.13 | hemidesmosome assembly | biological process | GO:0031581 | 6 | 1 | 18204 | 49 |
DST |
1.604e-02 | -4.13 | establishment of meiotic spindle localization | biological process | GO:0051295 | 6 | 1 | 18204 | 49 |
FMN2 |
1.610e-02 | -4.13 | central_nervous_system-brain-glioma | COSMIC cancer mutations | central_nervous_system-brain-glioma | 15470 | 49 | 16828 | 49 |
PPP2R2B,CDH20,ABR,WDR49,RYR3,LIFR,SLC1A2,DST,ADCY2,TNRC6A,ERBB4,GFAP,DTNA,MACF1,ARAP2,MGAT4C,NPAS3,BMPR1B,DPP10,TRPM3,SORBS1,TRPS1,HPSE2,DAAM2,PTGDS,NTM,SLC25A18,GLIS3,QKI,SLC39A11,RFX4,DCLK2,SOX5,IQCA1,CAMK2G,MSI2,PRKG1,NRG3,NAV2,SLC14A1,HIF3A,PITPNC1,RPS6KA2,AQP4,PCDH9,DCLK1,LSAMP,FMN2,CTNND2 |
1.614e-02 | -4.13 | - | gene3d domains | 6.10.140.620 | 5 | 1 | 14470 | 47 |
CAMK2G |
1.614e-02 | -4.13 | Formin, FH3 diaphanous domain | gene3d domains | 1.10.238.150 | 5 | 1 | 14470 | 47 |
DAAM2 |
1.614e-02 | -4.13 | ciliary neurotrophic factor receptor binding | molecular function | GO:0005127 | 6 | 1 | 18094 | 49 |
LIFR |
1.614e-02 | -4.13 | amino acid:proton symporter activity | molecular function | GO:0005280 | 6 | 1 | 18094 | 49 |
SLC25A18 |
1.614e-02 | -4.13 | calcium-induced calcium release activity | molecular function | GO:0048763 | 6 | 1 | 18094 | 49 |
RYR3 |
1.616e-02 | -4.13 | PITRANSFER | prints domains | PR00391 | 5 | 1 | 5227 | 17 |
PITPNC1 |
1.627e-02 | -4.12 | sarcoplasmic reticulum | cellular component | GO:0016529 | 76 | 2 | 19108 | 49 |
CAMK2G,RYR3 |
1.628e-02 | -4.12 | germ cell development | biological process | GO:0007281 | 363 | 4 | 18204 | 49 |
BMPR1B,PRKG1,FMN2,QKI |
1.628e-02 | -4.12 | haematopoietic_and_lymphoid_tissue-soft_tissue-lymphoid_neoplasm-diffuse_large_B_cell_lymphoma | COSMIC cancer mutations | haematopoietic_and_lymphoid_tissue-soft_tissue-lymphoid_neoplasm-diffuse_large_B_cell_lymphoma | 67 | 2 | 16828 | 49 |
DST,PCDH9 |
1.629e-02 | -4.12 | MKRN2 (makorin ring finger protein 2) | protein interactions | 23609 | 380 | 4 | 19454 | 50 |
TNRC6A,PRKG1,MACF1,BMPR1B |
1.633e-02 | -4.11 | GATAD2A (GATA zinc finger domain containing 2A) | protein interactions | 54815 | 208 | 3 | 19454 | 50 |
TRPS1,TNRC6A,SOX5 |
1.635e-02 | -4.11 | MIR200A (microRNA 200a) | protein interactions | 406983 | 76 | 2 | 19454 | 50 |
QKI,MSI2 |
1.647e-02 | -4.11 | meninges | COSMIC cancer mutations | meninges | 514 | 5 | 16828 | 49 |
SLC25A18,RYR3,FMN2,NAV2,RPS6KA2 |
1.647e-02 | -4.11 | meningioma | COSMIC cancer mutations | meningioma | 514 | 5 | 16828 | 49 |
NAV2,RPS6KA2,FMN2,SLC25A18,RYR3 |
1.647e-02 | -4.11 | cytoskeletal protein binding | molecular function | GO:0008092 | 989 | 7 | 18094 | 49 |
FMN2,SORBS1,DCLK2,MACF1,DAAM2,TTN,DST |
1.652e-02 | -4.10 | cardiac cell development | biological process | GO:0055006 | 73 | 2 | 18204 | 49 |
PRKG1,TTN |
1.668e-02 | -4.09 | breast-carcinoma-ductolobular_carcinoma | COSMIC cancer mutations | breast-carcinoma-ductolobular_carcinoma | 1619 | 10 | 16828 | 49 |
DPP10,LIFR,SORBS1,QKI,CDH20,WDR49,DTNA,MACF1,CTNND2,FMN2 |
1.668e-02 | -4.09 | ductolobular_carcinoma | COSMIC cancer mutations | ductolobular_carcinoma | 1619 | 10 | 16828 | 49 |
CDH20,SORBS1,QKI,DPP10,LIFR,CTNND2,FMN2,MACF1,DTNA,WDR49 |
1.675e-02 | -4.09 | ABI1 (abl interactor 1) | protein interactions | 10006 | 210 | 3 | 19454 | 50 |
SORBS1,RPS6KA2,DST |
1.680e-02 | -4.09 | RSK activation | REACTOME pathways | R-HSA-444257 | 6 | 1 | 10285 | 29 |
RPS6KA2 |
1.695e-02 | -4.08 | positive regulation of gliogenesis | biological process | GO:0014015 | 74 | 2 | 18204 | 49 |
GFAP,QKI |
1.695e-02 | -4.08 | positive regulation of protein localization to cell periphery | biological process | GO:1904377 | 74 | 2 | 18204 | 49 |
DPP10,SORBS1 |
1.708e-02 | -4.07 | regulation of localization | biological process | GO:0032879 | 2028 | 11 | 18204 | 49 |
DCLK2,PRKG1,DCLK1,ERBB4,GFAP,CAMK2G,RYR3,SLC1A2,DPP10,SORBS1,TTN |
1.709e-02 | -4.07 | human chr4q22.3 | chromosome location | human chr4q22.3 | 9 | 1 | 26134 | 50 |
BMPR1B |
1.717e-02 | -4.06 | MIR34C (microRNA 34c) | protein interactions | 407042 | 78 | 2 | 19454 | 50 |
QKI,MSI2 |
1.717e-02 | -4.06 | ATOH1 (atonal bHLH transcription factor 1) | protein interactions | 474 | 78 | 2 | 19454 | 50 |
GFAP,MACF1 |
1.735e-02 | -4.05 | cell adhesion molecule binding | molecular function | GO:0050839 | 560 | 5 | 18094 | 49 |
DST,GFAP,CDH20,MACF1,CTNND2 |
1.744e-02 | -4.05 | Intracellular Signalling Through PGD2 receptor and Prostaglandin D2 | SMPDB pathways | SMP0000343 | 6 | 1 | 1369 | 4 |
ADCY2 |
1.744e-02 | -4.05 | Dopamine Activation of Neurological Reward System | SMPDB pathways | SMP0000308 | 6 | 1 | 1369 | 4 |
ADCY2 |
1.754e-02 | -4.04 | Downstream signaling events of B Cell Receptor (BCR) | REACTOME pathways | R-HSA-1168372 | 197 | 3 | 10285 | 29 |
ERBB4,TNRC6A,NRG3 |
1.759e-02 | -4.04 | KRTAP3-2 (keratin associated protein 3-2) | protein interactions | 83897 | 79 | 2 | 19454 | 50 |
NTM,GFAP |
1.766e-02 | -4.04 | Long-term potentiation | KEGG pathways | ko04720 | 67 | 2 | 7161 | 22 |
CAMK2G,RPS6KA2 |
1.766e-02 | -4.04 | Long-term potentiation | KEGG pathways | hsa04720 | 67 | 2 | 7161 | 22 |
RPS6KA2,CAMK2G |
1.767e-02 | -4.04 | mannosyl-glycoprotein N-acetylglucosaminyltransferases | BIOCYC pathways | META_PWY-7426 | 8 | 1 | 902 | 2 |
MGAT4C |
1.769e-02 | -4.03 | prostate-adenoma | COSMIC cancer mutations | prostate-adenoma | 1634 | 10 | 16828 | 49 |
DST,TRPM3,ERBB4,NPAS3,SOX5,MACF1,HIF3A,DCLK2,PRKG1,WDR49 |
1.786e-02 | -4.03 | Smurf1 (SMAD specific E3 ubiquitin protein ligase 1) | protein interactions | 75788 | 7 | 1 | 19454 | 50 |
GLIS3 |
1.786e-02 | -4.03 | RGMB (repulsive guidance molecule BMP co-receptor b) | protein interactions | 285704 | 7 | 1 | 19454 | 50 |
BMPR1B |
1.786e-02 | -4.03 | SASH3 (SAM and SH3 domain containing 3) | protein interactions | 54440 | 7 | 1 | 19454 | 50 |
BMPR1B |
1.786e-02 | -4.03 | Pum2 (pumilio RNA-binding family member 2) | protein interactions | 80913 | 7 | 1 | 19454 | 50 |
QKI |
1.786e-02 | -4.03 | ABCC12 (ATP binding cassette subfamily C member 12) | protein interactions | 94160 | 7 | 1 | 19454 | 50 |
NPAS3 |
1.786e-02 | -4.03 | Uhmk1 (U2AF homology motif (UHM) kinase 1) | protein interactions | 16589 | 7 | 1 | 19454 | 50 |
BMPR1B |
1.786e-02 | -4.03 | Fbxo3 (F-box protein 3) | protein interactions | 57443 | 7 | 1 | 19454 | 50 |
BMPR1B |
1.786e-02 | -4.03 | Smad7 (SMAD family member 7) | protein interactions | 17131 | 7 | 1 | 19454 | 50 |
BMPR1B |
1.801e-02 | -4.02 | MED13 (mediator complex subunit 13) | protein interactions | 9969 | 80 | 2 | 19454 | 50 |
TNRC6A,QKI |
1.825e-02 | -4.00 | calmodulin binding | molecular function | GO:0005516 | 206 | 3 | 18094 | 49 |
CAMK2G,RYR3,TTN |
1.829e-02 | -4.00 | Oncogenic MAPK signaling | REACTOME pathways | R-HSA-6802957 | 74 | 2 | 10285 | 29 |
QKI,MACF1 |
1.835e-02 | -4.00 | Recep_L_domain | pfam domains | PF01030 | 7 | 1 | 17795 | 47 |
ERBB4 |
1.835e-02 | -4.00 | TGF_beta_GS | pfam domains | PF08515 | 7 | 1 | 17795 | 47 |
BMPR1B |
1.835e-02 | -4.00 | SDF | pfam domains | PF00375 | 7 | 1 | 17795 | 47 |
SLC1A2 |
1.835e-02 | -4.00 | Filament_head | pfam domains | PF04732 | 7 | 1 | 17795 | 47 |
GFAP |
1.835e-02 | -4.00 | Furin-like | pfam domains | PF00757 | 7 | 1 | 17795 | 47 |
ERBB4 |
1.836e-02 | -4.00 | sarcomere | cellular component | GO:0030017 | 218 | 3 | 19108 | 49 |
RYR3,TTN,DST |
1.838e-02 | -4.00 | Plakophilin/d_Catenin | interpro domains | IPR028435 | 7 | 1 | 18521 | 49 |
CTNND2 |
1.838e-02 | -4.00 | Na:dicarbo_symporter_sf | interpro domains | IPR036458 | 7 | 1 | 18521 | 49 |
SLC1A2 |
1.838e-02 | -4.00 | Rcpt_L-dom_sf | interpro domains | IPR036941 | 7 | 1 | 18521 | 49 |
ERBB4 |
1.838e-02 | -4.00 | Na-dicarboxylate_symporter | interpro domains | IPR001991 | 7 | 1 | 18521 | 49 |
SLC1A2 |
1.838e-02 | -4.00 | GS_dom | interpro domains | IPR003605 | 7 | 1 | 18521 | 49 |
BMPR1B |
1.838e-02 | -4.00 | Intermed_filament_DNA-bd | interpro domains | IPR006821 | 7 | 1 | 18521 | 49 |
GFAP |
1.838e-02 | -4.00 | Furin-like_Cys-rich_dom | interpro domains | IPR006211 | 7 | 1 | 18521 | 49 |
ERBB4 |
1.838e-02 | -4.00 | Ammonium/urea_transptr | interpro domains | IPR029020 | 7 | 1 | 18521 | 49 |
SLC14A1 |
1.838e-02 | -4.00 | Aquaporin_transptr | interpro domains | IPR034294 | 7 | 1 | 18521 | 49 |
AQP4 |
1.838e-02 | -4.00 | Na-dicarboxylate_symporter_CS | interpro domains | IPR018107 | 7 | 1 | 18521 | 49 |
SLC1A2 |
1.838e-02 | -4.00 | Hematopoietin_rcpt_Gp130_CS | interpro domains | IPR003529 | 7 | 1 | 18521 | 49 |
LIFR |
1.838e-02 | -4.00 | Rcpt_L-dom | interpro domains | IPR000494 | 7 | 1 | 18521 | 49 |
ERBB4 |
1.844e-02 | -3.99 | regulation of neurogenesis | biological process | GO:0050767 | 377 | 4 | 18204 | 49 |
MACF1,GFAP,QKI,DAAM2 |
1.866e-02 | -3.98 | KRT8 (keratin 8) | protein interactions | 3856 | 396 | 4 | 19454 | 50 |
GFAP,DTNA,TNRC6A,TTN |
1.867e-02 | -3.98 | transmembrane transport | biological process | GO:0055085 | 1264 | 8 | 18204 | 49 |
SLC39A11,SLC14A1,GFAP,AQP4,SLC25A18,TRPM3,SLC1A2,RYR3 |
1.869e-02 | -3.98 | cellular response to magnesium ion | biological process | GO:0071286 | 7 | 1 | 18204 | 49 |
RYR3 |
1.869e-02 | -3.98 | regulation of male germ cell proliferation | biological process | GO:2000254 | 7 | 1 | 18204 | 49 |
PTGDS |
1.869e-02 | -3.98 | relaxation of smooth muscle | biological process | GO:0044557 | 7 | 1 | 18204 | 49 |
PRKG1 |
1.869e-02 | -3.98 | regulation of 3'-UTR-mediated mRNA stabilization | biological process | GO:1905868 | 7 | 1 | 18204 | 49 |
QKI |
1.869e-02 | -3.98 | podocyte cell migration | biological process | GO:0090521 | 7 | 1 | 18204 | 49 |
DAAM2 |
1.869e-02 | -3.98 | regulation of testosterone biosynthetic process | biological process | GO:2000224 | 7 | 1 | 18204 | 49 |
PRKG1 |
1.869e-02 | -3.98 | detection of muscle stretch | biological process | GO:0035995 | 7 | 1 | 18204 | 49 |
TTN |
1.869e-02 | -3.98 | chromosome movement towards spindle pole | biological process | GO:0051305 | 7 | 1 | 18204 | 49 |
FMN2 |
1.869e-02 | -3.98 | parallel actin filament bundle assembly | biological process | GO:0030046 | 7 | 1 | 18204 | 49 |
FMN2 |
1.869e-02 | -3.98 | skeletal muscle thin filament assembly | biological process | GO:0030240 | 7 | 1 | 18204 | 49 |
TTN |
1.869e-02 | -3.98 | interneuron migration from the subpallium to the cortex | biological process | GO:0021830 | 7 | 1 | 18204 | 49 |
NRG3 |
1.872e-02 | -3.98 | regulation of glucose transmembrane transport | biological process | GO:0010827 | 78 | 2 | 18204 | 49 |
SORBS1,SLC1A2 |
1.881e-02 | -3.97 | phosphatidic acid transfer activity | molecular function | GO:1990050 | 7 | 1 | 18094 | 49 |
PITPNC1 |
1.881e-02 | -3.97 | copper ion transmembrane transporter activity | molecular function | GO:0005375 | 7 | 1 | 18094 | 49 |
SLC39A11 |
1.881e-02 | -3.97 | calcium-dependent protein serine/threonine phosphatase activity | molecular function | GO:0004723 | 7 | 1 | 18094 | 49 |
CAMK2G |
1.881e-02 | -3.97 | telethonin binding | molecular function | GO:0031433 | 7 | 1 | 18094 | 49 |
TTN |
1.881e-02 | -3.97 | mitogen-activated protein kinase p38 binding | molecular function | GO:0048273 | 7 | 1 | 18094 | 49 |
PRKG1 |
1.881e-02 | -3.97 | ribosomal protein S6 kinase activity | molecular function | GO:0004711 | 7 | 1 | 18094 | 49 |
RPS6KA2 |
1.884e-02 | -3.97 | ErbB Signaling Pathway | WikiPathways | WP673 | 54 | 2 | 5310 | 21 |
ERBB4,NRG3 |
1.886e-02 | -3.97 | GSC (goosecoid homeobox) | protein interactions | 145258 | 82 | 2 | 19454 | 50 |
TRPS1,SOX5 |
1.886e-02 | -3.97 | TNNT1 (troponin T1, slow skeletal type) | protein interactions | 7138 | 82 | 2 | 19454 | 50 |
BMPR1B,PRKG1 |
1.896e-02 | -3.97 | haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm | COSMIC cancer mutations | haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm | 7307 | 29 | 16828 | 49 |
PCDH9,BMPR1B,DPP10,LSAMP,HPSE2,DAAM2,FMN2,CTNND2,ARAP2,MGAT4C,TNRC6A,ADCY2,ERBB4,LIFR,SLC1A2,SOX5,MACF1,NAV2,PRKG1,NRG3,PPP2R2B,GLIS3,QKI,ABR,CDH20,WDR49,RYR3,SLC39A11,RFX4 |
1.897e-02 | -3.96 | human chr9p24.2 | chromosome location | human chr9p24.2 | 10 | 1 | 26134 | 50 |
GLIS3 |
1.905e-02 | -3.96 | Diseases of signal transduction | REACTOME pathways | R-HSA-5663202 | 369 | 4 | 10285 | 29 |
NRG3,ERBB4,MACF1,QKI |
1.914e-02 | -3.96 | central_nervous_system-brain-glioma-oligodendroglioma_Grade_II | COSMIC cancer mutations | central_nervous_system-brain-glioma-oligodendroglioma_Grade_II | 73 | 2 | 16828 | 49 |
NAV2,MACF1 |
1.917e-02 | -3.95 | regulation of glial cell differentiation | biological process | GO:0045685 | 79 | 2 | 18204 | 49 |
QKI,DAAM2 |
1.918e-02 | -3.95 | RHOGAP | prosite domains | PS50238 | 65 | 2 | 12186 | 40 |
ARAP2,ABR |
1.922e-02 | -3.95 | prostate | COSMIC cancer mutations | prostate | 13883 | 46 | 16828 | 49 |
RYR3,WDR49,CDH20,ABR,PPP2R2B,DTNA,GFAP,MACF1,SLC1A2,LIFR,TNRC6A,ADCY2,ERBB4,DST,MGAT4C,ARAP2,TRPS1,NTM,DAAM2,HPSE2,DPP10,BMPR1B,NPAS3,TRPM3,SORBS1,RFX4,SLC39A11,DCLK2,SLC25A18,QKI,GLIS3,NRG3,PRKG1,MSI2,HIF3A,NAV2,SLC14A1,SOX5,AQP4,RPS6KA2,PITPNC1,CTNND2,FMN2,DCLK1,LSAMP,PCDH9 |
1.929e-02 | -3.95 | localization | biological process | GO:0051179 | 4474 | 19 | 18204 | 49 |
DPP10,QKI,SLC14A1,SLC1A2,TRPM3,RYR3,CAMK2G,AQP4,PITPNC1,GFAP,FMN2,ERBB4,PTGDS,SLC39A11,DCLK2,DST,MACF1,SLC25A18,DCLK1 |
1.933e-02 | -3.95 | Single helix bin | gene3d domains | 1.20.5.490 | 6 | 1 | 14470 | 47 |
PRKG1 |
1.933e-02 | -3.95 | Dipeptidylpeptidase IV, N-terminal domain | gene3d domains | 2.140.10.30 | 6 | 1 | 14470 | 47 |
DPP10 |
1.933e-02 | -3.95 | IP3 receptor type 1 binding core, RIH domain | gene3d domains | 1.25.10.30 | 6 | 1 | 14470 | 47 |
RYR3 |
1.937e-02 | -3.94 | ACTIVIN2R | prints domains | PR00653 | 6 | 1 | 5227 | 17 |
BMPR1B |
1.939e-02 | -3.94 | PSEN1 (presenilin 1) | protein interactions | 5663 | 222 | 3 | 19454 | 50 |
DTNA,GFAP,CTNND2 |
1.941e-02 | -3.94 | Rho GTPase activation protein | gene3d domains | 1.10.555.10 | 66 | 2 | 14470 | 47 |
ARAP2,ABR |
1.956e-02 | -3.93 | Fc epsilon receptor (FCERI) signaling | REACTOME pathways | R-HSA-2454202 | 372 | 4 | 10285 | 29 |
NRG3,TNRC6A,ERBB4,CAMK2G |
1.958e-02 | -3.93 | CREB phosphorylation | REACTOME pathways | R-HSA-199920 | 7 | 1 | 10285 | 29 |
RPS6KA2 |
1.958e-02 | -3.93 | Post-transcriptional silencing by small RNAs | REACTOME pathways | R-HSA-426496 | 7 | 1 | 10285 | 29 |
TNRC6A |
1.964e-02 | -3.93 | oligodendroglioma_Grade_II | COSMIC cancer mutations | oligodendroglioma_Grade_II | 74 | 2 | 16828 | 49 |
NAV2,MACF1 |
1.970e-02 | -3.93 | Bile secretion | KEGG pathways | hsa04976 | 71 | 2 | 7161 | 22 |
ADCY2,AQP4 |
1.970e-02 | -3.93 | Bile secretion | KEGG pathways | ko04976 | 71 | 2 | 7161 | 22 |
AQP4,ADCY2 |
1.974e-02 | -3.93 | PSEN2 (presenilin 2) | protein interactions | 5664 | 84 | 2 | 19454 | 50 |
GFAP,CTNND2 |
1.976e-02 | -3.92 | AP2M1 (adaptor related protein complex 2 subunit mu 1) | protein interactions | 1173 | 403 | 4 | 19454 | 50 |
RPS6KA2,TNRC6A,GFAP,AQP4 |
1.989e-02 | -3.92 | central_nervous_system-brain-glioma-astrocytoma_Grade_III | COSMIC cancer mutations | central_nervous_system-brain-glioma-astrocytoma_Grade_III | 1419 | 9 | 16828 | 49 |
ADCY2,ERBB4,TRPM3,NRG3,RYR3,PRKG1,NAV2,DAAM2,HPSE2 |
1.992e-02 | -3.92 | EF_hand_dom | interpro domains | IPR002048 | 218 | 3 | 18521 | 49 |
DST,MACF1,RYR3 |
2.018e-02 | -3.90 | CFAP298 (cilia and flagella associated protein 298) | protein interactions | 56683 | 85 | 2 | 19454 | 50 |
TRPS1,FMN2 |
2.032e-02 | -3.90 | transmembrane receptor protein kinase activity | molecular function | GO:0019199 | 81 | 2 | 18094 | 49 |
BMPR1B,ERBB4 |
2.032e-02 | -3.90 | g-Secretase Mediated ErbB4 Signalling Pathway | SMPDB pathways | SMP0089975 | 7 | 1 | 1369 | 4 |
ERBB4 |
2.032e-02 | -3.90 | Vasopressin Regulation of Water Homeostasis | SMPDB pathways | SMP0000322 | 7 | 1 | 1369 | 4 |
ADCY2 |
2.034e-02 | -3.90 | zonula adherens | cellular component | GO:0005915 | 8 | 1 | 19108 | 49 |
SORBS1 |
2.034e-02 | -3.90 | hemidesmosome | cellular component | GO:0030056 | 8 | 1 | 19108 | 49 |
DST |
2.034e-02 | -3.90 | HFE-transferrin receptor complex | cellular component | GO:1990712 | 8 | 1 | 19108 | 49 |
BMPR1B |
2.038e-02 | -3.89 | BMP15 (bone morphogenetic protein 15) | protein interactions | 9210 | 8 | 1 | 19454 | 50 |
BMPR1B |
2.038e-02 | -3.89 | NKAIN3 (sodium/potassium transporting ATPase interacting 3) | protein interactions | 286183 | 8 | 1 | 19454 | 50 |
GFAP |
2.038e-02 | -3.89 | DEPP1 (DEPP autophagy regulator 1) | protein interactions | 11067 | 8 | 1 | 19454 | 50 |
QKI |
2.038e-02 | -3.89 | Rasd2 (RASD family, member 2) | protein interactions | 75141 | 8 | 1 | 19454 | 50 |
BMPR1B |
2.038e-02 | -3.89 | INSM1 (INSM transcriptional repressor 1) | protein interactions | 3642 | 8 | 1 | 19454 | 50 |
SORBS1 |
2.038e-02 | -3.89 | Mrps31 (mitochondrial ribosomal protein S31) | protein interactions | 57312 | 8 | 1 | 19454 | 50 |
DST |
2.038e-02 | -3.89 | UBALD2 (UBA like domain containing 2) | protein interactions | 283991 | 8 | 1 | 19454 | 50 |
GFAP |
2.038e-02 | -3.89 | Rps27a (ribosomal protein S27A) | protein interactions | 78294 | 8 | 1 | 19454 | 50 |
BMPR1B |
2.038e-02 | -3.89 | PTGER1 (prostaglandin E receptor 1) | protein interactions | 5731 | 8 | 1 | 19454 | 50 |
PTGDS |
2.039e-02 | -3.89 | nasopharyngeal_carcinoma | COSMIC cancer mutations | nasopharyngeal_carcinoma | 1425 | 9 | 16828 | 49 |
QKI,DST,SLC1A2,DPP10,PITPNC1,RPS6KA2,FMN2,CTNND2,RFX4 |
2.039e-02 | -3.89 | upper_aerodigestive_tract-pharynx-carcinoma-nasopharyngeal_carcinoma | COSMIC cancer mutations | upper_aerodigestive_tract-pharynx-carcinoma-nasopharyngeal_carcinoma | 1425 | 9 | 16828 | 49 |
DST,QKI,SLC1A2,PITPNC1,DPP10,CTNND2,FMN2,RPS6KA2,RFX4 |
2.049e-02 | -3.89 | Ion channel transport | REACTOME pathways | R-HSA-983712 | 209 | 3 | 10285 | 29 |
CAMK2G,TRPM3,RYR3 |
2.053e-02 | -3.89 | contractile actin filament bundle | cellular component | GO:0097517 | 86 | 2 | 19108 | 49 |
DST,SORBS1 |
2.053e-02 | -3.89 | stress fiber | cellular component | GO:0001725 | 86 | 2 | 19108 | 49 |
SORBS1,DST |
2.055e-02 | -3.88 | TOMM20 (translocase of outer mitochondrial membrane 20) | protein interactions | 9804 | 227 | 3 | 19454 | 50 |
ABR,DST,TNRC6A |
2.059e-02 | -3.88 | Calcium Regulation in the Cardiac Cell | WikiPathways | WP536 | 151 | 3 | 5310 | 21 |
ADCY2,RYR3,CAMK2G |
2.073e-02 | -3.88 | stomach | COSMIC cancer mutations | stomach | 15550 | 49 | 16828 | 49 |
DST,TNRC6A,ERBB4,ADCY2,SLC1A2,LIFR,MACF1,DTNA,GFAP,PPP2R2B,ABR,CDH20,RYR3,WDR49,SORBS1,TRPM3,DPP10,BMPR1B,NPAS3,PTGDS,DAAM2,HPSE2,NTM,TRPS1,MGAT4C,ARAP2,CAMK2G,SOX5,IQCA1,NAV2,SLC14A1,HIF3A,PRKG1,MSI2,NRG3,QKI,GLIS3,SLC25A18,DCLK2,SLC39A11,RFX4,PCDH9,LSAMP,DCLK1,CTNND2,FMN2,PITPNC1,RPS6KA2,AQP4 |
2.089e-02 | -3.87 | SH3_domain | interpro domains | IPR001452 | 222 | 3 | 18521 | 49 |
MACF1,SORBS1,DST |
2.092e-02 | -3.87 | RhoGAP | smart domains | SM00324 | 64 | 2 | 9717 | 34 |
ABR,ARAP2 |
2.092e-02 | -3.87 | cellular localization | biological process | GO:0051641 | 2660 | 13 | 18204 | 49 |
CAMK2G,SLC1A2,SLC14A1,QKI,DPP10,MACF1,DST,DCLK2,DCLK1,ERBB4,FMN2,GFAP,PTGDS |
2.094e-02 | -3.87 | LSDAT_euk | pfam domains | PF18139 | 8 | 1 | 17795 | 47 |
TRPM3 |
2.094e-02 | -3.87 | AC_N | pfam domains | PF16214 | 8 | 1 | 17795 | 47 |
ADCY2 |
2.097e-02 | -3.86 | Adcy | interpro domains | IPR030672 | 8 | 1 | 18521 | 49 |
ADCY2 |
2.097e-02 | -3.86 | TRPM_SLOG | interpro domains | IPR041491 | 8 | 1 | 18521 | 49 |
TRPM3 |
2.097e-02 | -3.86 | AC_N | interpro domains | IPR032628 | 8 | 1 | 18521 | 49 |
ADCY2 |
2.097e-02 | -3.86 | RFX-like | interpro domains | IPR039779 | 8 | 1 | 18521 | 49 |
RFX4 |
2.097e-02 | -3.86 | DAD_dom | interpro domains | IPR014767 | 8 | 1 | 18521 | 49 |
DAAM2 |
2.105e-02 | -3.86 | glutamatergic synapse | cellular component | GO:0098978 | 412 | 4 | 19108 | 49 |
ERBB4,SLC1A2,ABR,NRG3 |
2.106e-02 | -3.86 | eye-uveal_tract-malignant_melanoma-spindle | COSMIC cancer mutations | eye-uveal_tract-malignant_melanoma-spindle | 363 | 4 | 16828 | 49 |
PCDH9,CTNND2,MACF1,TRPM3 |
2.108e-02 | -3.86 | FGR (FGR proto-oncogene, Src family tyrosine kinase) | protein interactions | 2268 | 87 | 2 | 19454 | 50 |
SLC25A18,ERBB4 |
2.108e-02 | -3.86 | MIR141 (microRNA 141) | protein interactions | 406933 | 87 | 2 | 19454 | 50 |
QKI,MSI2 |
2.109e-02 | -3.86 | inorganic cation transmembrane transporter activity | molecular function | GO:0022890 | 589 | 5 | 18094 | 49 |
SLC39A11,RYR3,SLC1A2,SLC25A18,TRPM3 |
2.120e-02 | -3.85 | urinary_tract-bladder-carcinoma-transitional_cell_carcinoma | COSMIC cancer mutations | urinary_tract-bladder-carcinoma-transitional_cell_carcinoma | 6040 | 25 | 16828 | 49 |
RFX4,SLC39A11,ABR,CDH20,GLIS3,NRG3,DTNA,PRKG1,HIF3A,NAV2,MACF1,ERBB4,ADCY2,TNRC6A,CAMK2G,DST,MGAT4C,ARAP2,TRPS1,FMN2,HPSE2,DPP10,PCDH9,TRPM3,SORBS1 |
2.126e-02 | -3.85 | femur | COSMIC cancer mutations | femur | 1197 | 8 | 16828 | 49 |
RYR3,SLC39A11,NRG3,HPSE2,NAV2,FMN2,PCDH9,ADCY2 |
2.129e-02 | -3.85 | transitional_cell_carcinoma | COSMIC cancer mutations | transitional_cell_carcinoma | 6042 | 25 | 16828 | 49 |
DST,CAMK2G,TNRC6A,ERBB4,ADCY2,MACF1,NAV2,HIF3A,PRKG1,NRG3,DTNA,GLIS3,ABR,CDH20,SLC39A11,RFX4,TRPM3,SORBS1,PCDH9,DPP10,HPSE2,FMN2,TRPS1,ARAP2,MGAT4C |
2.134e-02 | -3.85 | meiotic cytokinesis | biological process | GO:0033206 | 8 | 1 | 18204 | 49 |
FMN2 |
2.134e-02 | -3.85 | regulation of germ cell proliferation | biological process | GO:1905936 | 8 | 1 | 18204 | 49 |
PTGDS |
2.134e-02 | -3.85 | regulation of chaperone-mediated autophagy | biological process | GO:1904714 | 8 | 1 | 18204 | 49 |
GFAP |
2.134e-02 | -3.85 | copper ion transmembrane transport | biological process | GO:0035434 | 8 | 1 | 18204 | 49 |
SLC39A11 |
2.146e-02 | -3.84 | urea transmembrane transporter activity | molecular function | GO:0015204 | 8 | 1 | 18094 | 49 |
SLC14A1 |
2.146e-02 | -3.84 | cyclic nucleotide-dependent protein kinase activity | molecular function | GO:0004690 | 8 | 1 | 18094 | 49 |
PRKG1 |
2.146e-02 | -3.84 | BMP receptor activity | molecular function | GO:0098821 | 8 | 1 | 18094 | 49 |
BMPR1B |
2.151e-02 | -3.84 | stem cell development | biological process | GO:0048864 | 84 | 2 | 18204 | 49 |
ERBB4,MSI2 |
2.151e-02 | -3.84 | L-amino acid transport | biological process | GO:0015807 | 84 | 2 | 18204 | 49 |
SLC1A2,SLC25A18 |
2.153e-02 | -3.84 | FAM241B (family with sequence similarity 241 member B) | protein interactions | 219738 | 88 | 2 | 19454 | 50 |
SLC39A11,ERBB4 |
2.159e-02 | -3.84 | SRC (SRC proto-oncogene, non-receptor tyrosine kinase) | protein interactions | 6714 | 624 | 5 | 19454 | 50 |
ERBB4,SORBS1,MSI2,SLC14A1,GFAP |
2.165e-02 | -3.83 | establishment of localization | biological process | GO:0051234 | 3887 | 17 | 18204 | 49 |
CAMK2G,RYR3,SLC1A2,TRPM3,AQP4,PITPNC1,SLC14A1,QKI,MACF1,DST,DCLK1,SLC25A18,FMN2,ERBB4,GFAP,SLC39A11,PTGDS |
2.168e-02 | -3.83 | hairy_cell_leukaemia | COSMIC cancer mutations | hairy_cell_leukaemia | 1440 | 9 | 16828 | 49 |
CDH20,DST,LIFR,FMN2,CTNND2,MACF1,NAV2,RFX4,RYR3 |
2.168e-02 | -3.83 | haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm-hairy_cell_leukaemia | COSMIC cancer mutations | haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm-hairy_cell_leukaemia | 1440 | 9 | 16828 | 49 |
DST,CDH20,LIFR,MACF1,NAV2,FMN2,CTNND2,RYR3,RFX4 |
2.175e-02 | -3.83 | CDC23 (cell division cycle 23) | protein interactions | 8697 | 232 | 3 | 19454 | 50 |
DCLK1,SOX5,TNRC6A |
2.184e-02 | -3.82 | Gastric acid secretion | KEGG pathways | hsa04971 | 75 | 2 | 7161 | 22 |
CAMK2G,ADCY2 |
2.184e-02 | -3.82 | Gastric acid secretion | KEGG pathways | ko04971 | 75 | 2 | 7161 | 22 |
ADCY2,CAMK2G |
2.199e-02 | -3.82 | chondrocyte differentiation | biological process | GO:0002062 | 85 | 2 | 18204 | 49 |
BMPR1B,SOX5 |
2.199e-02 | -3.82 | MTMR6 (myotubularin related protein 6) | protein interactions | 9107 | 89 | 2 | 19454 | 50 |
ERBB4,TTN |
2.201e-02 | -3.82 | cellular process involved in reproduction in multicellular organism | biological process | GO:0022412 | 398 | 4 | 18204 | 49 |
PRKG1,BMPR1B,FMN2,QKI |
2.221e-02 | -3.81 | haematopoietic_and_lymphoid_tissue-haematopoietic_neoplasm-polycythaemia_vera | COSMIC cancer mutations | haematopoietic_and_lymphoid_tissue-haematopoietic_neoplasm-polycythaemia_vera | 369 | 4 | 16828 | 49 |
CTNND2,ARAP2,DST,DCLK1 |
2.221e-02 | -3.81 | polycythaemia_vera | COSMIC cancer mutations | polycythaemia_vera | 369 | 4 | 16828 | 49 |
DCLK1,CTNND2,DST,ARAP2 |
2.224e-02 | -3.81 | EPHA1 (EPH receptor A1) | protein interactions | 2041 | 234 | 3 | 19454 | 50 |
SLC39A11,DST,TTN |
2.234e-02 | -3.80 | Downregulation of ERBB4 signaling | REACTOME pathways | R-HSA-1253288 | 8 | 1 | 10285 | 29 |
ERBB4 |
2.246e-02 | -3.80 | CTDSPL (CTD small phosphatase like) | protein interactions | 10217 | 90 | 2 | 19454 | 50 |
DTNA,FMN2 |
2.247e-02 | -3.80 | central nervous system neuron development | biological process | GO:0021954 | 86 | 2 | 18204 | 49 |
DCLK1,DCLK2 |
2.249e-02 | -3.79 | MARK3 (microtubule affinity regulating kinase 3) | protein interactions | 4140 | 235 | 3 | 19454 | 50 |
MACF1,PPP2R2B,DTNA |
2.252e-02 | -3.79 | Sodium:dicarboxylate symporter | gene3d domains | 1.10.3860.10 | 7 | 1 | 14470 | 47 |
SLC1A2 |
2.252e-02 | -3.79 | Receptor L-domain | gene3d domains | 3.80.20.20 | 7 | 1 | 14470 | 47 |
ERBB4 |
2.252e-02 | -3.79 | Ammonium transporter AmtB like domains | gene3d domains | 1.10.3430.10 | 7 | 1 | 14470 | 47 |
SLC14A1 |
2.256e-02 | -3.79 | EDTRNSPORT | prints domains | PR00173 | 7 | 1 | 5227 | 17 |
SLC1A2 |
2.272e-02 | -3.78 | human chr6q26 | chromosome location | human chr6q26 | 12 | 1 | 26134 | 50 |
QKI |
2.276e-02 | -3.78 | NA_DICARBOXYL_SYMP_2 | prosite domains | PS00714 | 7 | 1 | 12186 | 40 |
SLC1A2 |
2.276e-02 | -3.78 | GS | prosite domains | PS51256 | 7 | 1 | 12186 | 40 |
BMPR1B |
2.276e-02 | -3.78 | HEMATOPO_REC_L_F2 | prosite domains | PS01353 | 7 | 1 | 12186 | 40 |
LIFR |
2.276e-02 | -3.78 | NA_DICARBOXYL_SYMP_1 | prosite domains | PS00713 | 7 | 1 | 12186 | 40 |
SLC1A2 |
2.285e-02 | -3.78 | flotillin complex | cellular component | GO:0016600 | 9 | 1 | 19108 | 49 |
SORBS1 |
2.290e-02 | -3.78 | NRXN2 (neurexin 2) | protein interactions | 9379 | 9 | 1 | 19454 | 50 |
MACF1 |
2.290e-02 | -3.78 | LSB3 (Lsb3p) | protein interactions | 850580 | 9 | 1 | 19454 | 50 |
GFAP |
2.290e-02 | -3.78 | Ywhag (tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, gamma polypeptide) | protein interactions | 22628 | 9 | 1 | 19454 | 50 |
QKI |
2.290e-02 | -3.78 | MUC4 (mucin 4, cell surface associated) | protein interactions | 4585 | 9 | 1 | 19454 | 50 |
ERBB4 |
2.290e-02 | -3.78 | ADAM2 (ADAM metallopeptidase domain 2) | protein interactions | 2515 | 9 | 1 | 19454 | 50 |
TTN |
2.290e-02 | -3.78 | IER5 (immediate early response 5) | protein interactions | 51278 | 9 | 1 | 19454 | 50 |
PPP2R2B |
2.290e-02 | -3.78 | PI3 (peptidase inhibitor 3) | protein interactions | 5266 | 9 | 1 | 19454 | 50 |
PPP2R2B |
2.290e-02 | -3.78 | VEPH1 (ventricular zone expressed PH domain containing 1) | protein interactions | 79674 | 9 | 1 | 19454 | 50 |
BMPR1B |
2.290e-02 | -3.78 | CAMK2N1 (calcium/calmodulin dependent protein kinase II inhibitor 1) | protein interactions | 55450 | 9 | 1 | 19454 | 50 |
CAMK2G |
2.292e-02 | -3.78 | NEIL3 (nei like DNA glycosylase 3) | protein interactions | 55247 | 91 | 2 | 19454 | 50 |
QKI,GFAP |
2.292e-02 | -3.78 | DGUOK (deoxyguanosine kinase) | protein interactions | 1716 | 91 | 2 | 19454 | 50 |
DCLK1,NTM |
2.292e-02 | -3.78 | PTPN21 (protein tyrosine phosphatase non-receptor type 21) | protein interactions | 11099 | 91 | 2 | 19454 | 50 |
NRG3,ERBB4 |
2.292e-02 | -3.78 | THUMPD3 (THUMP domain containing 3) | protein interactions | 25917 | 91 | 2 | 19454 | 50 |
CTNND2,RPS6KA2 |
2.299e-02 | -3.77 | CAMK2A (calcium/calmodulin dependent protein kinase II alpha) | protein interactions | 815 | 237 | 3 | 19454 | 50 |
CAMK2G,GFAP,SOX5 |
2.306e-02 | -3.77 | central_nervous_system-chiasm-glioma-astrocytoma_Grade_I | COSMIC cancer mutations | central_nervous_system-chiasm-glioma-astrocytoma_Grade_I | 8 | 1 | 16828 | 49 |
QKI |
2.320e-02 | -3.76 | Intracellular Signalling Through Prostacyclin Receptor and Prostacyclin | SMPDB pathways | SMP0000354 | 8 | 1 | 1369 | 4 |
ADCY2 |
2.320e-02 | -3.76 | Myometrial Relaxation and Contraction Pathways | WikiPathways | WP289 | 158 | 3 | 5310 | 21 |
CAMK2G,RYR3,ADCY2 |
2.324e-02 | -3.76 | Proteoglycans in cancer | KEGG pathways | hsa05205 | 203 | 3 | 7161 | 22 |
HPSE2,CAMK2G,ERBB4 |
2.324e-02 | -3.76 | Proteoglycans in cancer | KEGG pathways | ko05205 | 203 | 3 | 7161 | 22 |
CAMK2G,HPSE2,ERBB4 |
2.329e-02 | -3.76 | actomyosin | cellular component | GO:0042641 | 92 | 2 | 19108 | 49 |
DST,SORBS1 |
2.330e-02 | -3.76 | RNF43 (ring finger protein 43) | protein interactions | 54894 | 424 | 4 | 19454 | 50 |
TTN,MACF1,TNRC6A,QKI |
2.334e-02 | -3.76 | myofibril | cellular component | GO:0030016 | 239 | 3 | 19108 | 49 |
DST,TTN,RYR3 |
2.353e-02 | -3.75 | RFX_DNA_binding | pfam domains | PF02257 | 9 | 1 | 17795 | 47 |
RFX4 |
2.353e-02 | -3.75 | Peptidase_S9 | pfam domains | PF00326 | 9 | 1 | 17795 | 47 |
DPP10 |
2.353e-02 | -3.75 | Activin_recp | pfam domains | PF01064 | 9 | 1 | 17795 | 47 |
BMPR1B |
2.353e-02 | -3.75 | Drf_GBD | pfam domains | PF06371 | 9 | 1 | 17795 | 47 |
DAAM2 |
2.353e-02 | -3.75 | Drf_FH3 | pfam domains | PF06367 | 9 | 1 | 17795 | 47 |
DAAM2 |
2.357e-02 | -3.75 | Activin_recp | interpro domains | IPR000472 | 9 | 1 | 18521 | 49 |
BMPR1B |
2.357e-02 | -3.75 | FH3_dom | interpro domains | IPR010472 | 9 | 1 | 18521 | 49 |
DAAM2 |
2.357e-02 | -3.75 | Peptidase_S9 | interpro domains | IPR001375 | 9 | 1 | 18521 | 49 |
DPP10 |
2.357e-02 | -3.75 | DNA-bd_RFX | interpro domains | IPR003150 | 9 | 1 | 18521 | 49 |
RFX4 |
2.357e-02 | -3.75 | GTPase-bd | interpro domains | IPR010473 | 9 | 1 | 18521 | 49 |
DAAM2 |
2.369e-02 | -3.74 | Rho_GTPase_activation_prot | interpro domains | IPR008936 | 90 | 2 | 18521 | 49 |
ABR,ARAP2 |
2.385e-02 | -3.74 | skin-neck-malignant_melanoma | COSMIC cancer mutations | skin-neck-malignant_melanoma | 1223 | 8 | 16828 | 49 |
CTNND2,ADCY2,ERBB4,ARAP2,TRPM3,DCLK1,WDR49,DPP10 |
2.387e-02 | -3.74 | TEX11 (testis expressed 11) | protein interactions | 56159 | 93 | 2 | 19454 | 50 |
QKI,SOX5 |
2.387e-02 | -3.74 | MIR19B2 (microRNA 19b-2) | protein interactions | 406981 | 93 | 2 | 19454 | 50 |
MSI2,QKI |
2.397e-02 | -3.73 | release of sequestered calcium ion into cytosol by sarcoplasmic reticulum | biological process | GO:0014808 | 9 | 1 | 18204 | 49 |
RYR3 |
2.397e-02 | -3.73 | cyclooxygenase pathway | biological process | GO:0019371 | 9 | 1 | 18204 | 49 |
PTGDS |
2.397e-02 | -3.73 | zinc ion import across plasma membrane | biological process | GO:0071578 | 9 | 1 | 18204 | 49 |
SLC39A11 |
2.401e-02 | -3.73 | ERBIN (erbb2 interacting protein) | protein interactions | 55914 | 241 | 3 | 19454 | 50 |
DST,CTNND2,ABR |
2.412e-02 | -3.72 | microtubule severing ATPase activity | molecular function | GO:0008568 | 9 | 1 | 18094 | 49 |
IQCA1 |
2.412e-02 | -3.72 | L-aspartate transmembrane transporter activity | molecular function | GO:0015183 | 9 | 1 | 18094 | 49 |
SLC25A18 |
2.412e-02 | -3.72 | striated_muscle | COSMIC cancer mutations | striated_muscle | 4228 | 19 | 16828 | 49 |
ARAP2,PPP2R2B,GLIS3,CDH20,RYR3,AQP4,DPP10,NPAS3,DCLK1,SORBS1,TRPM3,TNRC6A,ADCY2,CAMK2G,TRPS1,NAV2,MACF1,CTNND2,FMN2 |
2.424e-02 | -3.72 | GS | smart domains | SM00467 | 7 | 1 | 9717 | 34 |
BMPR1B |
2.435e-02 | -3.72 | TRAF3IP1 (TRAF3 interacting protein 1) | protein interactions | 26146 | 94 | 2 | 19454 | 50 |
MACF1,DST |
2.453e-02 | -3.71 | Ewings_sarcoma-peripheral_primitive_neuroectodermal_tumour | COSMIC cancer mutations | Ewings_sarcoma-peripheral_primitive_neuroectodermal_tumour | 7434 | 29 | 16828 | 49 |
ARAP2,NPAS3,DCLK1,TRPM3,SORBS1,TRPS1,DAAM2,PTGDS,FMN2,CTNND2,QKI,GLIS3,PPP2R2B,ABR,RYR3,DCLK2,LIFR,SOX5,DST,CAMK2G,ADCY2,ERBB4,TNRC6A,PRKG1,DTNA,NRG3,MACF1,NAV2,HIF3A |
2.464e-02 | -3.70 | nucleotide binding | molecular function | GO:0000166 | 2128 | 11 | 18094 | 49 |
ADCY2,PRKG1,DCLK1,RPS6KA2,NAV2,BMPR1B,DCLK2,CAMK2G,TTN,ERBB4,IQCA1 |
2.469e-02 | -3.70 | neck | COSMIC cancer mutations | neck | 1231 | 8 | 16828 | 49 |
DCLK1,DPP10,ERBB4,ADCY2,TRPM3,ARAP2,WDR49,CTNND2 |
2.472e-02 | -3.70 | nucleoside phosphate binding | molecular function | GO:1901265 | 2129 | 11 | 18094 | 49 |
CAMK2G,IQCA1,DCLK2,BMPR1B,NAV2,ERBB4,RPS6KA2,DCLK1,PRKG1,ADCY2,TTN |
2.477e-02 | -3.70 | PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | REACTOME pathways | R-HSA-6811558 | 87 | 2 | 10285 | 29 |
ERBB4,NRG3 |
2.495e-02 | -3.69 | axon | cellular component | GO:0030424 | 650 | 5 | 19108 | 49 |
SLC1A2,PCDH9,DST,DTNA,ABR |
2.521e-02 | -3.68 | sarcoplasm | cellular component | GO:0016528 | 96 | 2 | 19108 | 49 |
CAMK2G,RYR3 |
2.521e-02 | -3.68 | actin filament bundle | cellular component | GO:0032432 | 96 | 2 | 19108 | 49 |
DST,SORBS1 |
2.529e-02 | -3.68 | Ig_sub2 | interpro domains | IPR003598 | 239 | 3 | 18521 | 49 |
LSAMP,NTM,TTN |
2.531e-02 | -3.68 | PRKD2 (protein kinase D2) | protein interactions | 25865 | 246 | 3 | 19454 | 50 |
CAMK2G,PPP2R2B,DST |
2.537e-02 | -3.67 | HNRNPL (heterogeneous nuclear ribonucleoprotein L) | protein interactions | 3191 | 1958 | 10 | 19454 | 50 |
RPS6KA2,DCLK2,MSI2,TRPS1,MACF1,NRG3,QKI,DTNA,ABR,BMPR1B |
2.541e-02 | -3.67 | Smurf2 (SMAD specific E3 ubiquitin protein ligase 2) | protein interactions | 66313 | 10 | 1 | 19454 | 50 |
GLIS3 |
2.541e-02 | -3.67 | GSG1 (germ cell associated 1) | protein interactions | 83445 | 10 | 1 | 19454 | 50 |
PITPNC1 |
2.541e-02 | -3.67 | DEFA1B (defensin alpha 1B) | protein interactions | 728358 | 10 | 1 | 19454 | 50 |
PPP2R2B |
2.541e-02 | -3.67 | MYBPH (myosin binding protein H) | protein interactions | 4608 | 10 | 1 | 19454 | 50 |
TTN |
2.541e-02 | -3.67 | DOA4 (ubiquitin-specific protease DOA4) | protein interactions | 851641 | 10 | 1 | 19454 | 50 |
NAV2 |
2.541e-02 | -3.67 | Hsp90aa1 (heat shock protein 90, alpha (cytosolic), class A member 1) | protein interactions | 15519 | 10 | 1 | 19454 | 50 |
QKI |
2.541e-02 | -3.67 | EREG (epiregulin) | protein interactions | 2069 | 10 | 1 | 19454 | 50 |
ERBB4 |
2.541e-02 | -3.67 | PTPRT (protein tyrosine phosphatase receptor type T) | protein interactions | 11122 | 10 | 1 | 19454 | 50 |
ERBB4 |
2.541e-02 | -3.67 | Mrpl13 (mitochondrial ribosomal protein L13) | protein interactions | 68537 | 10 | 1 | 19454 | 50 |
QKI |
2.568e-02 | -3.66 | spindle | COSMIC cancer mutations | spindle | 386 | 4 | 16828 | 49 |
CTNND2,MACF1,TRPM3,PCDH9 |
2.574e-02 | -3.66 | LIPOCALIN | prints domains | PR00179 | 8 | 1 | 5227 | 17 |
PTGDS |
2.574e-02 | -3.66 | GATAZNFINGER | prints domains | PR00619 | 8 | 1 | 5227 | 17 |
TRPS1 |
2.580e-02 | -3.66 | Aldosterone synthesis and secretion | KEGG pathways | hsa04925 | 82 | 2 | 7161 | 22 |
ADCY2,CAMK2G |
2.580e-02 | -3.66 | Aldosterone synthesis and secretion | KEGG pathways | ko04925 | 82 | 2 | 7161 | 22 |
ADCY2,CAMK2G |
2.581e-02 | -3.66 | PLCB3 (phospholipase C beta 3) | protein interactions | 5331 | 97 | 2 | 19454 | 50 |
PRKG1,CAMK2G |
2.581e-02 | -3.66 | BTG3 (BTG anti-proliferation factor 3) | protein interactions | 10950 | 97 | 2 | 19454 | 50 |
DCLK2,TNRC6A |
2.585e-02 | -3.66 | ABL1 (ABL proto-oncogene 1, non-receptor tyrosine kinase) | protein interactions | 25 | 248 | 3 | 19454 | 50 |
CTNND2,SORBS1,ERBB4 |
2.595e-02 | -3.65 | contractile muscle fiber | cellular component | GO:0043292 | 249 | 3 | 19108 | 49 |
DST,RYR3,TTN |
2.597e-02 | -3.65 | GATA_ZN_FINGER_1 | prosite domains | PS00344 | 8 | 1 | 12186 | 40 |
TRPS1 |
2.597e-02 | -3.65 | DAD | prosite domains | PS51231 | 8 | 1 | 12186 | 40 |
DAAM2 |
2.599e-02 | -3.65 | enzyme-linked receptor protein signaling pathway | biological process | GO:0007167 | 626 | 5 | 18204 | 49 |
NRG3,ERBB4,BMPR1B,SORBS1,LIFR |
2.600e-02 | -3.65 | Signaling by the B Cell Receptor (BCR) | REACTOME pathways | R-HSA-983705 | 229 | 3 | 10285 | 29 |
NRG3,TNRC6A,ERBB4 |
2.607e-02 | -3.65 | Excitatory Neural Signalling Through 5-HTR 7 and Serotonin | SMPDB pathways | SMP0000311 | 9 | 1 | 1369 | 4 |
ADCY2 |
2.607e-02 | -3.65 | Excitatory Neural Signalling Through 5-HTR 6 and Serotonin | SMPDB pathways | SMP0000312 | 9 | 1 | 1369 | 4 |
ADCY2 |
2.607e-02 | -3.65 | Excitatory Neural Signalling Through 5-HTR 4 and Serotonin | SMPDB pathways | SMP0000309 | 9 | 1 | 1369 | 4 |
ADCY2 |
2.607e-02 | -3.65 | Intracellular Signalling Through FSH Receptor and Follicle Stimulating Hormone | SMPDB pathways | SMP0000333 | 9 | 1 | 1369 | 4 |
ADCY2 |
2.607e-02 | -3.65 | Intracellular Signalling Through Histamine H2 Receptor and Histamine | SMPDB pathways | SMP0000335 | 9 | 1 | 1369 | 4 |
ADCY2 |
2.611e-02 | -3.65 | PAS_3 | pfam domains | PF08447 | 10 | 1 | 17795 | 47 |
NPAS3 |
2.611e-02 | -3.65 | MIR | pfam domains | PF02815 | 10 | 1 | 17795 | 47 |
RYR3 |
2.612e-02 | -3.65 | GAN (gigaxonin) | protein interactions | 8139 | 249 | 3 | 19454 | 50 |
DST,GFAP,TTN |
2.615e-02 | -3.64 | PAS_fold_3 | interpro domains | IPR013655 | 10 | 1 | 18521 | 49 |
NPAS3 |
2.615e-02 | -3.64 | MIR_motif | interpro domains | IPR016093 | 10 | 1 | 18521 | 49 |
RYR3 |
2.615e-02 | -3.64 | MIR_dom_sf | interpro domains | IPR036300 | 10 | 1 | 18521 | 49 |
RYR3 |
2.615e-02 | -3.64 | MIP_CS | interpro domains | IPR022357 | 10 | 1 | 18521 | 49 |
AQP4 |
2.616e-02 | -3.64 | protein localization to cell periphery | biological process | GO:1990778 | 238 | 3 | 18204 | 49 |
MACF1,ERBB4,DPP10 |
2.616e-02 | -3.64 | muscle contraction | biological process | GO:0006936 | 238 | 3 | 18204 | 49 |
RYR3,DTNA,TTN |
2.619e-02 | -3.64 | Tyr_kinase_AS | interpro domains | IPR008266 | 95 | 2 | 18521 | 49 |
TTN,ERBB4 |
2.624e-02 | -3.64 | SYNE3 (spectrin repeat containing nuclear envelope family member 3) | protein interactions | 161176 | 440 | 4 | 19454 | 50 |
SORBS1,TNRC6A,DST,MACF1 |
2.631e-02 | -3.64 | VAV2 (vav guanine nucleotide exchange factor 2) | protein interactions | 7410 | 98 | 2 | 19454 | 50 |
TTN,ERBB4 |
2.631e-02 | -3.64 | FRS2 (fibroblast growth factor receptor substrate 2) | protein interactions | 10818 | 98 | 2 | 19454 | 50 |
SORBS1,RPS6KA2 |
2.631e-02 | -3.64 | DNAAF2 (dynein axonemal assembly factor 2) | protein interactions | 55172 | 98 | 2 | 19454 | 50 |
DCLK1,LSAMP |
2.631e-02 | -3.64 | FRAS1 (Fraser extracellular matrix complex subunit 1) | protein interactions | 80144 | 98 | 2 | 19454 | 50 |
MGAT4C,HPSE2 |
2.638e-02 | -3.64 | PI3K/AKT Signaling in Cancer | REACTOME pathways | R-HSA-2219528 | 90 | 2 | 10285 | 29 |
NRG3,ERBB4 |
2.660e-02 | -3.63 | substrate-independent telencephalic tangential migration | biological process | GO:0021826 | 10 | 1 | 18204 | 49 |
NRG3 |
2.660e-02 | -3.63 | release of sequestered calcium ion into cytosol by endoplasmic reticulum | biological process | GO:1903514 | 10 | 1 | 18204 | 49 |
RYR3 |
2.660e-02 | -3.63 | cAMP biosynthetic process | biological process | GO:0006171 | 10 | 1 | 18204 | 49 |
ADCY2 |
2.660e-02 | -3.63 | regulation of mesenchymal stem cell differentiation | biological process | GO:2000739 | 10 | 1 | 18204 | 49 |
SOX5 |
2.660e-02 | -3.63 | substrate-independent telencephalic tangential interneuron migration | biological process | GO:0021843 | 10 | 1 | 18204 | 49 |
NRG3 |
2.660e-02 | -3.63 | mitochondrial fragmentation involved in apoptotic process | biological process | GO:0043653 | 10 | 1 | 18204 | 49 |
ERBB4 |
2.660e-02 | -3.63 | skeletal myofibril assembly | biological process | GO:0014866 | 10 | 1 | 18204 | 49 |
TTN |
2.660e-02 | -3.63 | cellular response to cocaine | biological process | GO:0071314 | 10 | 1 | 18204 | 49 |
SLC1A2 |
2.660e-02 | -3.63 | urea transmembrane transport | biological process | GO:0071918 | 10 | 1 | 18204 | 49 |
SLC14A1 |
2.676e-02 | -3.62 | phosphatidylinositol transfer activity | molecular function | GO:0008526 | 10 | 1 | 18094 | 49 |
PITPNC1 |
2.680e-02 | -3.62 | ZFHX3 (zinc finger homeobox 3) | protein interactions | 463 | 99 | 2 | 19454 | 50 |
SOX5,TRPS1 |
2.702e-02 | -3.61 | gallbladder | COSMIC cancer mutations | gallbladder | 2821 | 14 | 16828 | 49 |
SLC39A11,RYR3,PITPNC1,CTNND2,FMN2,MACF1,NRG3,TRPS1,PRKG1,ERBB4,TRPM3,DCLK1,DPP10,PCDH9 |
2.702e-02 | -3.61 | biliary_tract-gallbladder-carcinoma-adenocarcinoma | COSMIC cancer mutations | biliary_tract-gallbladder-carcinoma-adenocarcinoma | 2821 | 14 | 16828 | 49 |
PCDH9,DPP10,DCLK1,TRPM3,ERBB4,PRKG1,TRPS1,NRG3,MACF1,FMN2,CTNND2,PITPNC1,RYR3,SLC39A11 |
2.704e-02 | -3.61 | cardiac muscle cell differentiation | biological process | GO:0055007 | 95 | 2 | 18204 | 49 |
TTN,PRKG1 |
2.706e-02 | -3.61 | peritoneum-appendix-other-pseudomyxoma_peritonei | COSMIC cancer mutations | peritoneum-appendix-other-pseudomyxoma_peritonei | 585 | 5 | 16828 | 49 |
DCLK1,TRPS1,WDR49,DST,MACF1 |
2.706e-02 | -3.61 | pseudomyxoma_peritonei | COSMIC cancer mutations | pseudomyxoma_peritonei | 585 | 5 | 16828 | 49 |
DCLK1,TRPS1,WDR49,DST,MACF1 |
2.712e-02 | -3.61 | EF-hand_7 | pfam domains | PF13499 | 97 | 2 | 17795 | 47 |
DST,MACF1 |
2.719e-02 | -3.61 | extrinsic component of plasma membrane | cellular component | GO:0019897 | 100 | 2 | 19108 | 49 |
DTNA,CDH20 |
2.723e-02 | -3.60 | appendix | COSMIC cancer mutations | appendix | 586 | 5 | 16828 | 49 |
DST,MACF1,DCLK1,TRPS1,WDR49 |
2.723e-02 | -3.60 | monoatomic cation transmembrane transporter activity | molecular function | GO:0008324 | 630 | 5 | 18094 | 49 |
SLC1A2,RYR3,SLC39A11,TRPM3,SLC25A18 |
2.733e-02 | -3.60 | Heparan sulfate degradation | KEGG pathways | hsa_M00078 | 9 | 1 | 7161 | 22 |
HPSE2 |
2.733e-02 | -3.60 | cGMP signaling | KEGG pathways | M00694 | 9 | 1 | 7161 | 22 |
PRKG1 |
2.733e-02 | -3.60 | cGMP signaling | KEGG pathways | hsa_M00694 | 9 | 1 | 7161 | 22 |
PRKG1 |
2.733e-02 | -3.60 | Heparan sulfate degradation | KEGG pathways | M00078 | 9 | 1 | 7161 | 22 |
HPSE2 |
2.737e-02 | -3.60 | pancreas-other-adenoma | COSMIC cancer mutations | pancreas-other-adenoma | 224 | 3 | 16828 | 49 |
CTNND2,PCDH9,BMPR1B |
2.741e-02 | -3.60 | peritoneum | COSMIC cancer mutations | peritoneum | 587 | 5 | 16828 | 49 |
MACF1,DST,DCLK1,WDR49,TRPS1 |
2.748e-02 | -3.59 | Post-translational modification: synthesis of GPI-anchored proteins | REACTOME pathways | R-HSA-163125 | 92 | 2 | 10285 | 29 |
NTM,LSAMP |
2.758e-02 | -3.59 | Insulin secretion | KEGG pathways | hsa04911 | 85 | 2 | 7161 | 22 |
ADCY2,CAMK2G |
2.776e-02 | -3.58 | LMO2 (LIM domain only 2) | protein interactions | 4005 | 255 | 3 | 19454 | 50 |
SOX5,PRKG1,GFAP |
2.785e-02 | -3.58 | Adenylate cyclase activating pathway | REACTOME pathways | R-HSA-170660 | 10 | 1 | 10285 | 29 |
ADCY2 |
2.785e-02 | -3.58 | Organic anion transporters | REACTOME pathways | R-HSA-428643 | 10 | 1 | 10285 | 29 |
SLC25A18 |
2.786e-02 | -3.58 | interstitial matrix | cellular component | GO:0005614 | 11 | 1 | 19108 | 49 |
NAV2 |
2.792e-02 | -3.58 | Wipi2 (WD repeat domain, phosphoinositide interacting 2) | protein interactions | 74781 | 11 | 1 | 19454 | 50 |
MACF1 |
2.792e-02 | -3.58 | Batf3 (basic leucine zipper transcription factor, ATF-like 3) | protein interactions | 381319 | 11 | 1 | 19454 | 50 |
MACF1 |
2.792e-02 | -3.58 | DAZ1 (deleted in azoospermia 1) | protein interactions | 1617 | 11 | 1 | 19454 | 50 |
QKI |
2.792e-02 | -3.58 | PTGDR (prostaglandin D2 receptor) | protein interactions | 5729 | 11 | 1 | 19454 | 50 |
PTGDS |
2.792e-02 | -3.58 | IRAG1 (inositol 1,4,5-triphosphate receptor associated 1) | protein interactions | 10335 | 11 | 1 | 19454 | 50 |
PRKG1 |
2.792e-02 | -3.58 | IL7 (interleukin 7) | protein interactions | 3574 | 11 | 1 | 19454 | 50 |
QKI |
2.792e-02 | -3.58 | ADCY5 (adenylate cyclase 5) | protein interactions | 111 | 11 | 1 | 19454 | 50 |
ADCY2 |
2.809e-02 | -3.57 | cellular component assembly | biological process | GO:0022607 | 2472 | 12 | 18204 | 49 |
FMN2,ERBB4,NRG3,DST,TTN,SORBS1,CDH20,AQP4,RFX4,TRPM3,SLC1A2,RYR3 |
2.814e-02 | -3.57 | basolateral plasma membrane | cellular component | GO:0016323 | 257 | 3 | 19108 | 49 |
AQP4,ERBB4,SLC14A1 |
2.832e-02 | -3.56 | human chr18q12.3 | chromosome location | human chr18q12.3 | 15 | 1 | 26134 | 50 |
SLC14A1 |
2.832e-02 | -3.56 | MIR7-1 (microRNA 7-1) | protein interactions | 407043 | 102 | 2 | 19454 | 50 |
MSI2,QKI |
2.832e-02 | -3.56 | KRTAP6-1 (keratin associated protein 6-1) | protein interactions | 337966 | 102 | 2 | 19454 | 50 |
GLIS3,CAMK2G |
2.832e-02 | -3.56 | GRAP2 (GRB2 related adaptor protein 2) | protein interactions | 9402 | 102 | 2 | 19454 | 50 |
ERBB4,GFAP |
2.847e-02 | -3.56 | positive regulation of neurogenesis | biological process | GO:0050769 | 246 | 3 | 18204 | 49 |
MACF1,QKI,GFAP |
2.859e-02 | -3.55 | Negative regulation of the PI3K/AKT network | REACTOME pathways | R-HSA-199418 | 94 | 2 | 10285 | 29 |
ERBB4,NRG3 |
2.868e-02 | -3.55 | PAS_11 | pfam domains | PF14598 | 11 | 1 | 17795 | 47 |
HIF3A |
2.873e-02 | -3.55 | GBD/FH3_dom | interpro domains | IPR014768 | 11 | 1 | 18521 | 49 |
DAAM2 |
2.875e-02 | -3.55 | chiasm | COSMIC cancer mutations | chiasm | 10 | 1 | 16828 | 49 |
QKI |
2.875e-02 | -3.55 | regulation of protein localization | biological process | GO:0032880 | 872 | 6 | 18204 | 49 |
DPP10,ERBB4,DCLK2,DCLK1,SORBS1,TTN |
2.884e-02 | -3.55 | ID2 (inhibitor of DNA binding 2) | protein interactions | 3398 | 103 | 2 | 19454 | 50 |
DST,MACF1 |
2.891e-02 | -3.54 | transmembrane transporter activity | molecular function | GO:0022857 | 1110 | 7 | 18094 | 49 |
SLC39A11,AQP4,RYR3,SLC1A2,SLC25A18,SLC14A1,TRPM3 |
2.893e-02 | -3.54 | Intracellular Signalling Through LHCGR Receptor and Luteinizing Hormone/Choriogonadotropin | SMPDB pathways | SMP0000338 | 10 | 1 | 1369 | 4 |
ADCY2 |
2.897e-02 | -3.54 | large_intestine-caecum-adenoma | COSMIC cancer mutations | large_intestine-caecum-adenoma | 229 | 3 | 16828 | 49 |
ERBB4,CTNND2,HPSE2 |
2.917e-02 | -3.53 | RFX_DBD | prosite domains | PS51526 | 9 | 1 | 12186 | 40 |
RFX4 |
2.922e-02 | -3.53 | Bergmann glial cell differentiation | biological process | GO:0060020 | 11 | 1 | 18204 | 49 |
GFAP |
2.922e-02 | -3.53 | ectodermal placode formation | biological process | GO:0060788 | 11 | 1 | 18204 | 49 |
NRG3 |
2.922e-02 | -3.53 | physiological cardiac muscle hypertrophy | biological process | GO:0003301 | 11 | 1 | 18204 | 49 |
PRKG1 |
2.922e-02 | -3.53 | negative regulation of platelet aggregation | biological process | GO:0090331 | 11 | 1 | 18204 | 49 |
PRKG1 |
2.922e-02 | -3.53 | L-glutamate import across plasma membrane | biological process | GO:0098712 | 11 | 1 | 18204 | 49 |
SLC1A2 |
2.922e-02 | -3.53 | intracellular mRNA localization | biological process | GO:0008298 | 11 | 1 | 18204 | 49 |
QKI |
2.922e-02 | -3.53 | pyramidal neuron development | biological process | GO:0021860 | 11 | 1 | 18204 | 49 |
DCLK2 |
2.922e-02 | -3.53 | regulation of Schwann cell proliferation | biological process | GO:0010624 | 11 | 1 | 18204 | 49 |
GFAP |
2.922e-02 | -3.53 | physiological muscle hypertrophy | biological process | GO:0003298 | 11 | 1 | 18204 | 49 |
PRKG1 |
2.922e-02 | -3.53 | cellular response to caffeine | biological process | GO:0071313 | 11 | 1 | 18204 | 49 |
RYR3 |
2.922e-02 | -3.53 | cell growth involved in cardiac muscle cell development | biological process | GO:0061049 | 11 | 1 | 18204 | 49 |
PRKG1 |
2.922e-02 | -3.53 | negative regulation of neuron migration | biological process | GO:2001223 | 11 | 1 | 18204 | 49 |
NRG3 |
2.922e-02 | -3.53 | ectodermal placode morphogenesis | biological process | GO:0071697 | 11 | 1 | 18204 | 49 |
NRG3 |
2.922e-02 | -3.53 | antral ovarian follicle growth | biological process | GO:0001547 | 11 | 1 | 18204 | 49 |
BMPR1B |
2.936e-02 | -3.53 | ANKHD1-EIF4EBP3 (ANKHD1-EIF4EBP3 readthrough) | protein interactions | 404734 | 104 | 2 | 19454 | 50 |
TNRC6A,HPSE2 |
2.936e-02 | -3.53 | HUNK (hormonally up-regulated Neu-associated kinase) | protein interactions | 30811 | 104 | 2 | 19454 | 50 |
DST,SORBS1 |
2.940e-02 | -3.53 | sulfur amino acid transmembrane transporter activity | molecular function | GO:0000099 | 11 | 1 | 18094 | 49 |
SLC1A2 |
2.941e-02 | -3.53 | Gap junction | KEGG pathways | ko04540 | 88 | 2 | 7161 | 22 |
ADCY2,PRKG1 |
2.941e-02 | -3.53 | Gap junction | KEGG pathways | hsa04540 | 88 | 2 | 7161 | 22 |
ADCY2,PRKG1 |
2.972e-02 | -3.52 | kidney-carcinoma | COSMIC cancer mutations | kidney-carcinoma | 3720 | 17 | 16828 | 49 |
DCLK2,RPS6KA2,PITPNC1,QKI,PPP2R2B,TRPS1,MSI2,PRKG1,CTNND2,HIF3A,DAAM2,DCLK1,BMPR1B,SOX5,LIFR,ERBB4,CAMK2G |
2.972e-02 | -3.52 | response to alkaloid | biological process | GO:0043279 | 100 | 2 | 18204 | 49 |
SLC1A2,RYR3 |
3.003e-02 | -3.51 | Dilated cardiomyopathy | KEGG pathways | ko05414 | 89 | 2 | 7161 | 22 |
TTN,ADCY2 |
3.003e-02 | -3.51 | Dilated cardiomyopathy | KEGG pathways | hsa05414 | 89 | 2 | 7161 | 22 |
TTN,ADCY2 |
3.005e-02 | -3.50 | amino acid transmembrane transporter activity | molecular function | GO:0015171 | 100 | 2 | 18094 | 49 |
SLC1A2,SLC25A18 |
3.027e-02 | -3.50 | regulation of carbohydrate biosynthetic process | biological process | GO:0043255 | 101 | 2 | 18204 | 49 |
SORBS1,PRKG1 |
3.030e-02 | -3.50 | abdomen | COSMIC cancer mutations | abdomen | 603 | 5 | 16828 | 49 |
DPP10,FMN2,ERBB4,CTNND2,DST |
3.040e-02 | -3.49 | MELK (maternal embryonic leucine zipper kinase) | protein interactions | 9833 | 106 | 2 | 19454 | 50 |
CAMK2G,DCLK1 |
3.042e-02 | -3.49 | CTF1 (cardiotrophin 1) | protein interactions | 1489 | 12 | 1 | 19454 | 50 |
LIFR |
3.042e-02 | -3.49 | ANKRD2 (ankyrin repeat domain 2) | protein interactions | 26287 | 12 | 1 | 19454 | 50 |
TTN |
3.042e-02 | -3.49 | INTS4P2 (integrator complex subunit 4 pseudogene 2) | protein interactions | 644619 | 12 | 1 | 19454 | 50 |
GFAP |
3.042e-02 | -3.49 | OAS2 (2'-5'-oligoadenylate synthetase 2) | protein interactions | 4939 | 12 | 1 | 19454 | 50 |
PRKG1 |
3.042e-02 | -3.49 | SMIM20 (small integral membrane protein 20) | protein interactions | 389203 | 12 | 1 | 19454 | 50 |
ERBB4 |
3.042e-02 | -3.49 | PTPN20 (protein tyrosine phosphatase non-receptor type 20) | protein interactions | 26095 | 12 | 1 | 19454 | 50 |
ERBB4 |
3.042e-02 | -3.49 | ABLIM2 (actin binding LIM protein family member 2) | protein interactions | 84448 | 12 | 1 | 19454 | 50 |
TTN |
3.042e-02 | -3.49 | CDHR2 (cadherin related family member 2) | protein interactions | 54825 | 12 | 1 | 19454 | 50 |
RPS6KA2 |
3.042e-02 | -3.49 | MYBPHL (myosin binding protein H like) | protein interactions | 343263 | 12 | 1 | 19454 | 50 |
GFAP |
3.042e-02 | -3.49 | BAMBI (BMP and activin membrane bound inhibitor) | protein interactions | 25805 | 12 | 1 | 19454 | 50 |
BMPR1B |
3.060e-02 | -3.49 | Type I hemidesmosome assembly | REACTOME pathways | R-HSA-446107 | 11 | 1 | 10285 | 29 |
DST |
3.092e-02 | -3.48 | GRB2 events in EGFR signaling | REACTOME pathways | R-HSA-179812 | 245 | 3 | 10285 | 29 |
ERBB4,CAMK2G,NRG3 |
3.092e-02 | -3.48 | SHC1 events in EGFR signaling | REACTOME pathways | R-HSA-180336 | 245 | 3 | 10285 | 29 |
NRG3,ERBB4,CAMK2G |
3.092e-02 | -3.48 | SOS-mediated signalling | REACTOME pathways | R-HSA-112412 | 245 | 3 | 10285 | 29 |
NRG3,ERBB4,CAMK2G |
3.092e-02 | -3.48 | RAF/MAP kinase cascade | REACTOME pathways | R-HSA-5673001 | 245 | 3 | 10285 | 29 |
NRG3,ERBB4,CAMK2G |
3.101e-02 | -3.47 | cell morphogenesis involved in neuron differentiation | biological process | GO:0048667 | 443 | 4 | 18204 | 49 |
DCLK1,CTNND2,PRKG1,BMPR1B |
3.107e-02 | -3.47 | Drf_GBD | smart domains | SM01140 | 9 | 1 | 9717 | 34 |
DAAM2 |
3.107e-02 | -3.47 | Drf_FH3 | smart domains | SM01139 | 9 | 1 | 9717 | 34 |
DAAM2 |
3.122e-02 | -3.47 | ESR1 (estrogen receptor 1) | protein interactions | 2099 | 2322 | 11 | 19454 | 50 |
MSI2,ERBB4,RFX4,TRPS1,TNRC6A,SLC39A11,DST,TTN,DCLK1,CTNND2,MACF1 |
3.129e-02 | -3.46 | mRNA surveillance pathway | KEGG pathways | ko03015 | 91 | 2 | 7161 | 22 |
MSI2,PPP2R2B |
3.129e-02 | -3.46 | mRNA surveillance pathway | KEGG pathways | hsa03015 | 91 | 2 | 7161 | 22 |
PPP2R2B,MSI2 |
3.130e-02 | -3.46 | Lipocalin_CS | interpro domains | IPR022272 | 12 | 1 | 18521 | 49 |
PTGDS |
3.130e-02 | -3.46 | TGFB_receptor | interpro domains | IPR000333 | 12 | 1 | 18521 | 49 |
BMPR1B |
3.130e-02 | -3.46 | Lipocalin | interpro domains | IPR002345 | 12 | 1 | 18521 | 49 |
PTGDS |
3.138e-02 | -3.46 | metal ion transmembrane transporter activity | molecular function | GO:0046873 | 442 | 4 | 18094 | 49 |
RYR3,SLC39A11,SLC1A2,TRPM3 |
3.142e-02 | -3.46 | ion binding | molecular function | GO:0043167 | 6007 | 23 | 18094 | 49 |
SLC1A2,ERBB4,RYR3,IQCA1,PCDH9,GLIS3,RPS6KA2,MGAT4C,DCLK1,PRKG1,DTNA,TRPS1,CAMK2G,ARAP2,PTGDS,BMPR1B,NAV2,PITPNC1,TTN,MACF1,ADCY2,DCLK2,DST |
3.147e-02 | -3.46 | CLASP1 (cytoplasmic linker associated protein 1) | protein interactions | 23332 | 108 | 2 | 19454 | 50 |
DCLK2,MACF1 |
3.147e-02 | -3.46 | ALDH3B1 (aldehyde dehydrogenase 3 family member B1) | protein interactions | 221 | 108 | 2 | 19454 | 50 |
GFAP,FMN2 |
3.151e-02 | -3.46 | VCL (vinculin) | protein interactions | 7414 | 268 | 3 | 19454 | 50 |
DST,MACF1,SORBS1 |
3.167e-02 | -3.45 | large_intestine-colon | COSMIC cancer mutations | large_intestine-colon | 1291 | 8 | 16828 | 49 |
DPP10,ARAP2,DST,ADCY2,ERBB4,NAV2,DAAM2,FMN2 |
3.172e-02 | -3.45 | anatomical structure morphogenesis | biological process | GO:0009653 | 2225 | 11 | 18204 | 49 |
HIF3A,NRG3,PRKG1,CTNND2,DCLK1,SOX5,BMPR1B,ERBB4,QKI,CDH20,TTN |
3.184e-02 | -3.45 | microglia differentiation | biological process | GO:0014004 | 12 | 1 | 18204 | 49 |
QKI |
3.184e-02 | -3.45 | urea transport | biological process | GO:0015840 | 12 | 1 | 18204 | 49 |
SLC14A1 |
3.184e-02 | -3.45 | positive regulation of extrinsic apoptotic signaling pathway via death domain receptors | biological process | GO:1902043 | 12 | 1 | 18204 | 49 |
BMPR1B |
3.184e-02 | -3.45 | negative regulation of smooth muscle contraction | biological process | GO:0045986 | 12 | 1 | 18204 | 49 |
PRKG1 |
3.184e-02 | -3.45 | sulfur amino acid transport | biological process | GO:0000101 | 12 | 1 | 18204 | 49 |
SLC1A2 |
3.184e-02 | -3.45 | mammalian oogenesis stage | biological process | GO:0022605 | 12 | 1 | 18204 | 49 |
BMPR1B |
3.192e-02 | -3.44 | Progesterone-mediated oocyte maturation | KEGG pathways | hsa04914 | 92 | 2 | 7161 | 22 |
ADCY2,RPS6KA2 |
3.192e-02 | -3.44 | GnRH signaling pathway | KEGG pathways | hsa04912 | 92 | 2 | 7161 | 22 |
CAMK2G,ADCY2 |
3.192e-02 | -3.44 | Progesterone-mediated oocyte maturation | KEGG pathways | ko04914 | 92 | 2 | 7161 | 22 |
ADCY2,RPS6KA2 |
3.192e-02 | -3.44 | GnRH signaling pathway | KEGG pathways | ko04912 | 92 | 2 | 7161 | 22 |
CAMK2G,ADCY2 |
3.200e-02 | -3.44 | MIR34B (microRNA 34b) | protein interactions | 407041 | 109 | 2 | 19454 | 50 |
QKI,MSI2 |
3.200e-02 | -3.44 | PRR20A (proline rich 20A) | protein interactions | 122183 | 109 | 2 | 19454 | 50 |
SOX5,TRPM3 |
3.203e-02 | -3.44 | dipeptidyl-peptidase activity | molecular function | GO:0008239 | 12 | 1 | 18094 | 49 |
DPP10 |
3.203e-02 | -3.44 | structural molecule activity conferring elasticity | molecular function | GO:0097493 | 12 | 1 | 18094 | 49 |
TTN |
3.203e-02 | -3.44 | adenylate cyclase binding | molecular function | GO:0008179 | 12 | 1 | 18094 | 49 |
ADCY2 |
3.207e-02 | -3.44 | biliary_tract-bile_duct-carcinoma-adenocarcinoma | COSMIC cancer mutations | biliary_tract-bile_duct-carcinoma-adenocarcinoma | 15095 | 48 | 16828 | 49 |
PITPNC1,AQP4,RPS6KA2,LSAMP,DCLK1,PCDH9,FMN2,CTNND2,SLC25A18,GLIS3,QKI,RFX4,SLC39A11,DCLK2,SOX5,CAMK2G,NRG3,MSI2,PRKG1,HIF3A,NAV2,SLC14A1,ARAP2,MGAT4C,NPAS3,BMPR1B,DPP10,TRPM3,SORBS1,TRPS1,NTM,HPSE2,PTGDS,DAAM2,CDH20,ABR,PPP2R2B,RYR3,WDR49,LIFR,SLC1A2,TNRC6A,ERBB4,ADCY2,DST,DTNA,GFAP,MACF1 |
3.207e-02 | -3.44 | bile_duct | COSMIC cancer mutations | bile_duct | 15095 | 48 | 16828 | 49 |
NTM,HPSE2,DAAM2,PTGDS,TRPS1,SORBS1,TRPM3,NPAS3,BMPR1B,DPP10,ARAP2,MGAT4C,MACF1,GFAP,DTNA,ADCY2,TNRC6A,ERBB4,DST,LIFR,SLC1A2,WDR49,RYR3,ABR,CDH20,PPP2R2B,FMN2,CTNND2,DCLK1,LSAMP,PCDH9,AQP4,RPS6KA2,PITPNC1,HIF3A,NAV2,SLC14A1,NRG3,PRKG1,MSI2,CAMK2G,SOX5,DCLK2,RFX4,SLC39A11,GLIS3,QKI,SLC25A18 |
3.223e-02 | -3.43 | ARMS-mediated activation | REACTOME pathways | R-HSA-170984 | 249 | 3 | 10285 | 29 |
CAMK2G,ERBB4,NRG3 |
3.223e-02 | -3.43 | Signalling to p38 via RIT and RIN | REACTOME pathways | R-HSA-187706 | 249 | 3 | 10285 | 29 |
NRG3,CAMK2G,ERBB4 |
3.236e-02 | -3.43 | MIP | prosite domains | PS00221 | 10 | 1 | 12186 | 40 |
AQP4 |
3.236e-02 | -3.43 | MIR | prosite domains | PS50919 | 10 | 1 | 12186 | 40 |
RYR3 |
3.251e-02 | -3.43 | positive regulation of protein localization to membrane | biological process | GO:1905477 | 105 | 2 | 18204 | 49 |
DPP10,SORBS1 |
3.256e-02 | -3.42 | Frs2-mediated activation | REACTOME pathways | R-HSA-170968 | 250 | 3 | 10285 | 29 |
NRG3,ERBB4,CAMK2G |
3.276e-02 | -3.42 | prostate-carcinoma-adenocarcinoma | COSMIC cancer mutations | prostate-carcinoma-adenocarcinoma | 12379 | 42 | 16828 | 49 |
ABR,CDH20,QKI,PPP2R2B,GLIS3,SLC25A18,RFX4,RYR3,WDR49,SLC39A11,ADCY2,ERBB4,TNRC6A,DST,LIFR,SOX5,SLC1A2,HIF3A,MACF1,SLC14A1,NAV2,NRG3,GFAP,PRKG1,ARAP2,MGAT4C,PITPNC1,AQP4,TRPM3,SORBS1,DCLK1,LSAMP,PCDH9,NPAS3,DPP10,BMPR1B,FMN2,NTM,CTNND2,HPSE2,DAAM2,TRPS1 |
3.284e-02 | -3.42 | cytoplasmic side of lysosomal membrane | cellular component | GO:0098574 | 13 | 1 | 19108 | 49 |
GFAP |
3.289e-02 | -3.41 | MAPK1/MAPK3 signaling | REACTOME pathways | R-HSA-5684996 | 251 | 3 | 10285 | 29 |
NRG3,CAMK2G,ERBB4 |
3.291e-02 | -3.41 | CEACAM16 (CEA cell adhesion molecule 16, tectorial membrane component) | protein interactions | 388551 | 13 | 1 | 19454 | 50 |
DST |
3.291e-02 | -3.41 | TBCC (tubulin folding cofactor C) | protein interactions | 6903 | 13 | 1 | 19454 | 50 |
NTM |
3.291e-02 | -3.41 | NPR2 (natriuretic peptide receptor 2) | protein interactions | 4882 | 13 | 1 | 19454 | 50 |
CAMK2G |
3.291e-02 | -3.41 | MYBPC3 (myosin binding protein C3) | protein interactions | 4607 | 13 | 1 | 19454 | 50 |
TTN |
3.291e-02 | -3.41 | Rbm47 (RNA binding motif protein 47) | protein interactions | 245945 | 13 | 1 | 19454 | 50 |
QKI |
3.302e-02 | -3.41 | FLOT2 (flotillin 2) | protein interactions | 2319 | 273 | 3 | 19454 | 50 |
SLC14A1,RPS6KA2,SOX5 |
3.306e-02 | -3.41 | pancreas-carcinoid-endocrine_tumour | COSMIC cancer mutations | pancreas-carcinoid-endocrine_tumour | 7250 | 28 | 16828 | 49 |
LSAMP,PCDH9,BMPR1B,DPP10,FMN2,CTNND2,HPSE2,ARAP2,LIFR,SOX5,SLC1A2,ADCY2,ERBB4,TNRC6A,NRG3,PRKG1,MACF1,NAV2,SLC25A18,ABR,CDH20,GLIS3,QKI,PPP2R2B,RFX4,WDR49,RYR3,SLC39A11 |
3.306e-02 | -3.41 | bone-tibia-other-chondroblastoma | COSMIC cancer mutations | bone-tibia-other-chondroblastoma | 98 | 2 | 16828 | 49 |
CTNND2,LSAMP |
3.307e-02 | -3.41 | oogenesis | biological process | GO:0048477 | 106 | 2 | 18204 | 49 |
FMN2,BMPR1B |
3.316e-02 | -3.41 | EF_HAND_2 | prosite domains | PS50222 | 215 | 3 | 12186 | 40 |
RYR3,DST,MACF1 |
3.322e-02 | -3.40 | Prolonged ERK activation events | REACTOME pathways | R-HSA-169893 | 252 | 3 | 10285 | 29 |
ERBB4,CAMK2G,NRG3 |
3.333e-02 | -3.40 | Regulation of gene expression by Hypoxia-inducible Factor | REACTOME pathways | R-HSA-1234158 | 12 | 1 | 10285 | 29 |
HIF3A |
3.349e-02 | -3.40 | phosphate-containing compound metabolic process | biological process | GO:0006796 | 1681 | 9 | 18204 | 49 |
TTN,ERBB4,RPS6KA2,PRKG1,DCLK1,BMPR1B,CAMK2G,DCLK2,ADCY2 |
3.356e-02 | -3.39 | Signaling by Leptin | REACTOME pathways | R-HSA-2586552 | 253 | 3 | 10285 | 29 |
NRG3,CAMK2G,ERBB4 |
3.361e-02 | -3.39 | Ion_trans | pfam domains | PF00520 | 109 | 2 | 17795 | 47 |
RYR3,TRPM3 |
3.363e-02 | -3.39 | MPP1 (MAGUK p55 scaffold protein 1) | protein interactions | 4354 | 112 | 2 | 19454 | 50 |
TRPS1,RPS6KA2 |
3.363e-02 | -3.39 | TBR1 (T-box brain transcription factor 1) | protein interactions | 10716 | 112 | 2 | 19454 | 50 |
TRPS1,SOX5 |
3.363e-02 | -3.39 | CEP170P1 (centrosomal protein 170 pseudogene 1) | protein interactions | 645455 | 112 | 2 | 19454 | 50 |
MACF1,TRPS1 |
3.363e-02 | -3.39 | EDA (ectodysplasin A) | protein interactions | 1896 | 112 | 2 | 19454 | 50 |
RPS6KA2,ERBB4 |
3.373e-02 | -3.39 | Cadherin_CS | interpro domains | IPR020894 | 109 | 2 | 18521 | 49 |
CDH20,PCDH9 |
3.373e-02 | -3.39 | Ion_trans_dom | interpro domains | IPR005821 | 109 | 2 | 18521 | 49 |
TRPM3,RYR3 |
3.389e-02 | -3.38 | human chr3q26.1 | chromosome location | human chr3q26.1 | 18 | 1 | 26134 | 50 |
WDR49 |
3.389e-02 | -3.38 | human chr18q21.33 | chromosome location | human chr18q21.33 | 18 | 1 | 26134 | 50 |
CDH20 |
3.394e-02 | -3.38 | ACTR3 (actin related protein 3) | protein interactions | 10096 | 276 | 3 | 19454 | 50 |
TNRC6A,DST,SORBS1 |
3.396e-02 | -3.38 | regulation of nervous system development | biological process | GO:0051960 | 456 | 4 | 18204 | 49 |
MACF1,GFAP,QKI,DAAM2 |
3.396e-02 | -3.38 | pattern specification process | biological process | GO:0007389 | 456 | 4 | 18204 | 49 |
ERBB4,NRG3,DAAM2,BMPR1B |
3.402e-02 | -3.38 | beta-catenin binding | molecular function | GO:0008013 | 107 | 2 | 18094 | 49 |
CTNND2,CDH20 |
3.405e-02 | -3.38 | NR3C1 (nuclear receptor subfamily 3 group C member 1) | protein interactions | 2908 | 950 | 6 | 19454 | 50 |
TRPS1,CTNND2,PPP2R2B,CAMK2G,TTN,ADCY2 |
3.424e-02 | -3.37 | Interleukin receptor SHC signaling | REACTOME pathways | R-HSA-912526 | 255 | 3 | 10285 | 29 |
NRG3,ERBB4,CAMK2G |
3.425e-02 | -3.37 | RBFOX2 (RNA binding fox-1 homolog 2) | protein interactions | 23543 | 277 | 3 | 19454 | 50 |
TNRC6A,QKI,MSI2 |
3.438e-02 | -3.37 | Gastrin-CREB signalling pathway via PKC and MAPK | REACTOME pathways | R-HSA-881907 | 443 | 4 | 10285 | 29 |
NRG3,RPS6KA2,ERBB4,CAMK2G |
3.440e-02 | -3.37 | central_nervous_system-fourth_ventricle-glioma-astrocytoma_Grade_I | COSMIC cancer mutations | central_nervous_system-fourth_ventricle-glioma-astrocytoma_Grade_I | 12 | 1 | 16828 | 49 |
QKI |
3.444e-02 | -3.37 | Stimuli-sensing channels | REACTOME pathways | R-HSA-2672351 | 104 | 2 | 10285 | 29 |
RYR3,TRPM3 |
3.444e-02 | -3.37 | nervous system process involved in regulation of systemic arterial blood pressure | biological process | GO:0001976 | 13 | 1 | 18204 | 49 |
NAV2 |
3.444e-02 | -3.37 | olfactory bulb interneuron differentiation | biological process | GO:0021889 | 13 | 1 | 18204 | 49 |
ERBB4 |
3.444e-02 | -3.37 | ectodermal placode development | biological process | GO:0071696 | 13 | 1 | 18204 | 49 |
NRG3 |
3.444e-02 | -3.37 | positive regulation of nuclear-transcribed mRNA poly(A) tail shortening | biological process | GO:0060213 | 13 | 1 | 18204 | 49 |
TNRC6A |
3.444e-02 | -3.37 | negative regulation of homotypic cell-cell adhesion | biological process | GO:0034111 | 13 | 1 | 18204 | 49 |
PRKG1 |
3.446e-02 | -3.37 | MIR | smart domains | SM00472 | 10 | 1 | 9717 | 34 |
RYR3 |
3.458e-02 | -3.36 | Signalling to RAS | REACTOME pathways | R-HSA-167044 | 256 | 3 | 10285 | 29 |
NRG3,CAMK2G,ERBB4 |
3.465e-02 | -3.36 | transforming growth factor beta receptor activity | molecular function | GO:0005024 | 13 | 1 | 18094 | 49 |
BMPR1B |
3.474e-02 | -3.36 | ORF3b (ORF3b protein) | protein interactions | 1489670 | 114 | 2 | 19454 | 50 |
PCDH9,MACF1 |
3.481e-02 | -3.36 | long-chain fatty acid metabolic process | biological process | GO:0001676 | 109 | 2 | 18204 | 49 |
PTGDS,QKI |
3.481e-02 | -3.36 | regulation of protein localization to plasma membrane | biological process | GO:1903076 | 109 | 2 | 18204 | 49 |
DPP10,SORBS1 |
3.501e-02 | -3.35 | lower_third | COSMIC cancer mutations | lower_third | 7961 | 30 | 16828 | 49 |
MGAT4C,AQP4,RPS6KA2,DCLK1,DPP10,PCDH9,NPAS3,SORBS1,TRPM3,TRPS1,CTNND2,FMN2,DAAM2,HPSE2,CDH20,QKI,SLC39A11,WDR49,RYR3,DCLK2,SOX5,LIFR,ADCY2,TNRC6A,ERBB4,DST,NRG3,PRKG1,NAV2,MACF1 |
3.506e-02 | -3.35 | EV release from cardiac cells and their functional effects | WikiPathways | WP3297 | 9 | 1 | 5310 | 21 |
ERBB4 |
3.518e-02 | -3.35 | Inflammatory mediator regulation of TRP channels | KEGG pathways | ko04750 | 97 | 2 | 7161 | 22 |
CAMK2G,ADCY2 |
3.518e-02 | -3.35 | Inflammatory mediator regulation of TRP channels | KEGG pathways | hsa04750 | 97 | 2 | 7161 | 22 |
ADCY2,CAMK2G |
3.527e-02 | -3.34 | VEGFR2 mediated cell proliferation | REACTOME pathways | R-HSA-5218921 | 258 | 3 | 10285 | 29 |
ERBB4,CAMK2G,NRG3 |
3.530e-02 | -3.34 | SMAD7 (SMAD family member 7) | protein interactions | 4092 | 115 | 2 | 19454 | 50 |
SOX5,BMPR1B |
3.531e-02 | -3.34 | Cadherin | pfam domains | PF00028 | 112 | 2 | 17795 | 47 |
CDH20,PCDH9 |
3.540e-02 | -3.34 | SH3YL1 (SH3 and SYLF domain containing 1) | protein interactions | 26751 | 14 | 1 | 19454 | 50 |
GFAP |
3.540e-02 | -3.34 | SLC1A2 (solute carrier family 1 member 2) | protein interactions | 6506 | 14 | 1 | 19454 | 50 |
SLC1A2 |
3.540e-02 | -3.34 | Asap1 (ArfGAP with SH3 domain, ankyrin repeat and PH domain1) | protein interactions | 13196 | 14 | 1 | 19454 | 50 |
MACF1 |
3.540e-02 | -3.34 | FCGBP (Fc gamma binding protein) | protein interactions | 8857 | 14 | 1 | 19454 | 50 |
PPP2R2B |
3.540e-02 | -3.34 | CABS1 (calcium binding protein, spermatid associated 1) | protein interactions | 85438 | 14 | 1 | 19454 | 50 |
GFAP |
3.540e-02 | -3.34 | Nedd4 (neural precursor cell expressed, developmentally down-regulated 4) | protein interactions | 17999 | 14 | 1 | 19454 | 50 |
GLIS3 |
3.540e-02 | -3.34 | CFAP58 (cilia and flagella associated protein 58) | protein interactions | 159686 | 14 | 1 | 19454 | 50 |
NAV2 |
3.540e-02 | -3.34 | GAGE1 (G antigen 1) | protein interactions | 2543 | 14 | 1 | 19454 | 50 |
PRKG1 |
3.540e-02 | -3.34 | CHAT (choline O-acetyltransferase) | protein interactions | 1103 | 14 | 1 | 19454 | 50 |
CAMK2G |
3.540e-02 | -3.34 | SPRR2D (small proline rich protein 2D) | protein interactions | 6703 | 14 | 1 | 19454 | 50 |
PPP2R2B |
3.540e-02 | -3.34 | DACT2 (dishevelled binding antagonist of beta catenin 2) | protein interactions | 168002 | 14 | 1 | 19454 | 50 |
CAMK2G |
3.540e-02 | -3.34 | RHEBL1 (RHEB like 1) | protein interactions | 121268 | 14 | 1 | 19454 | 50 |
BMPR1B |
3.540e-02 | -3.34 | JMJD7-PLA2G4B (JMJD7-PLA2G4B readthrough) | protein interactions | 8681 | 14 | 1 | 19454 | 50 |
PPP2R2B |
3.540e-02 | -3.34 | Ssbp1 (single-stranded DNA binding protein 1) | protein interactions | 381760 | 14 | 1 | 19454 | 50 |
TNRC6A |
3.540e-02 | -3.34 | Tecpr2 (tectonin beta-propeller repeat containing 2) | protein interactions | 104859 | 14 | 1 | 19454 | 50 |
DST |
3.540e-02 | -3.34 | BOD1L2 (biorientation of chromosomes in cell division 1 like 2) | protein interactions | 284257 | 14 | 1 | 19454 | 50 |
FMN2 |
3.540e-02 | -3.34 | TPSAB1 (tryptase alpha/beta 1) | protein interactions | 7177 | 14 | 1 | 19454 | 50 |
CAMK2G |
3.544e-02 | -3.34 | bHLH_dom | interpro domains | IPR011598 | 112 | 2 | 18521 | 49 |
NPAS3,HIF3A |
3.544e-02 | -3.34 | HLH_DNA-bd_sf | interpro domains | IPR036638 | 112 | 2 | 18521 | 49 |
HIF3A,NPAS3 |
3.553e-02 | -3.34 | GBD_FH3 | prosite domains | PS51232 | 11 | 1 | 12186 | 40 |
DAAM2 |
3.553e-02 | -3.34 | GATA_ZN_FINGER_2 | prosite domains | PS50114 | 11 | 1 | 12186 | 40 |
TRPS1 |
3.553e-02 | -3.34 | LIPOCALIN | prosite domains | PS00213 | 11 | 1 | 12186 | 40 |
PTGDS |
3.564e-02 | -3.33 | SH3 Domains | gene3d domains | 2.30.30.40 | 223 | 3 | 14470 | 47 |
MACF1,DST,SORBS1 |
3.574e-02 | -3.33 | human chr11q25 | chromosome location | human chr11q25 | 19 | 1 | 26134 | 50 |
NTM |
3.574e-02 | -3.33 | human chr5p15.2 | chromosome location | human chr5p15.2 | 19 | 1 | 26134 | 50 |
CTNND2 |
3.593e-02 | -3.33 | skin-upper_leg-malignant_melanoma | COSMIC cancer mutations | skin-upper_leg-malignant_melanoma | 850 | 6 | 16828 | 49 |
PCDH9,DCLK1,GLIS3,HIF3A,FMN2,ERBB4 |
3.596e-02 | -3.33 | SH3 | prosite domains | PS50002 | 222 | 3 | 12186 | 40 |
MACF1,DST,SORBS1 |
3.603e-02 | -3.32 | stomach-adenocarcinoma | COSMIC cancer mutations | stomach-adenocarcinoma | 4101 | 18 | 16828 | 49 |
ERBB4,DST,DCLK1,PCDH9,SLC1A2,FMN2,CTNND2,MACF1,NAV2,NRG3,TRPS1,CDH20,QKI,PPP2R2B,ARAP2,MGAT4C,RFX4,WDR49 |
3.606e-02 | -3.32 | Passive transport by Aquaporins | REACTOME pathways | R-HSA-432047 | 13 | 1 | 10285 | 29 |
AQP4 |
3.627e-02 | -3.32 | Transport of inorganic cations/anions and amino acids/oligopeptides | REACTOME pathways | R-HSA-425393 | 107 | 2 | 10285 | 29 |
SLC1A2,SLC25A18 |
3.636e-02 | -3.31 | GATA | pfam domains | PF00320 | 14 | 1 | 17795 | 47 |
TRPS1 |
3.636e-02 | -3.31 | MIP | pfam domains | PF00230 | 14 | 1 | 17795 | 47 |
AQP4 |
3.636e-02 | -3.31 | Zip | pfam domains | PF02535 | 14 | 1 | 17795 | 47 |
SLC39A11 |
3.637e-02 | -3.31 | Cellular responses to stress | REACTOME pathways | R-HSA-2262752 | 451 | 4 | 10285 | 29 |
CAMK2G,RPS6KA2,HIF3A,TNRC6A |
3.642e-02 | -3.31 | MIP | interpro domains | IPR000425 | 14 | 1 | 18521 | 49 |
AQP4 |
3.642e-02 | -3.31 | ZIP | interpro domains | IPR003689 | 14 | 1 | 18521 | 49 |
SLC39A11 |
3.642e-02 | -3.31 | Aquaporin-like | interpro domains | IPR023271 | 14 | 1 | 18521 | 49 |
AQP4 |
3.642e-02 | -3.31 | PPP1R9A (protein phosphatase 1 regulatory subunit 9A) | protein interactions | 55607 | 117 | 2 | 19454 | 50 |
DCLK1,DCLK2 |
3.647e-02 | -3.31 | phosphorus metabolic process | biological process | GO:0006793 | 1707 | 9 | 18204 | 49 |
RPS6KA2,ERBB4,TTN,ADCY2,DCLK2,CAMK2G,BMPR1B,DCLK1,PRKG1 |
3.660e-02 | -3.31 | Cadherin-like_dom | interpro domains | IPR002126 | 114 | 2 | 18521 | 49 |
CDH20,PCDH9 |
3.666e-02 | -3.31 | Interleukin-2 signaling | REACTOME pathways | R-HSA-451927 | 262 | 3 | 10285 | 29 |
NRG3,CAMK2G,ERBB4 |
3.668e-02 | -3.31 | CAV1 (caveolin 1) | protein interactions | 857 | 719 | 5 | 19454 | 50 |
DST,DTNA,FMN2,MACF1,RPS6KA2 |
3.670e-02 | -3.30 | cell morphogenesis | biological process | GO:0000902 | 687 | 5 | 18204 | 49 |
CDH20,BMPR1B,DCLK1,CTNND2,PRKG1 |
3.673e-02 | -3.30 | calcium ion binding | molecular function | GO:0005509 | 683 | 5 | 18094 | 49 |
PCDH9,DST,TTN,MACF1,RYR3 |
3.676e-02 | -3.30 | heterocyclic compound binding | molecular function | GO:1901363 | 2263 | 11 | 18094 | 49 |
DCLK2,CAMK2G,NAV2,BMPR1B,DCLK1,RPS6KA2,ADCY2,PRKG1,IQCA1,ERBB4,TTN |
3.702e-02 | -3.30 | Signalling to ERKs | REACTOME pathways | R-HSA-187687 | 263 | 3 | 10285 | 29 |
NRG3,ERBB4,CAMK2G |
3.704e-02 | -3.30 | cerebrospinal fluid circulation | biological process | GO:0090660 | 14 | 1 | 18204 | 49 |
AQP4 |
3.704e-02 | -3.30 | negative regulation of oligodendrocyte differentiation | biological process | GO:0048715 | 14 | 1 | 18204 | 49 |
DAAM2 |
3.704e-02 | -3.30 | neurotransmitter receptor localization to postsynaptic specialization membrane | biological process | GO:0099645 | 14 | 1 | 18204 | 49 |
ERBB4 |
3.704e-02 | -3.30 | regulation of skeletal muscle adaptation | biological process | GO:0014733 | 14 | 1 | 18204 | 49 |
CAMK2G |
3.704e-02 | -3.30 | cellular response to purine-containing compound | biological process | GO:0071415 | 14 | 1 | 18204 | 49 |
RYR3 |
3.704e-02 | -3.30 | protein localization to postsynaptic specialization membrane | biological process | GO:0099633 | 14 | 1 | 18204 | 49 |
ERBB4 |
3.704e-02 | -3.30 | cellular response to forskolin | biological process | GO:1904322 | 14 | 1 | 18204 | 49 |
ADCY2 |
3.704e-02 | -3.30 | glutathione biosynthetic process | biological process | GO:0006750 | 14 | 1 | 18204 | 49 |
SLC1A2 |
3.704e-02 | -3.30 | response to forskolin | biological process | GO:1904321 | 14 | 1 | 18204 | 49 |
ADCY2 |
3.717e-02 | -3.29 | developmental cell growth | biological process | GO:0048588 | 113 | 2 | 18204 | 49 |
DCLK1,PRKG1 |
3.721e-02 | -3.29 | central_nervous_system-hypothalamus-glioma-astrocytoma_Grade_I | COSMIC cancer mutations | central_nervous_system-hypothalamus-glioma-astrocytoma_Grade_I | 13 | 1 | 16828 | 49 |
QKI |
3.727e-02 | -3.29 | microtubule minus-end binding | molecular function | GO:0051011 | 14 | 1 | 18094 | 49 |
MACF1 |
3.729e-02 | -3.29 | soft_tissue-striated_muscle-rhabdomyosarcoma-embryonal | COSMIC cancer mutations | soft_tissue-striated_muscle-rhabdomyosarcoma-embryonal | 2659 | 13 | 16828 | 49 |
AQP4,RYR3,ARAP2,GLIS3,CTNND2,FMN2,NAV2,MACF1,ADCY2,CAMK2G,TRPM3,SORBS1,NPAS3 |
3.729e-02 | -3.29 | embryonal | COSMIC cancer mutations | embryonal | 2659 | 13 | 16828 | 49 |
CTNND2,FMN2,NAV2,MACF1,ADCY2,CAMK2G,TRPM3,SORBS1,NPAS3,AQP4,RYR3,ARAP2,GLIS3 |
3.755e-02 | -3.28 | MAPK1 (mitogen-activated protein kinase 1) | protein interactions | 5594 | 493 | 4 | 19454 | 50 |
RPS6KA2,TRPS1,LIFR,TTN |
3.756e-02 | -3.28 | RBM7 (RNA binding motif protein 7) | protein interactions | 10179 | 119 | 2 | 19454 | 50 |
PPP2R2B,QKI |
3.756e-02 | -3.28 | ITGB4 (integrin subunit beta 4) | protein interactions | 3691 | 119 | 2 | 19454 | 50 |
TNRC6A,DST |
3.773e-02 | -3.28 | FCERI mediated MAPK activation | REACTOME pathways | R-HSA-2871796 | 265 | 3 | 10285 | 29 |
NRG3,CAMK2G,ERBB4 |
3.775e-02 | -3.28 | skin-malignant_melanoma | COSMIC cancer mutations | skin-malignant_melanoma | 15741 | 49 | 16828 | 49 |
MGAT4C,ARAP2,TRPS1,PTGDS,DAAM2,HPSE2,NTM,DPP10,BMPR1B,NPAS3,SORBS1,TRPM3,RYR3,WDR49,PPP2R2B,CDH20,ABR,GFAP,DTNA,MACF1,SLC1A2,LIFR,DST,ADCY2,ERBB4,TNRC6A,RPS6KA2,AQP4,PITPNC1,CTNND2,FMN2,PCDH9,LSAMP,DCLK1,SLC39A11,RFX4,DCLK2,SLC25A18,QKI,GLIS3,MSI2,PRKG1,NRG3,NAV2,SLC14A1,HIF3A,SOX5,IQCA1,CAMK2G |
3.777e-02 | -3.28 | regulation of circadian rhythm | biological process | GO:0042752 | 114 | 2 | 18204 | 49 |
PTGDS,PRKG1 |
3.778e-02 | -3.28 | Cadherin-like_sf | interpro domains | IPR015919 | 116 | 2 | 18521 | 49 |
CDH20,PCDH9 |
3.780e-02 | -3.28 | axolemma | cellular component | GO:0030673 | 15 | 1 | 19108 | 49 |
SLC1A2 |
3.788e-02 | -3.27 | PCSK1N (proprotein convertase subtilisin/kexin type 1 inhibitor) | protein interactions | 27344 | 15 | 1 | 19454 | 50 |
MGAT4C |
3.788e-02 | -3.27 | IGSF1 (immunoglobulin superfamily member 1) | protein interactions | 3547 | 15 | 1 | 19454 | 50 |
BMPR1B |
3.788e-02 | -3.27 | NPR1 (natriuretic peptide receptor 1) | protein interactions | 4881 | 15 | 1 | 19454 | 50 |
PRKG1 |
3.788e-02 | -3.27 | Melanogenesis | KEGG pathways | hsa04916 | 101 | 2 | 7161 | 22 |
ADCY2,CAMK2G |
3.788e-02 | -3.27 | Melanogenesis | KEGG pathways | ko04916 | 101 | 2 | 7161 | 22 |
CAMK2G,ADCY2 |
3.788e-02 | -3.27 | neuron projection development | biological process | GO:0031175 | 693 | 5 | 18204 | 49 |
GFAP,BMPR1B,DCLK1,CTNND2,PRKG1 |
3.799e-02 | -3.27 | PROTEIN_KINASE_TYR | prosite domains | PS00109 | 94 | 2 | 12186 | 40 |
ERBB4,TTN |
3.810e-02 | -3.27 | YTHDF1 (YTH N6-methyladenosine RNA binding protein F1) | protein interactions | 54915 | 289 | 3 | 19454 | 50 |
TNRC6A,QKI,RPS6KA2 |
3.814e-02 | -3.27 | EYA2 (EYA transcriptional coactivator and phosphatase 2) | protein interactions | 2139 | 120 | 2 | 19454 | 50 |
TRPS1,TNRC6A |
3.814e-02 | -3.27 | PJA1 (praja ring finger ubiquitin ligase 1) | protein interactions | 64219 | 120 | 2 | 19454 | 50 |
ABR,SLC25A18 |
3.814e-02 | -3.27 | FHL1 (four and a half LIM domains 1) | protein interactions | 2273 | 120 | 2 | 19454 | 50 |
TTN,MACF1 |
3.814e-02 | -3.27 | HNRNPA1L2 (heterogeneous nuclear ribonucleoprotein A1 like 2) | protein interactions | 144983 | 120 | 2 | 19454 | 50 |
TTN,MGAT4C |
3.819e-02 | -3.27 | membrane raft | cellular component | GO:0045121 | 290 | 3 | 19108 | 49 |
SLC1A2,SORBS1,ADCY2 |
3.830e-02 | -3.26 | - | gene3d domains | 3.10.450.50 | 12 | 1 | 14470 | 47 |
CAMK2G |
3.837e-02 | -3.26 | cell growth | biological process | GO:0016049 | 115 | 2 | 18204 | 49 |
PRKG1,DCLK1 |
3.837e-02 | -3.26 | fatty acid biosynthetic process | biological process | GO:0006633 | 115 | 2 | 18204 | 49 |
PTGDS,QKI |
3.857e-02 | -3.26 | Glucagon signaling pathway | KEGG pathways | ko04922 | 102 | 2 | 7161 | 22 |
ADCY2,CAMK2G |
3.857e-02 | -3.26 | Glucagon signaling pathway | KEGG pathways | hsa04922 | 102 | 2 | 7161 | 22 |
ADCY2,CAMK2G |
3.870e-02 | -3.25 | CNMP_BINDING_2 | prosite domains | PS00889 | 12 | 1 | 12186 | 40 |
PRKG1 |
3.878e-02 | -3.25 | actin filament organization | biological process | GO:0007015 | 278 | 3 | 18204 | 49 |
FMN2,TTN,SORBS1 |
3.885e-02 | -3.25 | membrane microdomain | cellular component | GO:0098857 | 292 | 3 | 19108 | 49 |
SORBS1,SLC1A2,ADCY2 |
3.897e-02 | -3.24 | NTF2-like_dom_sf | interpro domains | IPR032710 | 15 | 1 | 18521 | 49 |
CAMK2G |
3.897e-02 | -3.24 | Znf_GATA | interpro domains | IPR000679 | 15 | 1 | 18521 | 49 |
TRPS1 |
3.930e-02 | -3.24 | A2ML1 (alpha-2-macroglobulin like 1) | protein interactions | 144568 | 122 | 2 | 19454 | 50 |
PPP2R2B,SLC39A11 |
3.943e-02 | -3.23 | EIF4ENIF1 (eukaryotic translation initiation factor 4E nuclear import factor 1) | protein interactions | 56478 | 293 | 3 | 19454 | 50 |
TNRC6A,DST,QKI |
3.943e-02 | -3.23 | human chr10q23.1 | chromosome location | human chr10q23.1 | 21 | 1 | 26134 | 50 |
NRG3 |
3.954e-02 | -3.23 | RET signaling | REACTOME pathways | R-HSA-8853659 | 270 | 3 | 10285 | 29 |
ERBB4,CAMK2G,NRG3 |
3.964e-02 | -3.23 | pyramidal neuron differentiation | biological process | GO:0021859 | 15 | 1 | 18204 | 49 |
DCLK2 |
3.964e-02 | -3.23 | neuroblast division | biological process | GO:0055057 | 15 | 1 | 18204 | 49 |
SOX5 |
3.964e-02 | -3.23 | negative regulation of amino acid transport | biological process | GO:0051956 | 15 | 1 | 18204 | 49 |
PRKG1 |
3.964e-02 | -3.23 | regulation of neuron projection arborization | biological process | GO:0150011 | 15 | 1 | 18204 | 49 |
MACF1 |
3.964e-02 | -3.23 | response to caffeine | biological process | GO:0031000 | 15 | 1 | 18204 | 49 |
RYR3 |
3.964e-02 | -3.23 | positive regulation of glycogen biosynthetic process | biological process | GO:0045725 | 15 | 1 | 18204 | 49 |
SORBS1 |
3.964e-02 | -3.23 | sarcoplasmic reticulum calcium ion transport | biological process | GO:0070296 | 15 | 1 | 18204 | 49 |
RYR3 |
3.964e-02 | -3.23 | regulation of circadian sleep/wake cycle, sleep | biological process | GO:0045187 | 15 | 1 | 18204 | 49 |
PTGDS |
3.964e-02 | -3.23 | protein homotrimerization | biological process | GO:0070207 | 15 | 1 | 18204 | 49 |
SLC1A2 |
3.964e-02 | -3.23 | regulation of nuclear-transcribed mRNA poly(A) tail shortening | biological process | GO:0060211 | 15 | 1 | 18204 | 49 |
TNRC6A |
3.964e-02 | -3.23 | regulation of inositol phosphate biosynthetic process | biological process | GO:0010919 | 15 | 1 | 18204 | 49 |
PRKG1 |
3.964e-02 | -3.23 | collateral sprouting | biological process | GO:0048668 | 15 | 1 | 18204 | 49 |
PRKG1 |
3.972e-02 | -3.23 | microtubule binding | molecular function | GO:0008017 | 279 | 3 | 18094 | 49 |
MACF1,DCLK2,DST |
3.983e-02 | -3.22 | positive regulation of protein localization | biological process | GO:1903829 | 480 | 4 | 18204 | 49 |
TTN,SORBS1,DPP10,ERBB4 |
3.988e-02 | -3.22 | C4-dicarboxylate transmembrane transporter activity | molecular function | GO:0015556 | 15 | 1 | 18094 | 49 |
SLC25A18 |
3.988e-02 | -3.22 | 3'-5' DNA helicase activity | molecular function | GO:0043138 | 15 | 1 | 18094 | 49 |
NAV2 |
3.988e-02 | -3.22 | phosphatidylglycerol binding | molecular function | GO:1901611 | 15 | 1 | 18094 | 49 |
PITPNC1 |
3.988e-02 | -3.22 | protein-containing complex destabilizing activity | molecular function | GO:0140776 | 15 | 1 | 18094 | 49 |
IQCA1 |
3.988e-02 | -3.22 | muscle alpha-actinin binding | molecular function | GO:0051371 | 15 | 1 | 18094 | 49 |
TTN |
3.988e-02 | -3.22 | ITPR1 (inositol 1,4,5-trisphosphate receptor type 1) | protein interactions | 3708 | 123 | 2 | 19454 | 50 |
CAMK2G,PRKG1 |
3.991e-02 | -3.22 | Interleukin-3, 5 and GM-CSF signaling | REACTOME pathways | R-HSA-512988 | 271 | 3 | 10285 | 29 |
CAMK2G,ERBB4,NRG3 |
4.002e-02 | -3.22 | solute:monoatomic cation symporter activity | molecular function | GO:0015294 | 117 | 2 | 18094 | 49 |
SLC25A18,SLC1A2 |
4.002e-02 | -3.22 | calcium channel activity | molecular function | GO:0005262 | 117 | 2 | 18094 | 49 |
TRPM3,RYR3 |
4.015e-02 | -3.22 | rhabdomyosarcoma | COSMIC cancer mutations | rhabdomyosarcoma | 4150 | 18 | 16828 | 49 |
NPAS3,DCLK1,TRPM3,SORBS1,ADCY2,TNRC6A,CAMK2G,TRPS1,NAV2,MACF1,CTNND2,FMN2,GLIS3,PPP2R2B,ARAP2,CDH20,RYR3,AQP4 |
4.020e-02 | -3.21 | MAPRE1 (microtubule associated protein RP/EB family member 1) | protein interactions | 22919 | 504 | 4 | 19454 | 50 |
NAV2,MACF1,DST,CAMK2G |
4.020e-02 | -3.21 | synapse assembly | biological process | GO:0007416 | 118 | 2 | 18204 | 49 |
NRG3,ERBB4 |
4.022e-02 | -3.21 | ErbB receptor signaling network | Pathway Interaction DB | erbb_network_pathway | 13 | 1 | 2226 | 7 |
NRG3 |
4.035e-02 | -3.21 | ADAM18 (ADAM metallopeptidase domain 18) | protein interactions | 8749 | 16 | 1 | 19454 | 50 |
RPS6KA2 |
4.035e-02 | -3.21 | CNTFR (ciliary neurotrophic factor receptor) | protein interactions | 1271 | 16 | 1 | 19454 | 50 |
LIFR |
4.035e-02 | -3.21 | KLHL25 (kelch like family member 25) | protein interactions | 64410 | 16 | 1 | 19454 | 50 |
RPS6KA2 |
4.035e-02 | -3.21 | GABRR1 (gamma-aminobutyric acid type A receptor subunit rho1) | protein interactions | 2569 | 16 | 1 | 19454 | 50 |
PRKG1 |
4.035e-02 | -3.21 | TMEM134 (transmembrane protein 134) | protein interactions | 80194 | 16 | 1 | 19454 | 50 |
ERBB4 |
4.035e-02 | -3.21 | Prkcz (protein kinase C, zeta) | protein interactions | 18762 | 16 | 1 | 19454 | 50 |
DST |
4.035e-02 | -3.21 | AMMECR1L (AMMECR1 like) | protein interactions | 83607 | 16 | 1 | 19454 | 50 |
MACF1 |
4.035e-02 | -3.21 | CAMK1G (calcium/calmodulin dependent protein kinase IG) | protein interactions | 57172 | 16 | 1 | 19454 | 50 |
CAMK2G |
4.035e-02 | -3.21 | IFFO2 (intermediate filament family orphan 2) | protein interactions | 126917 | 16 | 1 | 19454 | 50 |
GFAP |
4.035e-02 | -3.21 | CASTOR2 (cytosolic arginine sensor for mTORC1 subunit 2) | protein interactions | 729438 | 16 | 1 | 19454 | 50 |
DST |
4.035e-02 | -3.21 | CNTNAP2 (contactin associated protein 2) | protein interactions | 26047 | 16 | 1 | 19454 | 50 |
MACF1 |
4.035e-02 | -3.21 | ORM2 (orosomucoid 2) | protein interactions | 5005 | 16 | 1 | 19454 | 50 |
PPP2R2B |
4.035e-02 | -3.21 | DUS1L (dihydrouridine synthase 1 like) | protein interactions | 64118 | 16 | 1 | 19454 | 50 |
CAMK2G |
4.047e-02 | -3.21 | CEBPA (CCAAT enhancer binding protein alpha) | protein interactions | 1050 | 124 | 2 | 19454 | 50 |
MACF1,GFAP |
4.054e-02 | -3.21 | Wnt signaling pathway | biological process | GO:0016055 | 283 | 3 | 18204 | 49 |
CTNND2,DAAM2,MACF1 |
4.079e-02 | -3.20 | SP7 (Sp7 transcription factor) | protein interactions | 121340 | 297 | 3 | 19454 | 50 |
QKI,TRPS1,SOX5 |
4.106e-02 | -3.19 | TCHP (trichoplein keratin filament binding) | protein interactions | 84260 | 125 | 2 | 19454 | 50 |
TNRC6A,GFAP |
4.106e-02 | -3.19 | SLAMF1 (signaling lymphocytic activation molecule family member 1) | protein interactions | 6504 | 125 | 2 | 19454 | 50 |
LIFR,SLC39A11 |
4.106e-02 | -3.19 | CARD10 (caspase recruitment domain family member 10) | protein interactions | 29775 | 125 | 2 | 19454 | 50 |
GFAP,PTGDS |
4.118e-02 | -3.19 | skin-extremity-malignant_melanoma | COSMIC cancer mutations | skin-extremity-malignant_melanoma | 1875 | 10 | 16828 | 49 |
HPSE2,FMN2,RYR3,WDR49,ARAP2,ERBB4,ADCY2,CDH20,PITPNC1,PCDH9 |
4.121e-02 | -3.19 | ZnF_GATA | smart domains | SM00401 | 12 | 1 | 9717 | 34 |
TRPS1 |
4.127e-02 | -3.19 | human chr2q31.2 | chromosome location | human chr2q31.2 | 22 | 1 | 26134 | 50 |
TTN |
4.127e-02 | -3.19 | human chr3q13.31 | chromosome location | human chr3q13.31 | 22 | 1 | 26134 | 50 |
LSAMP |
4.131e-02 | -3.19 | extremity | COSMIC cancer mutations | extremity | 1876 | 10 | 16828 | 49 |
PCDH9,PITPNC1,CDH20,ERBB4,ADCY2,ARAP2,WDR49,RYR3,FMN2,HPSE2 |
4.138e-02 | -3.18 | neuron projection morphogenesis | biological process | GO:0048812 | 486 | 4 | 18204 | 49 |
BMPR1B,PRKG1,DCLK1,CTNND2 |
4.146e-02 | -3.18 | upper_leg | COSMIC cancer mutations | upper_leg | 880 | 6 | 16828 | 49 |
HIF3A,FMN2,PCDH9,DCLK1,GLIS3,ERBB4 |
4.150e-02 | -3.18 | N-Glycan antennae elongation | REACTOME pathways | R-HSA-975577 | 15 | 1 | 10285 | 29 |
MGAT4C |
4.150e-02 | -3.18 | Inhibition of adenylate cyclase pathway | REACTOME pathways | R-HSA-997269 | 15 | 1 | 10285 | 29 |
ADCY2 |
4.150e-02 | -3.18 | Synthesis of Prostaglandins (PG) and Thromboxanes (TX) | REACTOME pathways | R-HSA-2162123 | 15 | 1 | 10285 | 29 |
PTGDS |
4.150e-02 | -3.18 | Adenylate cyclase inhibitory pathway | REACTOME pathways | R-HSA-170670 | 15 | 1 | 10285 | 29 |
ADCY2 |
4.152e-02 | -3.18 | cNMP-bd_CS | interpro domains | IPR018488 | 16 | 1 | 18521 | 49 |
PRKG1 |
4.178e-02 | -3.18 | NCAM signaling for neurite out-growth | REACTOME pathways | R-HSA-375165 | 276 | 3 | 10285 | 29 |
NRG3,CAMK2G,ERBB4 |
4.207e-02 | -3.17 | catalytic activity, acting on a protein | molecular function | GO:0140096 | 2312 | 11 | 18094 | 49 |
CAMK2G,IQCA1,DCLK2,DPP10,BMPR1B,MGAT4C,ERBB4,RPS6KA2,DCLK1,PRKG1,TTN |
4.208e-02 | -3.17 | mesothelioma | COSMIC cancer mutations | mesothelioma | 4477 | 19 | 16828 | 49 |
RPS6KA2,DCLK2,PPP2R2B,QKI,PITPNC1,DAAM2,HIF3A,FMN2,CTNND2,PRKG1,MSI2,TRPS1,DST,CAMK2G,ERBB4,LIFR,BMPR1B,SOX5,DCLK1 |
4.211e-02 | -3.17 | cell-cell junction | cellular component | GO:0005911 | 513 | 4 | 19108 | 49 |
SORBS1,CTNND2,CDH20,PCDH9 |
4.223e-02 | -3.16 | nonribosomal peptide biosynthetic process | biological process | GO:0019184 | 16 | 1 | 18204 | 49 |
SLC1A2 |
4.223e-02 | -3.16 | asymmetric cell division | biological process | GO:0008356 | 16 | 1 | 18204 | 49 |
SOX5 |
4.226e-02 | -3.16 | PAX9 (paired box 9) | protein interactions | 5083 | 127 | 2 | 19454 | 50 |
QKI,TRPS1 |
4.226e-02 | -3.16 | DES (desmin) | protein interactions | 1674 | 127 | 2 | 19454 | 50 |
DTNA,GFAP |
4.248e-02 | -3.16 | adenylate cyclase activity | molecular function | GO:0004016 | 16 | 1 | 18094 | 49 |
ADCY2 |
4.248e-02 | -3.16 | cGMP binding | molecular function | GO:0030553 | 16 | 1 | 18094 | 49 |
PRKG1 |
4.248e-02 | -3.16 | water channel activity | molecular function | GO:0015250 | 16 | 1 | 18094 | 49 |
AQP4 |
4.270e-02 | -3.15 | plasma membrane bounded cell projection morphogenesis | biological process | GO:0120039 | 491 | 4 | 18204 | 49 |
PRKG1,CTNND2,DCLK1,BMPR1B |
4.271e-02 | -3.15 | muscle cell differentiation | biological process | GO:0042692 | 289 | 3 | 18204 | 49 |
QKI,PRKG1,TTN |
4.282e-02 | -3.15 | hypothalamus | COSMIC cancer mutations | hypothalamus | 15 | 1 | 16828 | 49 |
QKI |
4.282e-02 | -3.15 | MSANTD2 (Myb/SANT DNA binding domain containing 2) | protein interactions | 79684 | 17 | 1 | 19454 | 50 |
SOX5 |
4.282e-02 | -3.15 | Sqstm1 (sequestosome 1) | protein interactions | 18412 | 17 | 1 | 19454 | 50 |
BMPR1B |
4.282e-02 | -3.15 | KRTAP19-3 (keratin associated protein 19-3) | protein interactions | 337970 | 17 | 1 | 19454 | 50 |
CAMK2G |
4.282e-02 | -3.15 | RASL12 (RAS like family 12) | protein interactions | 51285 | 17 | 1 | 19454 | 50 |
BMPR1B |
4.282e-02 | -3.15 | SHD (Src homology 2 domain containing transforming protein D) | protein interactions | 56961 | 17 | 1 | 19454 | 50 |
ERBB4 |
4.282e-02 | -3.15 | PAX4 (paired box 4) | protein interactions | 5078 | 17 | 1 | 19454 | 50 |
NTM |
4.282e-02 | -3.15 | TAGAP (T cell activation RhoGTPase activating protein) | protein interactions | 117289 | 17 | 1 | 19454 | 50 |
DTNA |
4.282e-02 | -3.15 | Pef1 (penta-EF hand domain containing 1) | protein interactions | 67898 | 17 | 1 | 19454 | 50 |
QKI |
4.282e-02 | -3.15 | CLEC4M (C-type lectin domain family 4 member M) | protein interactions | 10332 | 17 | 1 | 19454 | 50 |
GFAP |
4.282e-02 | -3.15 | FAM163B (family with sequence similarity 163 member B) | protein interactions | 642968 | 17 | 1 | 19454 | 50 |
CAMK2G |
4.283e-02 | -3.15 | central_nervous_system-brainstem-glioma-astrocytoma_Grade_III | COSMIC cancer mutations | central_nervous_system-brainstem-glioma-astrocytoma_Grade_III | 113 | 2 | 16828 | 49 |
TNRC6A,ADCY2 |
4.286e-02 | -3.15 | CDCA8 (cell division cycle associated 8) | protein interactions | 55143 | 128 | 2 | 19454 | 50 |
PPP2R2B,DCLK1 |
4.286e-02 | -3.15 | ATF7IP (activating transcription factor 7 interacting protein) | protein interactions | 55729 | 128 | 2 | 19454 | 50 |
SOX5,MACF1 |
4.297e-02 | -3.15 | RAC1 (Rac family small GTPase 1) | protein interactions | 5879 | 1005 | 6 | 19454 | 50 |
DTNA,DST,PPP2R2B,MACF1,FMN2,ARAP2 |
4.311e-02 | -3.14 | human chr2q34 | chromosome location | human chr2q34 | 23 | 1 | 26134 | 50 |
ERBB4 |
4.311e-02 | -3.14 | human chr5p15.31 | chromosome location | human chr5p15.31 | 23 | 1 | 26134 | 50 |
ADCY2 |
4.312e-02 | -3.14 | regulation of multicellular organismal development | biological process | GO:2000026 | 1484 | 8 | 18204 | 49 |
QKI,GFAP,ERBB4,TRPS1,MACF1,DAAM2,BMPR1B,SOX5 |
4.321e-02 | -3.14 | plasma membrane region | cellular component | GO:0098590 | 1278 | 7 | 19108 | 49 |
SORBS1,AQP4,ERBB4,SLC14A1,MACF1,DST,SLC1A2 |
4.321e-02 | -3.14 | CARM1 (coactivator associated arginine methyltransferase 1) | protein interactions | 10498 | 304 | 3 | 19454 | 50 |
QKI,CAMK2G,DTNA |
4.389e-02 | -3.13 | actin cytoskeleton | cellular component | GO:0015629 | 520 | 4 | 19108 | 49 |
FMN2,SORBS1,DST,MACF1 |
4.397e-02 | -3.12 | cardiocyte differentiation | biological process | GO:0035051 | 124 | 2 | 18204 | 49 |
PRKG1,TTN |
4.398e-02 | -3.12 | ZZ | pfam domains | PF00569 | 17 | 1 | 17795 | 47 |
DTNA |
4.404e-02 | -3.12 | cell projection morphogenesis | biological process | GO:0048858 | 496 | 4 | 18204 | 49 |
PRKG1,CTNND2,DCLK1,BMPR1B |
4.406e-02 | -3.12 | PAC | interpro domains | IPR001610 | 17 | 1 | 18521 | 49 |
HIF3A |
4.406e-02 | -3.12 | A/G_cyclase_CS | interpro domains | IPR018297 | 17 | 1 | 18521 | 49 |
ADCY2 |
4.420e-02 | -3.12 | Rap1 signalling | REACTOME pathways | R-HSA-392517 | 16 | 1 | 10285 | 29 |
PRKG1 |
4.420e-02 | -3.12 | PKA activation | REACTOME pathways | R-HSA-163615 | 16 | 1 | 10285 | 29 |
ADCY2 |
4.455e-02 | -3.11 | Glycerol uptake facilitator protein | gene3d domains | 1.20.1080.10 | 14 | 1 | 14470 | 47 |
AQP4 |
4.456e-02 | -3.11 | small molecule binding | molecular function | GO:0036094 | 6197 | 23 | 18094 | 49 |
NAV2,BMPR1B,CAMK2G,PTGDS,ARAP2,PRKG1,DTNA,TRPS1,GLIS3,RPS6KA2,MGAT4C,DCLK1,PCDH9,IQCA1,ERBB4,SLC1A2,RYR3,DST,DCLK2,ADCY2,MACF1,TTN,PITPNC1 |
4.459e-02 | -3.11 | regulation of anatomical structure size | biological process | GO:0090066 | 498 | 4 | 18204 | 49 |
PRKG1,DAAM2,AQP4,MACF1 |
4.461e-02 | -3.11 | actomyosin structure organization | biological process | GO:0031032 | 125 | 2 | 18204 | 49 |
TTN,SORBS1 |
4.461e-02 | -3.11 | mammary gland development | biological process | GO:0030879 | 125 | 2 | 18204 | 49 |
ERBB4,NRG3 |
4.464e-02 | -3.11 | MINTRINSICP | prints domains | PR00783 | 14 | 1 | 5227 | 17 |
AQP4 |
4.481e-02 | -3.11 | protein trimerization | biological process | GO:0070206 | 17 | 1 | 18204 | 49 |
SLC1A2 |
4.481e-02 | -3.11 | preganglionic parasympathetic fiber development | biological process | GO:0021783 | 17 | 1 | 18204 | 49 |
NAV2 |
4.481e-02 | -3.11 | positive regulation of glycogen metabolic process | biological process | GO:0070875 | 17 | 1 | 18204 | 49 |
SORBS1 |
4.481e-02 | -3.11 | cellular response to ATP | biological process | GO:0071318 | 17 | 1 | 18204 | 49 |
RYR3 |
4.481e-02 | -3.11 | mammary gland epithelial cell differentiation | biological process | GO:0060644 | 17 | 1 | 18204 | 49 |
ERBB4 |
4.507e-02 | -3.10 | ductal_carcinoma | COSMIC cancer mutations | ductal_carcinoma | 15798 | 49 | 16828 | 49 |
SLC25A18,QKI,GLIS3,SLC39A11,RFX4,DCLK2,SOX5,IQCA1,CAMK2G,MSI2,PRKG1,NRG3,NAV2,SLC14A1,HIF3A,PITPNC1,RPS6KA2,AQP4,PCDH9,DCLK1,LSAMP,CTNND2,FMN2,PPP2R2B,ABR,CDH20,WDR49,RYR3,SLC1A2,LIFR,DST,ADCY2,ERBB4,TNRC6A,GFAP,DTNA,MACF1,MGAT4C,ARAP2,BMPR1B,DPP10,NPAS3,TRPM3,SORBS1,TRPS1,PTGDS,DAAM2,HPSE2,NTM |
4.519e-02 | -3.10 | protein phosphatase type 2A complex | cellular component | GO:0000159 | 18 | 1 | 19108 | 49 |
PPP2R2B |
4.529e-02 | -3.09 | ADAT2 (adenosine deaminase tRNA specific 2) | protein interactions | 134637 | 18 | 1 | 19454 | 50 |
NAV2 |
4.529e-02 | -3.09 | NKIRAS1 (NFKB inhibitor interacting Ras like 1) | protein interactions | 28512 | 18 | 1 | 19454 | 50 |
BMPR1B |
4.529e-02 | -3.09 | SERTAD4 (SERTA domain containing 4) | protein interactions | 56256 | 18 | 1 | 19454 | 50 |
PPP2R2B |
4.529e-02 | -3.09 | Cnot2 (CCR4-NOT transcription complex, subunit 2) | protein interactions | 72068 | 18 | 1 | 19454 | 50 |
MACF1 |
4.529e-02 | -3.09 | TTC29 (tetratricopeptide repeat domain 29) | protein interactions | 83894 | 18 | 1 | 19454 | 50 |
MACF1 |
4.529e-02 | -3.09 | PTGFR (prostaglandin F receptor) | protein interactions | 5737 | 18 | 1 | 19454 | 50 |
PTGDS |
4.529e-02 | -3.09 | ORF45 (ORF45) | protein interactions | 4961474 | 18 | 1 | 19454 | 50 |
RPS6KA2 |
4.529e-02 | -3.09 | IRGC (immunity related GTPase cinema) | protein interactions | 56269 | 18 | 1 | 19454 | 50 |
RPS6KA2 |
4.529e-02 | -3.09 | OPCML (opioid binding protein/cell adhesion molecule like) | protein interactions | 4978 | 18 | 1 | 19454 | 50 |
NTM |
4.529e-02 | -3.09 | KLHL1 (kelch like family member 1) | protein interactions | 57626 | 18 | 1 | 19454 | 50 |
BMPR1B |
4.529e-02 | -3.09 | SELL (selectin L) | protein interactions | 6402 | 18 | 1 | 19454 | 50 |
PRKG1 |
4.529e-02 | -3.09 | Tgfbr1 (transforming growth factor, beta receptor I) | protein interactions | 21812 | 18 | 1 | 19454 | 50 |
BMPR1B |
4.530e-02 | -3.09 | SUDS3 (SDS3 homolog, SIN3A corepressor complex component) | protein interactions | 64426 | 132 | 2 | 19454 | 50 |
RPS6KA2,PPP2R2B |
4.530e-02 | -3.09 | HAL (histidine ammonia-lyase) | protein interactions | 3034 | 132 | 2 | 19454 | 50 |
SLC39A11,PPP2R2B |
4.531e-02 | -3.09 | positive regulation of nervous system development | biological process | GO:0051962 | 296 | 3 | 18204 | 49 |
QKI,GFAP,MACF1 |
4.561e-02 | -3.09 | eye-uveal_tract-malignant_melanoma-epithelioid | COSMIC cancer mutations | eye-uveal_tract-malignant_melanoma-epithelioid | 16 | 1 | 16828 | 49 |
TNRC6A |
4.569e-02 | -3.09 | carboxylic acid transport | biological process | GO:0046942 | 297 | 3 | 18204 | 49 |
SLC25A18,SLC1A2,GFAP |
4.569e-02 | -3.09 | Cholinergic synapse | KEGG pathways | hsa04725 | 112 | 2 | 7161 | 22 |
ADCY2,CAMK2G |
4.591e-02 | -3.08 | NES (nestin) | protein interactions | 10763 | 133 | 2 | 19454 | 50 |
TNRC6A,GFAP |
4.604e-02 | -3.08 | SLC-mediated transmembrane transport | REACTOME pathways | R-HSA-425407 | 287 | 3 | 10285 | 29 |
SLC14A1,SLC1A2,SLC25A18 |
4.607e-02 | -3.08 | organic acid transport | biological process | GO:0015849 | 298 | 3 | 18204 | 49 |
SLC1A2,GFAP,SLC25A18 |
4.624e-02 | -3.07 | PK_Tyr_Ser-Thr | pfam domains | PF07714 | 130 | 2 | 17795 | 47 |
ERBB4,BMPR1B |
4.629e-02 | -3.07 | LPA4-mediated signaling events | Pathway Interaction DB | lpa4_pathway | 15 | 1 | 2226 | 7 |
ADCY2 |
4.629e-02 | -3.07 | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha | Pathway Interaction DB | hif1apathway | 15 | 1 | 2226 | 7 |
HIF3A |
4.649e-02 | -3.07 | MFAP5-mediated ovarian cancer cell motility and invasiveness | WikiPathways | WP3301 | 12 | 1 | 5310 | 21 |
RYR3 |
4.649e-02 | -3.07 | Bone Morphogenic Protein (BMP) Signalling and Regulation | WikiPathways | WP1425 | 12 | 1 | 5310 | 21 |
BMPR1B |
4.651e-02 | -3.07 | Guanylate_cyc | pfam domains | PF00211 | 18 | 1 | 17795 | 47 |
ADCY2 |
4.653e-02 | -3.07 | NUFIP1 (nuclear FMR1 interacting protein 1) | protein interactions | 26747 | 134 | 2 | 19454 | 50 |
DCLK1,NTM |
4.654e-02 | -3.07 | channel activity | molecular function | GO:0015267 | 502 | 4 | 18094 | 49 |
SLC14A1,TRPM3,AQP4,RYR3 |
4.654e-02 | -3.07 | nitrogen compound transport | biological process | GO:0071705 | 1507 | 8 | 18204 | 49 |
SLC1A2,CAMK2G,MACF1,SLC25A18,QKI,GFAP,FMN2,SLC14A1 |
4.659e-02 | -3.07 | A/G_cyclase | interpro domains | IPR001054 | 18 | 1 | 18521 | 49 |
ADCY2 |
4.659e-02 | -3.07 | Furin_repeat | interpro domains | IPR006212 | 18 | 1 | 18521 | 49 |
ERBB4 |
4.659e-02 | -3.07 | Nucleotide_cyclase | interpro domains | IPR029787 | 18 | 1 | 18521 | 49 |
ADCY2 |
4.682e-02 | -3.06 | passive transmembrane transporter activity | molecular function | GO:0022803 | 503 | 4 | 18094 | 49 |
SLC14A1,TRPM3,AQP4,RYR3 |
4.690e-02 | -3.06 | PKA activation in glucagon signalling | REACTOME pathways | R-HSA-164378 | 17 | 1 | 10285 | 29 |
ADCY2 |
4.690e-02 | -3.06 | Unblocking of NMDA receptor, glutamate binding and activation | REACTOME pathways | R-HSA-438066 | 17 | 1 | 10285 | 29 |
CAMK2G |
4.690e-02 | -3.06 | CREB phosphorylation through the activation of CaMKII | REACTOME pathways | R-HSA-442729 | 17 | 1 | 10285 | 29 |
CAMK2G |
4.690e-02 | -3.06 | PKA-mediated phosphorylation of CREB | REACTOME pathways | R-HSA-111931 | 17 | 1 | 10285 | 29 |
ADCY2 |
4.716e-02 | -3.05 | MTNR1B (melatonin receptor 1B) | protein interactions | 4544 | 135 | 2 | 19454 | 50 |
DST,MACF1 |
4.716e-02 | -3.05 | FAM83H (family with sequence similarity 83 member H) | protein interactions | 286077 | 135 | 2 | 19454 | 50 |
GFAP,PPP2R2B |
4.718e-02 | -3.05 | Glutamatergic synapse | KEGG pathways | ko04724 | 114 | 2 | 7161 | 22 |
ADCY2,SLC1A2 |
4.718e-02 | -3.05 | Glutamatergic synapse | KEGG pathways | hsa04724 | 114 | 2 | 7161 | 22 |
SLC1A2,ADCY2 |
4.722e-02 | -3.05 | central_nervous_system-brain-glioma-astrocytoma_Grade_IV | COSMIC cancer mutations | central_nervous_system-brain-glioma-astrocytoma_Grade_IV | 15813 | 49 | 16828 | 49 |
CAMK2G,SOX5,IQCA1,SLC14A1,NAV2,HIF3A,PRKG1,MSI2,NRG3,QKI,GLIS3,SLC25A18,DCLK2,SLC39A11,RFX4,PCDH9,LSAMP,DCLK1,FMN2,CTNND2,PITPNC1,RPS6KA2,AQP4,DST,ERBB4,ADCY2,TNRC6A,LIFR,SLC1A2,MACF1,DTNA,GFAP,PPP2R2B,CDH20,ABR,WDR49,RYR3,TRPM3,SORBS1,NPAS3,DPP10,BMPR1B,HPSE2,DAAM2,PTGDS,NTM,TRPS1,ARAP2,MGAT4C |
4.727e-02 | -3.05 | regulation of cellular localization | biological process | GO:0060341 | 983 | 6 | 18204 | 49 |
DCLK2,ERBB4,DPP10,TTN,SORBS1,DCLK1 |
4.737e-02 | -3.05 | circulatory system process | biological process | GO:0003013 | 508 | 4 | 18204 | 49 |
SLC1A2,NAV2,TTN,PRKG1 |
4.738e-02 | -3.05 | positive regulation of circadian rhythm | biological process | GO:0042753 | 18 | 1 | 18204 | 49 |
PRKG1 |
4.738e-02 | -3.05 | negative regulation of platelet activation | biological process | GO:0010544 | 18 | 1 | 18204 | 49 |
PRKG1 |
4.738e-02 | -3.05 | copper ion transport | biological process | GO:0006825 | 18 | 1 | 18204 | 49 |
SLC39A11 |
4.738e-02 | -3.05 | dendritic spine morphogenesis | biological process | GO:0060997 | 18 | 1 | 18204 | 49 |
CTNND2 |
4.738e-02 | -3.05 | maintenance of cell polarity | biological process | GO:0030011 | 18 | 1 | 18204 | 49 |
DST |
4.738e-02 | -3.05 | cardiac myofibril assembly | biological process | GO:0055003 | 18 | 1 | 18204 | 49 |
TTN |
4.738e-02 | -3.05 | mitotic chromosome condensation | biological process | GO:0007076 | 18 | 1 | 18204 | 49 |
TTN |
4.744e-02 | -3.05 | kidney-carcinoma-renal_cell_carcinoma | COSMIC cancer mutations | kidney-carcinoma-renal_cell_carcinoma | 4535 | 19 | 16828 | 49 |
PITPNC1,QKI,PPP2R2B,DCLK2,RPS6KA2,DCLK1,PCDH9,LIFR,BMPR1B,SOX5,CAMK2G,ERBB4,PRKG1,MSI2,TRPS1,HIF3A,CTNND2,MACF1,DAAM2 |
4.744e-02 | -3.05 | renal_cell_carcinoma | COSMIC cancer mutations | renal_cell_carcinoma | 4535 | 19 | 16828 | 49 |
DCLK2,RPS6KA2,PITPNC1,QKI,PPP2R2B,TRPS1,MSI2,PRKG1,CTNND2,HIF3A,DAAM2,MACF1,DCLK1,SOX5,BMPR1B,PCDH9,LIFR,ERBB4,CAMK2G |
4.754e-02 | -3.05 | ZYX (zyxin) | protein interactions | 7791 | 316 | 3 | 19454 | 50 |
TNRC6A,MACF1,SORBS1 |
4.761e-02 | -3.04 | postsynaptic density | cellular component | GO:0014069 | 317 | 3 | 19108 | 49 |
CTNND2,ERBB4,DCLK1 |
4.766e-02 | -3.04 | heparan sulfate proteoglycan binding | molecular function | GO:0043395 | 18 | 1 | 18094 | 49 |
HPSE2 |
4.766e-02 | -3.04 | GABA receptor binding | molecular function | GO:0050811 | 18 | 1 | 18094 | 49 |
ERBB4 |
4.766e-02 | -3.04 | transmembrane receptor protein tyrosine kinase activator activity | molecular function | GO:0030297 | 18 | 1 | 18094 | 49 |
NRG3 |
4.766e-02 | -3.04 | intracellularly gated calcium channel activity | molecular function | GO:0015278 | 18 | 1 | 18094 | 49 |
RYR3 |
4.766e-02 | -3.04 | phosphatidylcholine transporter activity | molecular function | GO:0008525 | 18 | 1 | 18094 | 49 |
PITPNC1 |
4.774e-02 | -3.04 | HBEGF (heparin binding EGF like growth factor) | protein interactions | 1839 | 19 | 1 | 19454 | 50 |
ERBB4 |
4.774e-02 | -3.04 | Mtx1 (metaxin 1) | protein interactions | 17827 | 19 | 1 | 19454 | 50 |
CAMK2G |
4.774e-02 | -3.04 | CNTNAP4 (contactin associated protein family member 4) | protein interactions | 85445 | 19 | 1 | 19454 | 50 |
MACF1 |
4.774e-02 | -3.04 | RRAD (RRAD, Ras related glycolysis inhibitor and calcium channel regulator) | protein interactions | 6236 | 19 | 1 | 19454 | 50 |
CAMK2G |
4.774e-02 | -3.04 | LTC4S (leukotriene C4 synthase) | protein interactions | 4056 | 19 | 1 | 19454 | 50 |
CAMK2G |
4.774e-02 | -3.04 | ZNF532 (zinc finger protein 532) | protein interactions | 55205 | 19 | 1 | 19454 | 50 |
ERBB4 |
4.774e-02 | -3.04 | PDP2 (pyruvate dehydrogenase phosphatase catalytic subunit 2) | protein interactions | 57546 | 19 | 1 | 19454 | 50 |
GFAP |
4.774e-02 | -3.04 | KCNF1 (potassium voltage-gated channel modifier subfamily F member 1) | protein interactions | 3754 | 19 | 1 | 19454 | 50 |
GFAP |
4.774e-02 | -3.04 | RIT2 (Ras like without CAAX 2) | protein interactions | 6014 | 19 | 1 | 19454 | 50 |
DTNA |
4.774e-02 | -3.04 | SPZ1 (spermatogenic leucine zipper 1) | protein interactions | 84654 | 19 | 1 | 19454 | 50 |
DTNA |
4.774e-02 | -3.04 | PLA2G4E (phospholipase A2 group IVE) | protein interactions | 123745 | 19 | 1 | 19454 | 50 |
PPP2R2B |
4.809e-02 | -3.03 | N-glycan biosynthesis, complex type | KEGG pathways | M00075 | 16 | 1 | 7161 | 22 |
MGAT4C |
4.809e-02 | -3.03 | N-glycan biosynthesis, complex type | KEGG pathways | hsa_M00075 | 16 | 1 | 7161 | 22 |
MGAT4C |
4.809e-02 | -3.03 | cAMP signaling | KEGG pathways | hsa_M00695 | 16 | 1 | 7161 | 22 |
ADCY2 |
4.809e-02 | -3.03 | cAMP signaling | KEGG pathways | M00695 | 16 | 1 | 7161 | 22 |
ADCY2 |
4.834e-02 | -3.03 | Ser-Thr/Tyr_kinase_cat_dom | interpro domains | IPR001245 | 133 | 2 | 18521 | 49 |
BMPR1B,ERBB4 |
4.839e-02 | -3.03 | central_nervous_system-optic_nerve-glioma-astrocytoma_Grade_I | COSMIC cancer mutations | central_nervous_system-optic_nerve-glioma-astrocytoma_Grade_I | 17 | 1 | 16828 | 49 |
QKI |
4.839e-02 | -3.03 | optic_nerve | COSMIC cancer mutations | optic_nerve | 17 | 1 | 16828 | 49 |
QKI |
4.843e-02 | -3.03 | oligoastrocytoma_Grade_II | COSMIC cancer mutations | oligoastrocytoma_Grade_II | 121 | 2 | 16828 | 49 |
DTNA,CDH20 |
4.852e-02 | -3.03 | response to calcium ion | biological process | GO:0051592 | 131 | 2 | 18204 | 49 |
RYR3,TTN |
4.859e-02 | -3.02 | human chr18q12.1 | chromosome location | human chr18q12.1 | 26 | 1 | 26134 | 50 |
DTNA |
4.881e-02 | -3.02 | Ion Channels and Their Functional Role in Vascular Endothelium | SMPDB pathways | SMP0063778 | 17 | 1 | 1369 | 4 |
PRKG1 |
4.886e-02 | -3.02 | IRS-mediated signalling | REACTOME pathways | R-HSA-112399 | 294 | 3 | 10285 | 29 |
ERBB4,CAMK2G,NRG3 |
4.905e-02 | -3.01 | EXOC1 (exocyst complex component 1) | protein interactions | 55763 | 138 | 2 | 19454 | 50 |
MACF1,DST |
4.905e-02 | -3.01 | NFIB (nuclear factor I B) | protein interactions | 4781 | 138 | 2 | 19454 | 50 |
SOX5,TRPS1 |
4.911e-02 | -3.01 | Znf_ZZ | interpro domains | IPR000433 | 19 | 1 | 18521 | 49 |
DTNA |
4.911e-02 | -3.01 | Znf_ZZ_sf | interpro domains | IPR043145 | 19 | 1 | 18521 | 49 |
DTNA |
4.933e-02 | -3.01 | parathyroid | COSMIC cancer mutations | parathyroid | 476 | 4 | 16828 | 49 |
TRPS1,RYR3,PRKG1,MACF1 |
4.960e-02 | -3.00 | cGMP effects | REACTOME pathways | R-HSA-418457 | 18 | 1 | 10285 | 29 |
PRKG1 |
4.961e-02 | -3.00 | CADHERIN_1 | prosite domains | PS00232 | 109 | 2 | 12186 | 40 |
CDH20,PCDH9 |
4.962e-02 | -3.00 | thalamus | COSMIC cancer mutations | thalamus | 284 | 3 | 16828 | 49 |
TNRC6A,QKI,DTNA |
4.968e-02 | -3.00 | KRTAP9-3 (keratin associated protein 9-3) | protein interactions | 83900 | 139 | 2 | 19454 | 50 |
SLC25A18,NTM |
4.968e-02 | -3.00 | MAGI1 (membrane associated guanylate kinase, WW and PDZ domain containing 1) | protein interactions | 9223 | 139 | 2 | 19454 | 50 |
RPS6KA2,DCLK1 |
4.995e-02 | -3.00 | negative regulation of alcohol biosynthetic process | biological process | GO:1902931 | 19 | 1 | 18204 | 49 |
PRKG1 |
4.995e-02 | -3.00 | parasympathetic nervous system development | biological process | GO:0048486 | 19 | 1 | 18204 | 49 |
NAV2 |
4.995e-02 | -3.00 | vascular associated smooth muscle cell differentiation | biological process | GO:0035886 | 19 | 1 | 18204 | 49 |
QKI |
4.995e-02 | -3.00 | regulation of circadian sleep/wake cycle | biological process | GO:0042749 | 19 | 1 | 18204 | 49 |
PTGDS |
4.995e-02 | -3.00 | regulation of glutamate secretion | biological process | GO:0014048 | 19 | 1 | 18204 | 49 |
PRKG1 |
4.995e-02 | -3.00 | regulation of neurotransmitter uptake | biological process | GO:0051580 | 19 | 1 | 18204 | 49 |
GFAP |